id	sid	tid	token	lemma	pos
dpc-1651	1	1	dermatology	dermatology	NOUN
dpc-1651	1	2	:	:	PUNCT
dpc-1651	1	3	practical	practical	ADJ
dpc-1651	1	4	and	and	CCONJ
dpc-1651	1	5	conceptual	conceptual	ADJ
dpc-1651	1	6	dermatology	dermatology	NOUN
dpc-1651	1	7	practical	practical	ADJ
dpc-1651	1	8	&	&	CCONJ
dpc-1651	1	9	conceptual	conceptual	ADJ
dpc-1651	1	10	review	review	NOUN
dpc-1651	1	11	|	|	ADV
dpc-1651	1	12	dermatol	dermatol	ADJ
dpc-1651	1	13	pract	pract	NOUN
dpc-1651	1	14	concept	concept	NOUN
dpc-1651	1	15	.	.	PUNCT
dpc-1651	2	1	2021;11(4):e2021099	2021;11(4):e2021099	NUM
dpc-1651	2	2	1	1	NUM
dpc-1651	2	3	recurrent	recurrent	ADJ
dpc-1651	2	4	aphthous	aphthous	ADJ
dpc-1651	2	5	stomatitis	stomatitis	NOUN
dpc-1651	2	6	:	:	PUNCT
dpc-1651	2	7	treatment	treatment	NOUN
dpc-1651	2	8	and	and	CCONJ
dpc-1651	2	9	management	management	NOUN
dpc-1651	2	10	marco	marco	PROPN
dpc-1651	2	11	manfredini1	manfredini1	PROPN
dpc-1651	2	12	,	,	PUNCT
dpc-1651	2	13	stefania	stefania	PROPN
dpc-1651	2	14	guida1	guida1	PROPN
dpc-1651	2	15	,	,	PUNCT
dpc-1651	2	16	matteo	matteo	PROPN
dpc-1651	2	17	giovani1	giovani1	PROPN
dpc-1651	2	18	,	,	PUNCT
dpc-1651	2	19	nicola	nicola	PROPN
dpc-1651	2	20	lippolis1	lippolis1	PROPN
dpc-1651	2	21	,	,	PUNCT
dpc-1651	2	22	enrico	enrico	PROPN
dpc-1651	2	23	spinas2	spinas2	PROPN
dpc-1651	2	24	,	,	PUNCT
dpc-1651	2	25	francesca	francesca	PROPN
dpc-1651	2	26	farnetani1	farnetani1	PROPN
dpc-1651	2	27	,	,	PUNCT
dpc-1651	2	28	annunziata	annunziata	PROPN
dpc-1651	2	29	dattola3	dattola3	PROPN
dpc-1651	2	30	,	,	PUNCT
dpc-1651	2	31	eleonora	eleonora	PROPN
dpc-1651	2	32	di	di	PROPN
dpc-1651	2	33	matteo3	matteo3	PROPN
dpc-1651	2	34	,	,	PUNCT
dpc-1651	2	35	giovanni	giovanni	PROPN
dpc-1651	2	36	pellacani4	pellacani4	PROPN
dpc-1651	2	37	,	,	PUNCT
dpc-1651	2	38	luca	luca	PROPN
dpc-1651	2	39	giannetti5	giannetti5	PROPN
dpc-1651	2	40	1	1	NUM
dpc-1651	2	41	surgical	surgical	ADJ
dpc-1651	2	42	,	,	PUNCT
dpc-1651	2	43	medical	medical	ADJ
dpc-1651	2	44	and	and	CCONJ
dpc-1651	2	45	dental	dental	ADJ
dpc-1651	2	46	department	department	NOUN
dpc-1651	2	47	of	of	ADP
dpc-1651	2	48	morphological	morphological	ADJ
dpc-1651	2	49	sciences	science	NOUN
dpc-1651	2	50	related	relate	VERB
dpc-1651	2	51	to	to	ADP
dpc-1651	2	52	transplant	transplant	NOUN
dpc-1651	2	53	,	,	PUNCT
dpc-1651	2	54	oncology	oncology	NOUN
dpc-1651	2	55	and	and	CCONJ
dpc-1651	2	56	regenerative	regenerative	ADJ
dpc-1651	2	57	medicine	medicine	NOUN
dpc-1651	2	58	,	,	PUNCT
dpc-1651	2	59	university	university	NOUN
dpc-1651	2	60	of	of	ADP
dpc-1651	2	61	modena	modena	PROPN
dpc-1651	2	62	and	and	CCONJ
dpc-1651	2	63	reggio	reggio	PROPN
dpc-1651	2	64	emilia	emilia	PROPN
dpc-1651	2	65	,	,	PUNCT
dpc-1651	2	66	modena	modena	PROPN
dpc-1651	2	67	,	,	PUNCT
dpc-1651	2	68	italy	italy	PROPN
dpc-1651	2	69	2	2	NUM
dpc-1651	2	70	department	department	NOUN
dpc-1651	2	71	of	of	ADP
dpc-1651	2	72	surgical	surgical	ADJ
dpc-1651	2	73	sciences	science	NOUN
dpc-1651	2	74	,	,	PUNCT
dpc-1651	2	75	university	university	NOUN
dpc-1651	2	76	of	of	ADP
dpc-1651	2	77	cagliari	cagliari	PROPN
dpc-1651	2	78	,	,	PUNCT
dpc-1651	2	79	cagliari	cagliari	PROPN
dpc-1651	2	80	,	,	PUNCT
dpc-1651	2	81	italy	italy	PROPN
dpc-1651	2	82	3	3	NUM
dpc-1651	2	83	dermatology	dermatology	NOUN
dpc-1651	2	84	clinic	clinic	NOUN
dpc-1651	2	85	,	,	PUNCT
dpc-1651	2	86	department	department	NOUN
dpc-1651	2	87	of	of	ADP
dpc-1651	2	88	systems	system	NOUN
dpc-1651	2	89	medicine	medicine	NOUN
dpc-1651	2	90	,	,	PUNCT
dpc-1651	2	91	tor	tor	NOUN
dpc-1651	2	92	vergata	vergata	PROPN
dpc-1651	2	93	university	university	PROPN
dpc-1651	2	94	,	,	PUNCT
dpc-1651	2	95	rome	rome	PROPN
dpc-1651	2	96	,	,	PUNCT
dpc-1651	2	97	italy	italy	PROPN
dpc-1651	2	98	4	4	NUM
dpc-1651	2	99	dermatology	dermatology	NOUN
dpc-1651	2	100	clinic	clinic	NOUN
dpc-1651	2	101	,	,	PUNCT
dpc-1651	2	102	department	department	NOUN
dpc-1651	2	103	of	of	ADP
dpc-1651	2	104	clinical	clinical	ADJ
dpc-1651	2	105	internal	internal	ADJ
dpc-1651	2	106	,	,	PUNCT
dpc-1651	2	107	anesthesiological	anesthesiological	ADJ
dpc-1651	2	108	and	and	CCONJ
dpc-1651	2	109	cardiovascular	cardiovascular	ADJ
dpc-1651	2	110	sciences	science	NOUN
dpc-1651	2	111	,	,	PUNCT
dpc-1651	2	112	sapienza	sapienza	PROPN
dpc-1651	2	113	university	university	PROPN
dpc-1651	2	114	of	of	ADP
dpc-1651	2	115	rome	rome	PROPN
dpc-1651	2	116	,	,	PUNCT
dpc-1651	2	117	rome	rome	PROPN
dpc-1651	2	118	,	,	PUNCT
dpc-1651	2	119	italy	italy	PROPN
dpc-1651	2	120	5	5	NUM
dpc-1651	2	121	surgical	surgical	ADJ
dpc-1651	2	122	,	,	PUNCT
dpc-1651	2	123	medical	medical	ADJ
dpc-1651	2	124	and	and	CCONJ
dpc-1651	2	125	dental	dental	ADJ
dpc-1651	2	126	department	department	NOUN
dpc-1651	2	127	of	of	ADP
dpc-1651	2	128	morphological	morphological	ADJ
dpc-1651	2	129	sciences	science	NOUN
dpc-1651	2	130	related	relate	VERB
dpc-1651	2	131	to	to	ADP
dpc-1651	2	132	transplant	transplant	NOUN
dpc-1651	2	133	,	,	PUNCT
dpc-1651	2	134	oncology	oncology	NOUN
dpc-1651	2	135	and	and	CCONJ
dpc-1651	2	136	regenerative	regenerative	ADJ
dpc-1651	2	137	medicine	medicine	NOUN
dpc-1651	2	138	,	,	PUNCT
dpc-1651	2	139	dental	dental	ADJ
dpc-1651	2	140	unit	unit	NOUN
dpc-1651	2	141	,	,	PUNCT
dpc-1651	2	142	university	university	PROPN
dpc-1651	2	143	of	of	ADP
dpc-1651	2	144	modena	modena	PROPN
dpc-1651	2	145	and	and	CCONJ
dpc-1651	2	146	reggio	reggio	PROPN
dpc-1651	2	147	emilia	emilia	PROPN
dpc-1651	2	148	,	,	PUNCT
dpc-1651	2	149	modena	modena	PROPN
dpc-1651	2	150	,	,	PUNCT
dpc-1651	2	151	italy	italy	PROPN
dpc-1651	2	152	key	key	ADJ
dpc-1651	2	153	words	word	NOUN
dpc-1651	2	154	:	:	PUNCT
dpc-1651	2	155	oral	oral	ADJ
dpc-1651	2	156	,	,	PUNCT
dpc-1651	2	157	aphthae	aphthae	NOUN
dpc-1651	2	158	,	,	PUNCT
dpc-1651	2	159	recurrent	recurrent	ADJ
dpc-1651	2	160	,	,	PUNCT
dpc-1651	2	161	autoimmune	autoimmune	ADJ
dpc-1651	2	162	,	,	PUNCT
dpc-1651	2	163	treatment	treatment	NOUN
dpc-1651	2	164	,	,	PUNCT
dpc-1651	2	165	herpetiform	herpetiform	NOUN
dpc-1651	2	166	,	,	PUNCT
dpc-1651	2	167	aphthosis	aphthosis	NOUN
dpc-1651	2	168	,	,	PUNCT
dpc-1651	2	169	behçet	behçet	ADJ
dpc-1651	2	170	disease	disease	NOUN
dpc-1651	2	171	citation	citation	NOUN
dpc-1651	2	172	:	:	PUNCT
dpc-1651	3	1	manfredini	manfredini	PROPN
dpc-1651	3	2	m	m	PROPN
dpc-1651	3	3	,	,	PUNCT
dpc-1651	3	4	guida	guida	PROPN
dpc-1651	3	5	s	s	PROPN
dpc-1651	3	6	,	,	PUNCT
dpc-1651	3	7	giovani	giovani	PROPN
dpc-1651	3	8	m	m	PROPN
dpc-1651	3	9	,	,	PUNCT
dpc-1651	3	10	lippolis	lippoli	VERB
dpc-1651	3	11	n	n	CCONJ
dpc-1651	3	12	,	,	PUNCT
dpc-1651	3	13	spinas	spinas	PROPN
dpc-1651	3	14	e	e	PROPN
dpc-1651	3	15	,	,	PUNCT
dpc-1651	4	1	farnetani	farnetani	PROPN
dpc-1651	4	2	f	f	X
dpc-1651	4	3	,	,	PUNCT
dpc-1651	4	4	dattola	dattola	PROPN
dpc-1651	4	5	a	a	PRON
dpc-1651	4	6	,	,	PUNCT
dpc-1651	4	7	di	di	PROPN
dpc-1651	4	8	matteo	matteo	PROPN
dpc-1651	4	9	e	e	PROPN
dpc-1651	4	10	,	,	PUNCT
dpc-1651	4	11	pellacani	pellacani	VERB
dpc-1651	4	12	g	g	PROPN
dpc-1651	4	13	,	,	PUNCT
dpc-1651	4	14	giannetti	giannetti	NOUN
dpc-1651	4	15	l.	l.	PROPN
dpc-1651	4	16	recurrent	recurrent	PROPN
dpc-1651	4	17	aphthous	aphthous	ADJ
dpc-1651	4	18	stomatitis	stomatitis	NOUN
dpc-1651	4	19	:	:	PUNCT
dpc-1651	4	20	treatment	treatment	NOUN
dpc-1651	4	21	and	and	CCONJ
dpc-1651	4	22	management	management	NOUN
dpc-1651	4	23	.	.	PUNCT
dpc-1651	5	1	dermatol	dermatol	NOUN
dpc-1651	5	2	pract	pract	PROPN
dpc-1651	5	3	concept	concept	NOUN
dpc-1651	5	4	.	.	PUNCT
dpc-1651	6	1	2021;11(4):e2021099	2021;11(4):e2021099	X
dpc-1651	6	2	.	.	PUNCT
dpc-1651	6	3	doi	doi	PROPN
dpc-1651	6	4	:	:	PUNCT
dpc-1651	6	5	https://doi.org/10.5826	https://doi.org/10.5826	PROPN
dpc-1651	6	6	/dpc.1104a99	/dpc.1104a99	PUNCT
dpc-1651	6	7	accepted	accept	VERB
dpc-1651	6	8	:	:	PUNCT
dpc-1651	6	9	february	february	PROPN
dpc-1651	6	10	28	28	NUM
dpc-1651	6	11	,	,	PUNCT
dpc-1651	6	12	2021	2021	NUM
dpc-1651	6	13	;	;	PUNCT
dpc-1651	6	14	published	publish	VERB
dpc-1651	6	15	:	:	PUNCT
dpc-1651	6	16	september	september	PROPN
dpc-1651	6	17	,	,	PUNCT
dpc-1651	6	18	2021	2021	NUM
dpc-1651	6	19	copyright	copyright	NOUN
dpc-1651	6	20	:	:	PUNCT
dpc-1651	6	21	©	©	PROPN
dpc-1651	6	22	2021	2021	NUM
dpc-1651	6	23	manfredini	manfredini	NOUN
dpc-1651	6	24	et	et	PROPN
dpc-1651	6	25	al	al	PROPN
dpc-1651	6	26	.	.	PUNCT
dpc-1651	7	1	this	this	PRON
dpc-1651	7	2	is	be	AUX
dpc-1651	7	3	an	an	DET
dpc-1651	7	4	open	open	ADJ
dpc-1651	7	5	-	-	PUNCT
dpc-1651	7	6	access	access	NOUN
dpc-1651	7	7	article	article	NOUN
dpc-1651	7	8	distributed	distribute	VERB
dpc-1651	7	9	under	under	ADP
dpc-1651	7	10	the	the	DET
dpc-1651	7	11	terms	term	NOUN
dpc-1651	7	12	of	of	ADP
dpc-1651	7	13	the	the	DET
dpc-1651	7	14	creative	creative	ADJ
dpc-1651	7	15	commons	common	NOUN
dpc-1651	7	16	attribution	attribution	NOUN
dpc-1651	7	17	license	license	NOUN
dpc-1651	7	18	by	by	ADP
dpc-1651	7	19	-	-	PUNCT
dpc-1651	7	20	nc-4.0	nc-4.0	NOUN
dpc-1651	7	21	,	,	PUNCT
dpc-1651	7	22	which	which	PRON
dpc-1651	7	23	permits	permit	VERB
dpc-1651	7	24	unrestricted	unrestricted	ADJ
dpc-1651	7	25	noncommercial	noncommercial	ADJ
dpc-1651	7	26	use	use	NOUN
dpc-1651	7	27	,	,	PUNCT
dpc-1651	7	28	distribution	distribution	NOUN
dpc-1651	7	29	,	,	PUNCT
dpc-1651	7	30	and	and	CCONJ
dpc-1651	7	31	reproduction	reproduction	NOUN
dpc-1651	7	32	in	in	ADP
dpc-1651	7	33	any	any	DET
dpc-1651	7	34	medium	medium	NOUN
dpc-1651	7	35	,	,	PUNCT
dpc-1651	7	36	provided	provide	VERB
dpc-1651	7	37	the	the	DET
dpc-1651	7	38	original	original	ADJ
dpc-1651	7	39	authors	author	NOUN
dpc-1651	7	40	and	and	CCONJ
dpc-1651	7	41	source	source	NOUN
dpc-1651	7	42	are	be	AUX
dpc-1651	7	43	credited	credit	VERB
dpc-1651	7	44	.	.	PUNCT
dpc-1651	8	1	funding	funding	NOUN
dpc-1651	8	2	:	:	PUNCT
dpc-1651	8	3	none	none	NOUN
dpc-1651	8	4	.	.	PUNCT
dpc-1651	9	1	competing	compete	VERB
dpc-1651	9	2	interests	interest	NOUN
dpc-1651	9	3	:	:	PUNCT
dpc-1651	9	4	the	the	DET
dpc-1651	9	5	authors	author	NOUN
dpc-1651	9	6	have	have	VERB
dpc-1651	9	7	no	no	DET
dpc-1651	9	8	conflicts	conflict	NOUN
dpc-1651	9	9	of	of	ADP
dpc-1651	9	10	interest	interest	NOUN
dpc-1651	9	11	to	to	PART
dpc-1651	9	12	disclose	disclose	VERB
dpc-1651	9	13	.	.	PUNCT
dpc-1651	10	1	authorship	authorship	NOUN
dpc-1651	10	2	:	:	PUNCT
dpc-1651	10	3	all	all	DET
dpc-1651	10	4	authors	author	NOUN
dpc-1651	10	5	have	have	AUX
dpc-1651	10	6	contributed	contribute	VERB
dpc-1651	10	7	significantly	significantly	ADV
dpc-1651	10	8	to	to	ADP
dpc-1651	10	9	this	this	DET
dpc-1651	10	10	publication	publication	NOUN
dpc-1651	10	11	.	.	PUNCT
dpc-1651	11	1	corresponding	correspond	VERB
dpc-1651	11	2	author	author	NOUN
dpc-1651	11	3	:	:	PUNCT
dpc-1651	11	4	marco	marco	PROPN
dpc-1651	11	5	manfredini	manfredini	PROPN
dpc-1651	11	6	,	,	PUNCT
dpc-1651	11	7	md	md	PROPN
dpc-1651	11	8	,	,	PUNCT
dpc-1651	11	9	surgical	surgical	ADJ
dpc-1651	11	10	,	,	PUNCT
dpc-1651	11	11	medical	medical	ADJ
dpc-1651	11	12	and	and	CCONJ
dpc-1651	11	13	dental	dental	ADJ
dpc-1651	11	14	department	department	NOUN
dpc-1651	11	15	of	of	ADP
dpc-1651	11	16	morphological	morphological	ADJ
dpc-1651	11	17	sciences	science	NOUN
dpc-1651	11	18	related	relate	VERB
dpc-1651	11	19	to	to	ADP
dpc-1651	11	20	transplant	transplant	NOUN
dpc-1651	11	21	,	,	PUNCT
dpc-1651	11	22	oncology	oncology	NOUN
dpc-1651	11	23	and	and	CCONJ
dpc-1651	11	24	regenerative	regenerative	ADJ
dpc-1651	11	25	medicine	medicine	NOUN
dpc-1651	11	26	,	,	PUNCT
dpc-1651	11	27	university	university	NOUN
dpc-1651	11	28	of	of	ADP
dpc-1651	11	29	modena	modena	PROPN
dpc-1651	11	30	and	and	CCONJ
dpc-1651	11	31	reggio	reggio	PROPN
dpc-1651	11	32	emilia	emilia	PROPN
dpc-1651	11	33	,	,	PUNCT
dpc-1651	11	34	via	via	ADP
dpc-1651	11	35	università	università	PROPN
dpc-1651	11	36	,	,	PUNCT
dpc-1651	11	37	4	4	NUM
dpc-1651	11	38	,	,	PUNCT
dpc-1651	11	39	modena	modena	PROPN
dpc-1651	11	40	,	,	PUNCT
dpc-1651	11	41	italy	italy	PROPN
dpc-1651	11	42	.	.	PUNCT
dpc-1651	12	1	email	email	NOUN
dpc-1651	12	2	:	:	PUNCT
dpc-1651	12	3	manfredini07@gmail.com	manfredini07@gmail.com	X
dpc-1651	12	4	background	background	NOUN
dpc-1651	12	5	:	:	PUNCT
dpc-1651	12	6	recurrent	recurrent	ADJ
dpc-1651	12	7	aphthous	aphthous	ADJ
dpc-1651	12	8	stomatitis	stomatitis	NOUN
dpc-1651	12	9	consists	consist	VERB
dpc-1651	12	10	of	of	ADP
dpc-1651	12	11	the	the	DET
dpc-1651	12	12	presence	presence	NOUN
dpc-1651	12	13	of	of	ADP
dpc-1651	12	14	abrasions	abrasion	NOUN
dpc-1651	12	15	or	or	CCONJ
dpc-1651	12	16	ulcerations	ulceration	NOUN
dpc-1651	12	17	located	locate	VERB
dpc-1651	12	18	on	on	ADP
dpc-1651	12	19	mucosae	mucosae	PROPN
dpc-1651	12	20	(	(	PUNCT
dpc-1651	12	21	oral	oral	ADJ
dpc-1651	12	22	or	or	CCONJ
dpc-1651	12	23	genital	genital	ADJ
dpc-1651	12	24	)	)	PUNCT
dpc-1651	12	25	.	.	PUNCT
dpc-1651	13	1	objectives	objective	NOUN
dpc-1651	13	2	:	:	PUNCT
dpc-1651	13	3	the	the	DET
dpc-1651	13	4	aim	aim	NOUN
dpc-1651	13	5	of	of	ADP
dpc-1651	13	6	this	this	DET
dpc-1651	13	7	article	article	NOUN
dpc-1651	13	8	is	be	AUX
dpc-1651	13	9	to	to	PART
dpc-1651	13	10	review	review	VERB
dpc-1651	13	11	the	the	DET
dpc-1651	13	12	current	current	ADJ
dpc-1651	13	13	literature	literature	NOUN
dpc-1651	13	14	providing	provide	VERB
dpc-1651	13	15	the	the	DET
dpc-1651	13	16	main	main	ADJ
dpc-1651	13	17	causes	cause	NOUN
dpc-1651	13	18	related	relate	VERB
dpc-1651	13	19	to	to	PART
dpc-1651	13	20	recurrent	recurrent	VERB
dpc-1651	13	21	aphthous	aphthous	ADJ
dpc-1651	13	22	stomatitis	stomatitis	NOUN
dpc-1651	13	23	and	and	CCONJ
dpc-1651	13	24	insights	insight	NOUN
dpc-1651	13	25	into	into	ADP
dpc-1651	13	26	treatment	treatment	NOUN
dpc-1651	13	27	and	and	CCONJ
dpc-1651	13	28	management	management	NOUN
dpc-1651	13	29	of	of	ADP
dpc-1651	13	30	this	this	DET
dpc-1651	13	31	clinical	clinical	ADJ
dpc-1651	13	32	condition	condition	NOUN
dpc-1651	13	33	methods	method	NOUN
dpc-1651	13	34	:	:	PUNCT
dpc-1651	13	35	articles	article	NOUN
dpc-1651	13	36	matching	match	VERB
dpc-1651	13	37	terms	term	NOUN
dpc-1651	13	38	that	that	PRON
dpc-1651	13	39	correlated	correlate	VERB
dpc-1651	13	40	with	with	ADP
dpc-1651	13	41	“	"	PUNCT
dpc-1651	13	42	recurrent	recurrent	ADJ
dpc-1651	13	43	aphthous	aphthous	ADJ
dpc-1651	13	44	stomatitis	stomatitis	NOUN
dpc-1651	13	45	”	"	PUNCT
dpc-1651	13	46	were	be	AUX
dpc-1651	13	47	searched	search	VERB
dpc-1651	13	48	on	on	ADP
dpc-1651	13	49	pubmed	pubmed	PROPN
dpc-1651	13	50	,	,	PUNCT
dpc-1651	13	51	embase	embase	NOUN
dpc-1651	13	52	,	,	PUNCT
dpc-1651	13	53	and	and	CCONJ
dpc-1651	13	54	cochrane	cochrane	NOUN
dpc-1651	13	55	library	library	NOUN
dpc-1651	13	56	and	and	CCONJ
dpc-1651	13	57	selected	select	VERB
dpc-1651	13	58	according	accord	VERB
dpc-1651	13	59	to	to	ADP
dpc-1651	13	60	their	their	PRON
dpc-1651	13	61	pertinence	pertinence	NOUN
dpc-1651	13	62	.	.	PUNCT
dpc-1651	14	1	results	result	NOUN
dpc-1651	14	2	:	:	PUNCT
dpc-1651	14	3	several	several	ADJ
dpc-1651	14	4	forms	form	NOUN
dpc-1651	14	5	of	of	ADP
dpc-1651	14	6	aphthous	aphthous	ADJ
dpc-1651	14	7	stomatitis	stomatitis	NOUN
dpc-1651	14	8	have	have	AUX
dpc-1651	14	9	been	be	AUX
dpc-1651	14	10	described	describe	VERB
dpc-1651	14	11	,	,	PUNCT
dpc-1651	14	12	based	base	VERB
dpc-1651	14	13	on	on	ADP
dpc-1651	14	14	the	the	DET
dpc-1651	14	15	extent	extent	NOUN
dpc-1651	14	16	(	(	PUNCT
dpc-1651	14	17	minor	minor	ADJ
dpc-1651	14	18	,	,	PUNCT
dpc-1651	14	19	major	major	ADJ
dpc-1651	14	20	)	)	PUNCT
dpc-1651	14	21	,	,	PUNCT
dpc-1651	14	22	morphology	morphology	NOUN
dpc-1651	14	23	(	(	PUNCT
dpc-1651	14	24	herpetiform	herpetiform	NOUN
dpc-1651	14	25	)	)	PUNCT
dpc-1651	14	26	and	and	CCONJ
dpc-1651	14	27	associations	association	NOUN
dpc-1651	14	28	to	to	ADP
dpc-1651	14	29	other	other	ADJ
dpc-1651	14	30	signs	sign	NOUN
dpc-1651	14	31	(	(	PUNCT
dpc-1651	14	32	behçet	behçet	NOUN
dpc-1651	14	33	syndrome	syndrome	NOUN
dpc-1651	14	34	or	or	CCONJ
dpc-1651	14	35	more	more	ADV
dpc-1651	14	36	complex	complex	ADJ
dpc-1651	14	37	inflammatory	inflammatory	ADJ
dpc-1651	14	38	syndromes	syndrome	NOUN
dpc-1651	14	39	)	)	PUNCT
dpc-1651	14	40	.	.	PUNCT
dpc-1651	15	1	topical	topical	ADJ
dpc-1651	15	2	as	as	ADV
dpc-1651	15	3	well	well	ADV
dpc-1651	15	4	as	as	ADP
dpc-1651	15	5	systemic	systemic	ADJ
dpc-1651	15	6	treatments	treatment	NOUN
dpc-1651	15	7	have	have	AUX
dpc-1651	15	8	been	be	AUX
dpc-1651	15	9	described	describe	VERB
dpc-1651	15	10	to	to	PART
dpc-1651	15	11	obtain	obtain	VERB
dpc-1651	15	12	a	a	DET
dpc-1651	15	13	faster	fast	ADJ
dpc-1651	15	14	remission	remission	NOUN
dpc-1651	15	15	of	of	ADP
dpc-1651	15	16	the	the	DET
dpc-1651	15	17	aphthosis	aphthosis	NOUN
dpc-1651	15	18	or	or	CCONJ
dpc-1651	15	19	to	to	PART
dpc-1651	15	20	reduce	reduce	VERB
dpc-1651	15	21	associated	associated	ADJ
dpc-1651	15	22	symptoms	symptom	NOUN
dpc-1651	15	23	such	such	ADJ
dpc-1651	15	24	as	as	ADP
dpc-1651	15	25	pain	pain	NOUN
dpc-1651	15	26	.	.	PUNCT
dpc-1651	16	1	conclusions	conclusion	NOUN
dpc-1651	16	2	:	:	PUNCT
dpc-1651	16	3	recurrent	recurrent	ADJ
dpc-1651	16	4	aphthous	aphthous	ADJ
dpc-1651	16	5	stomatitis	stomatitis	NOUN
dpc-1651	16	6	can	can	AUX
dpc-1651	16	7	have	have	AUX
dpc-1651	16	8	a	a	DET
dpc-1651	16	9	mild	mild	ADJ
dpc-1651	16	10	-	-	PUNCT
dpc-1651	16	11	to	to	ADP
dpc-1651	16	12	-	-	PUNCT
dpc-1651	16	13	severe	severe	ADJ
dpc-1651	16	14	clinical	clinical	ADJ
dpc-1651	16	15	appearance	appearance	NOUN
dpc-1651	16	16	,	,	PUNCT
dpc-1651	16	17	being	be	AUX
dpc-1651	16	18	mainly	mainly	ADV
dpc-1651	16	19	localized	localize	VERB
dpc-1651	16	20	on	on	ADP
dpc-1651	16	21	the	the	DET
dpc-1651	16	22	oral	oral	ADJ
dpc-1651	16	23	mucosa	mucosa	NOUN
dpc-1651	16	24	or	or	CCONJ
dpc-1651	16	25	at	at	ADP
dpc-1651	16	26	the	the	DET
dpc-1651	16	27	level	level	NOUN
dpc-1651	16	28	of	of	ADP
dpc-1651	16	29	the	the	DET
dpc-1651	16	30	genital	genital	ADJ
dpc-1651	16	31	area	area	NOUN
dpc-1651	16	32	.	.	PUNCT
dpc-1651	17	1	different	different	ADJ
dpc-1651	17	2	strategies	strategy	NOUN
dpc-1651	17	3	have	have	AUX
dpc-1651	17	4	been	be	AUX
dpc-1651	17	5	described	describe	VERB
dpc-1651	17	6	so	so	ADV
dpc-1651	17	7	far	far	ADV
dpc-1651	17	8	for	for	ADP
dpc-1651	17	9	its	its	PRON
dpc-1651	17	10	management	management	NOUN
dpc-1651	17	11	and	and	CCONJ
dpc-1651	17	12	treatment	treatment	NOUN
dpc-1651	17	13	.	.	PUNCT
dpc-1651	18	1	abstract	abstract	ADJ
dpc-1651	18	2	2	2	NUM
dpc-1651	18	3	review	review	NOUN
dpc-1651	18	4	|	|	ADV
dpc-1651	18	5	dermatol	dermatol	ADJ
dpc-1651	18	6	pract	pract	NOUN
dpc-1651	18	7	concept	concept	NOUN
dpc-1651	18	8	.	.	PUNCT
dpc-1651	19	1	2021;11(4):e2021099	2021;11(4):e2021099	NUM
dpc-1651	19	2	introduction	introduction	NOUN
dpc-1651	19	3	aphtha	aphtha	ADJ
dpc-1651	19	4	is	be	AUX
dpc-1651	19	5	defined	define	VERB
dpc-1651	19	6	as	as	ADP
dpc-1651	19	7	a	a	DET
dpc-1651	19	8	round	round	ADJ
dpc-1651	19	9	abrasion	abrasion	NOUN
dpc-1651	19	10	or	or	CCONJ
dpc-1651	19	11	ulceration	ulceration	NOUN
dpc-1651	19	12	of	of	ADP
dpc-1651	19	13	oral	oral	ADJ
dpc-1651	19	14	(	(	PUNCT
dpc-1651	19	15	or	or	CCONJ
dpc-1651	19	16	genital	genital	ADJ
dpc-1651	19	17	)	)	PUNCT
dpc-1651	19	18	mucosa	mucosa	NOUN
dpc-1651	19	19	with	with	ADP
dpc-1651	19	20	a	a	DET
dpc-1651	19	21	2to	2to	ADJ
dpc-1651	19	22	5	5	NUM
dpc-1651	19	23	-	-	PUNCT
dpc-1651	19	24	mm	mm	NOUN
dpc-1651	19	25	diameter	diameter	NOUN
dpc-1651	20	1	[	[	X
dpc-1651	20	2	1	1	NUM
dpc-1651	20	3	]	]	PUNCT
dpc-1651	20	4	.	.	PUNCT
dpc-1651	21	1	lesions	lesion	NOUN
dpc-1651	21	2	are	be	AUX
dpc-1651	21	3	usually	usually	ADV
dpc-1651	21	4	covered	cover	VERB
dpc-1651	21	5	by	by	ADP
dpc-1651	21	6	a	a	DET
dpc-1651	21	7	fibrinous	fibrinous	ADJ
dpc-1651	21	8	pseudomembrane	pseudomembrane	NOUN
dpc-1651	21	9	,	,	PUNCT
dpc-1651	21	10	may	may	AUX
dpc-1651	21	11	be	be	AUX
dpc-1651	21	12	single	single	ADJ
dpc-1651	21	13	or	or	CCONJ
dpc-1651	21	14	multiple	multiple	ADJ
dpc-1651	21	15	,	,	PUNCT
dpc-1651	21	16	and	and	CCONJ
dpc-1651	21	17	usually	usually	ADV
dpc-1651	21	18	resolve	resolve	VERB
dpc-1651	21	19	in	in	ADP
dpc-1651	21	20	10	10	NUM
dpc-1651	21	21	-	-	SYM
dpc-1651	21	22	15	15	NUM
dpc-1651	21	23	days	day	NOUN
dpc-1651	21	24	,	,	PUNCT
dpc-1651	21	25	but	but	CCONJ
dpc-1651	21	26	generally	generally	ADV
dpc-1651	21	27	recur	recur	VERB
dpc-1651	21	28	.	.	PUNCT
dpc-1651	22	1	lesions	lesion	NOUN
dpc-1651	22	2	are	be	AUX
dpc-1651	22	3	painful	painful	ADJ
dpc-1651	22	4	and	and	CCONJ
dpc-1651	22	5	are	be	AUX
dpc-1651	22	6	often	often	ADV
dpc-1651	22	7	exacerbated	exacerbate	VERB
dpc-1651	22	8	by	by	ADP
dpc-1651	22	9	food	food	NOUN
dpc-1651	22	10	intake	intake	NOUN
dpc-1651	22	11	[	[	X
dpc-1651	22	12	1	1	NUM
dpc-1651	22	13	]	]	PUNCT
dpc-1651	22	14	.	.	PUNCT
dpc-1651	23	1	a	a	DET
dpc-1651	23	2	specific	specific	ADJ
dpc-1651	23	3	etiologic	etiologic	ADJ
dpc-1651	23	4	factor	factor	NOUN
dpc-1651	23	5	has	have	AUX
dpc-1651	23	6	not	not	PART
dpc-1651	23	7	been	be	AUX
dpc-1651	23	8	identified	identify	VERB
dpc-1651	23	9	yet	yet	ADV
dpc-1651	23	10	.	.	PUNCT
dpc-1651	24	1	there	there	PRON
dpc-1651	24	2	are	be	VERB
dpc-1651	24	3	at	at	ADV
dpc-1651	24	4	least	least	ADJ
dpc-1651	24	5	5	5	NUM
dpc-1651	24	6	forms	form	NOUN
dpc-1651	24	7	of	of	ADP
dpc-1651	24	8	aphthosis	aphthosis	NOUN
dpc-1651	24	9	[	[	X
dpc-1651	24	10	1,2	1,2	NUM
dpc-1651	24	11	]	]	SYM
dpc-1651	24	12	:	:	PUNCT
dpc-1651	24	13	1	1	X
dpc-1651	24	14	.	.	X
dpc-1651	24	15	recurrent	recurrent	ADJ
dpc-1651	24	16	aphthosis	aphthosis	NOUN
dpc-1651	24	17	minor	minor	ADJ
dpc-1651	24	18	2	2	NUM
dpc-1651	24	19	.	.	PUNCT
dpc-1651	24	20	recurrent	recurrent	ADJ
dpc-1651	24	21	aphthosis	aphthosis	NOUN
dpc-1651	24	22	ulcer	ulcer	NOUN
dpc-1651	24	23	minor	minor	ADJ
dpc-1651	24	24	(	(	PUNCT
dpc-1651	24	25	mikulicz	mikulicz	NOUN
dpc-1651	24	26	ulcer	ulcer	NOUN
dpc-1651	24	27	)	)	PUNCT
dpc-1651	24	28	3	3	NUM
dpc-1651	24	29	.	.	X
dpc-1651	24	30	recurrent	recurrent	ADJ
dpc-1651	24	31	aphthosis	aphthosis	NOUN
dpc-1651	24	32	ulcer	ulcer	NOUN
dpc-1651	24	33	major	major	NOUN
dpc-1651	24	34	(	(	PUNCT
dpc-1651	24	35	sutton	sutton	PROPN
dpc-1651	24	36	ulcer	ulcer	NOUN
dpc-1651	24	37	)	)	PUNCT
dpc-1651	24	38	4	4	NUM
dpc-1651	24	39	.	.	PUNCT
dpc-1651	24	40	recurrent	recurrent	ADJ
dpc-1651	24	41	herpetiform	herpetiform	NOUN
dpc-1651	24	42	ulcerations	ulceration	NOUN
dpc-1651	24	43	5	5	NUM
dpc-1651	24	44	.	.	PUNCT
dpc-1651	25	1	behçet	behçet	PROPN
dpc-1651	25	2	syndrome	syndrome	PROPN
dpc-1651	25	3	methods	method	VERB
dpc-1651	25	4	a	a	DET
dpc-1651	25	5	search	search	NOUN
dpc-1651	25	6	on	on	ADP
dpc-1651	25	7	the	the	DET
dpc-1651	25	8	major	major	ADJ
dpc-1651	25	9	medical	medical	ADJ
dpc-1651	25	10	literature	literature	NOUN
dpc-1651	25	11	databases	database	NOUN
dpc-1651	25	12	including	include	VERB
dpc-1651	25	13	pubmed	pubmed	PROPN
dpc-1651	25	14	,	,	PUNCT
dpc-1651	25	15	embase	embase	NOUN
dpc-1651	25	16	and	and	CCONJ
dpc-1651	25	17	cochrane	cochrane	PROPN
dpc-1651	25	18	library	library	NOUN
dpc-1651	25	19	was	be	AUX
dpc-1651	25	20	performed	perform	VERB
dpc-1651	25	21	.	.	PUNCT
dpc-1651	26	1	the	the	DET
dpc-1651	26	2	search	search	NOUN
dpc-1651	26	3	was	be	AUX
dpc-1651	26	4	used	use	VERB
dpc-1651	26	5	the	the	DET
dpc-1651	26	6	following	follow	VERB
dpc-1651	26	7	search	search	NOUN
dpc-1651	26	8	keys	key	NOUN
dpc-1651	26	9	:	:	PUNCT
dpc-1651	26	10	“	"	PUNCT
dpc-1651	26	11	aphtha	aphtha	ADJ
dpc-1651	26	12	”	"	PUNCT
dpc-1651	26	13	and	and	CCONJ
dpc-1651	26	14	“	"	PUNCT
dpc-1651	26	15	recurrent	recurrent	NOUN
dpc-1651	26	16	”	"	PUNCT
dpc-1651	26	17	or	or	CCONJ
dpc-1651	26	18	“	"	PUNCT
dpc-1651	26	19	aphtha	aphtha	ADJ
dpc-1651	26	20	”	"	PUNCT
dpc-1651	26	21	and	and	CCONJ
dpc-1651	26	22	“	"	PUNCT
dpc-1651	26	23	treatment	treatment	NOUN
dpc-1651	26	24	.	.	PUNCT
dpc-1651	26	25	”	"	PUNCT
dpc-1651	27	1	each	each	DET
dpc-1651	27	2	article	article	NOUN
dpc-1651	27	3	reporting	report	VERB
dpc-1651	27	4	relevant	relevant	ADJ
dpc-1651	27	5	information	information	NOUN
dpc-1651	27	6	on	on	ADP
dpc-1651	27	7	the	the	DET
dpc-1651	27	8	pathogenesis	pathogenesis	NOUN
dpc-1651	27	9	as	as	ADV
dpc-1651	27	10	well	well	ADV
dpc-1651	27	11	as	as	ADP
dpc-1651	27	12	the	the	DET
dpc-1651	27	13	management	management	NOUN
dpc-1651	27	14	and	and	CCONJ
dpc-1651	27	15	treatment	treatment	NOUN
dpc-1651	27	16	strategies	strategy	NOUN
dpc-1651	27	17	was	be	AUX
dpc-1651	27	18	considered	consider	VERB
dpc-1651	27	19	,	,	PUNCT
dpc-1651	27	20	and	and	CCONJ
dpc-1651	27	21	the	the	DET
dpc-1651	27	22	main	main	ADJ
dpc-1651	27	23	findings	finding	NOUN
dpc-1651	27	24	were	be	AUX
dpc-1651	27	25	included	include	VERB
dpc-1651	27	26	in	in	ADP
dpc-1651	27	27	the	the	DET
dpc-1651	27	28	current	current	ADJ
dpc-1651	27	29	review	review	NOUN
dpc-1651	27	30	.	.	PUNCT
dpc-1651	28	1	diagnosis	diagnosis	NOUN
dpc-1651	28	2	and	and	CCONJ
dpc-1651	28	3	treatment	treatment	NOUN
dpc-1651	28	4	recurrent	recurrent	ADJ
dpc-1651	28	5	aphthous	aphthous	ADJ
dpc-1651	28	6	stomatitis	stomatitis	NOUN
dpc-1651	28	7	(	(	PUNCT
dpc-1651	28	8	ras	ras	NOUN
dpc-1651	28	9	)	)	PUNCT
dpc-1651	29	1	[	[	X
dpc-1651	29	2	1	1	NUM
dpc-1651	29	3	]	]	PUNCT
dpc-1651	29	4	,	,	PUNCT
dpc-1651	29	5	is	be	AUX
dpc-1651	29	6	a	a	DET
dpc-1651	29	7	common	common	ADJ
dpc-1651	29	8	oral	oral	ADJ
dpc-1651	29	9	disease	disease	NOUN
dpc-1651	29	10	characterized	characterize	VERB
dpc-1651	29	11	by	by	ADP
dpc-1651	29	12	multiple	multiple	ADJ
dpc-1651	29	13	,	,	PUNCT
dpc-1651	29	14	small	small	ADJ
dpc-1651	29	15	,	,	PUNCT
dpc-1651	29	16	round	round	ADJ
dpc-1651	29	17	or	or	CCONJ
dpc-1651	29	18	oval	oval	NOUN
dpc-1651	29	19	mucosal	mucosal	NOUN
dpc-1651	29	20	ulcers	ulcer	NOUN
dpc-1651	29	21	with	with	ADP
dpc-1651	29	22	circumscribed	circumscribed	ADJ
dpc-1651	29	23	margins	margin	NOUN
dpc-1651	29	24	,	,	PUNCT
dpc-1651	29	25	erythematous	erythematous	ADJ
dpc-1651	29	26	haloes	halo	NOUN
dpc-1651	29	27	,	,	PUNCT
dpc-1651	29	28	and	and	CCONJ
dpc-1651	29	29	yellow	yellow	ADJ
dpc-1651	29	30	or	or	CCONJ
dpc-1651	29	31	gray	gray	ADJ
dpc-1651	29	32	floors	floor	NOUN
dpc-1651	29	33	that	that	PRON
dpc-1651	29	34	initially	initially	ADV
dpc-1651	29	35	appear	appear	VERB
dpc-1651	29	36	during	during	ADP
dpc-1651	29	37	childhood	childhood	NOUN
dpc-1651	29	38	or	or	CCONJ
dpc-1651	29	39	adolescence	adolescence	NOUN
dpc-1651	29	40	.	.	PUNCT
dpc-1651	30	1	many	many	ADJ
dpc-1651	30	2	diseases	disease	NOUN
dpc-1651	30	3	[	[	X
dpc-1651	30	4	3	3	NUM
dpc-1651	30	5	-	-	SYM
dpc-1651	30	6	10	10	NUM
dpc-1651	30	7	]	]	PUNCT
dpc-1651	30	8	that	that	PRON
dpc-1651	30	9	affect	affect	VERB
dpc-1651	30	10	the	the	DET
dpc-1651	30	11	oral	oral	ADJ
dpc-1651	30	12	cavity	cavity	NOUN
dpc-1651	30	13	can	can	AUX
dpc-1651	30	14	have	have	VERB
dpc-1651	30	15	similar	similar	ADJ
dpc-1651	30	16	clinical	clinical	ADJ
dpc-1651	30	17	presentations	presentation	NOUN
dpc-1651	30	18	,	,	PUNCT
dpc-1651	30	19	making	make	VERB
dpc-1651	30	20	correct	correct	ADJ
dpc-1651	30	21	diagnosis	diagnosis	NOUN
dpc-1651	30	22	difficult	difficult	ADJ
dpc-1651	30	23	and	and	CCONJ
dpc-1651	30	24	sometimes	sometimes	ADV
dpc-1651	30	25	delaying	delay	VERB
dpc-1651	30	26	therapy	therapy	NOUN
dpc-1651	30	27	.	.	PUNCT
dpc-1651	31	1	unfortunately	unfortunately	ADV
dpc-1651	31	2	,	,	PUNCT
dpc-1651	31	3	the	the	DET
dpc-1651	31	4	etiology	etiology	NOUN
dpc-1651	31	5	of	of	ADP
dpc-1651	31	6	ras	ras	PROPN
dpc-1651	31	7	of	of	ADP
dpc-1651	31	8	is	be	AUX
dpc-1651	31	9	still	still	ADV
dpc-1651	31	10	unknown	unknown	ADJ
dpc-1651	31	11	.	.	PUNCT
dpc-1651	32	1	an	an	DET
dpc-1651	32	2	ras	ras	NOUN
dpc-1651	32	3	diagnosis	diagnosis	NOUN
dpc-1651	32	4	is	be	AUX
dpc-1651	32	5	based	base	VERB
dpc-1651	32	6	on	on	ADP
dpc-1651	32	7	history	history	NOUN
dpc-1651	32	8	and	and	CCONJ
dpc-1651	32	9	clinical	clinical	ADJ
dpc-1651	32	10	findings	finding	NOUN
dpc-1651	32	11	[	[	X
dpc-1651	32	12	2	2	NUM
dpc-1651	32	13	]	]	PUNCT
dpc-1651	32	14	.	.	PUNCT
dpc-1651	33	1	the	the	DET
dpc-1651	33	2	lesions	lesion	NOUN
dpc-1651	33	3	can	can	AUX
dpc-1651	33	4	range	range	VERB
dpc-1651	33	5	from	from	ADP
dpc-1651	33	6	1	1	NUM
dpc-1651	33	7	to	to	ADP
dpc-1651	33	8	several	several	ADJ
dpc-1651	33	9	rounded	rounded	ADJ
dpc-1651	33	10	,	,	PUNCT
dpc-1651	33	11	shallow	shallow	ADJ
dpc-1651	33	12	,	,	PUNCT
dpc-1651	33	13	painful	painful	ADJ
dpc-1651	33	14	ulcers	ulcer	NOUN
dpc-1651	33	15	and	and	CCONJ
dpc-1651	33	16	recur	recur	VERB
dpc-1651	33	17	in	in	ADP
dpc-1651	33	18	bouts	bout	NOUN
dpc-1651	33	19	from	from	ADP
dpc-1651	33	20	a	a	DET
dpc-1651	33	21	few	few	ADJ
dpc-1651	33	22	days	day	NOUN
dpc-1651	33	23	to	to	ADP
dpc-1651	33	24	few	few	ADJ
dpc-1651	33	25	months	month	NOUN
dpc-1651	33	26	.	.	PUNCT
dpc-1651	34	1	there	there	PRON
dpc-1651	34	2	are	be	VERB
dpc-1651	34	3	at	at	ADV
dpc-1651	34	4	least	least	ADJ
dpc-1651	34	5	5	5	NUM
dpc-1651	34	6	forms	form	NOUN
dpc-1651	34	7	of	of	ADP
dpc-1651	34	8	ras	ras	NOUN
dpc-1651	34	9	,	,	PUNCT
dpc-1651	34	10	but	but	CCONJ
dpc-1651	34	11	the	the	DET
dpc-1651	34	12	most	most	ADV
dpc-1651	34	13	common	common	ADJ
dpc-1651	34	14	are	be	AUX
dpc-1651	34	15	minor	minor	ADJ
dpc-1651	34	16	(	(	PUNCT
dpc-1651	34	17	miras	miras	PROPN
dpc-1651	34	18	)	)	PUNCT
dpc-1651	34	19	,	,	PUNCT
dpc-1651	34	20	major	major	ADJ
dpc-1651	34	21	(	(	PUNCT
dpc-1651	34	22	maras	mara	NOUN
dpc-1651	34	23	)	)	PUNCT
dpc-1651	34	24	,	,	PUNCT
dpc-1651	34	25	and	and	CCONJ
dpc-1651	34	26	herpetiformis	herpetiformis	ADJ
dpc-1651	34	27	ulcers	ulcer	NOUN
dpc-1651	34	28	(	(	PUNCT
dpc-1651	34	29	hu	hu	NOUN
dpc-1651	34	30	)	)	PUNCT
dpc-1651	35	1	[	[	X
dpc-1651	35	2	2	2	NUM
dpc-1651	35	3	]	]	PUNCT
dpc-1651	35	4	.	.	PUNCT
dpc-1651	36	1	minor	minor	PROPN
dpc-1651	36	2	ras	ras	PROPN
dpc-1651	36	3	is	be	AUX
dpc-1651	36	4	the	the	DET
dpc-1651	36	5	most	most	ADV
dpc-1651	36	6	frequent	frequent	ADJ
dpc-1651	36	7	,	,	PUNCT
dpc-1651	36	8	and	and	CCONJ
dpc-1651	36	9	it	it	PRON
dpc-1651	36	10	affects	affect	VERB
dpc-1651	36	11	about	about	ADV
dpc-1651	36	12	80	80	NUM
dpc-1651	36	13	%	%	NOUN
dpc-1651	36	14	of	of	ADP
dpc-1651	36	15	patients	patient	NOUN
dpc-1651	36	16	with	with	ADP
dpc-1651	36	17	ras	ras	PROPN
dpc-1651	36	18	.	.	PROPN
dpc-1651	37	1	aphthae	aphthae	NOUN
dpc-1651	37	2	are	be	AUX
dpc-1651	37	3	small	small	ADJ
dpc-1651	37	4	,	,	PUNCT
dpc-1651	37	5	round	round	ADJ
dpc-1651	37	6	or	or	CCONJ
dpc-1651	37	7	oval	oval	NOUN
dpc-1651	37	8	,	,	PUNCT
dpc-1651	37	9	usually	usually	ADV
dpc-1651	37	10	with	with	ADP
dpc-1651	37	11	a	a	DET
dpc-1651	37	12	gray	gray	ADJ
dpc-1651	37	13	-	-	PUNCT
dpc-1651	37	14	white	white	ADJ
dpc-1651	37	15	pseudomembrane	pseudomembrane	NOUN
dpc-1651	37	16	and	and	CCONJ
dpc-1651	37	17	an	an	DET
dpc-1651	37	18	erythematous	erythematous	ADJ
dpc-1651	37	19	halo	halo	NOUN
dpc-1651	37	20	[	[	X
dpc-1651	37	21	1,2	1,2	NUM
dpc-1651	37	22	]	]	PUNCT
dpc-1651	37	23	.	.	PUNCT
dpc-1651	38	1	it	it	PRON
dpc-1651	38	2	usually	usually	ADV
dpc-1651	38	3	occurs	occur	VERB
dpc-1651	38	4	on	on	ADP
dpc-1651	38	5	non	non	ADJ
dpc-1651	38	6	-	-	ADJ
dpc-1651	38	7	keratinized	keratinized	ADJ
dpc-1651	38	8	surfaces	surface	NOUN
dpc-1651	38	9	,	,	PUNCT
dpc-1651	38	10	particularly	particularly	ADV
dpc-1651	38	11	the	the	DET
dpc-1651	38	12	labial	labial	ADJ
dpc-1651	38	13	and	and	CCONJ
dpc-1651	38	14	buccal	buccal	ADJ
dpc-1651	38	15	mucosa	mucosa	NOUN
dpc-1651	38	16	and	and	CCONJ
dpc-1651	38	17	the	the	DET
dpc-1651	38	18	floor	floor	NOUN
dpc-1651	38	19	of	of	ADP
dpc-1651	38	20	the	the	DET
dpc-1651	38	21	mouth	mouth	NOUN
dpc-1651	38	22	,	,	PUNCT
dpc-1651	38	23	although	although	SCONJ
dpc-1651	38	24	it	it	PRON
dpc-1651	38	25	is	be	AUX
dpc-1651	38	26	uncommon	uncommon	ADJ
dpc-1651	38	27	on	on	ADP
dpc-1651	38	28	the	the	DET
dpc-1651	38	29	gingiva	gingiva	NOUN
dpc-1651	38	30	,	,	PUNCT
dpc-1651	38	31	palate	palate	VERB
dpc-1651	38	32	,	,	PUNCT
dpc-1651	38	33	or	or	CCONJ
dpc-1651	38	34	the	the	DET
dpc-1651	38	35	back	back	NOUN
dpc-1651	38	36	of	of	ADP
dpc-1651	38	37	the	the	DET
dpc-1651	38	38	tongue	tongue	NOUN
dpc-1651	39	1	[	[	X
dpc-1651	39	2	1,2	1,2	NUM
dpc-1651	39	3	]	]	PUNCT
dpc-1651	39	4	.	.	PUNCT
dpc-1651	40	1	aphthae	aphthae	NOUN
dpc-1651	40	2	usually	usually	ADV
dpc-1651	40	3	heal	heal	VERB
dpc-1651	40	4	within	within	ADP
dpc-1651	40	5	10	10	NUM
dpc-1651	40	6	-	-	SYM
dpc-1651	40	7	14	14	NUM
dpc-1651	40	8	days	day	NOUN
dpc-1651	41	1	[	[	X
dpc-1651	41	2	2,11,12	2,11,12	NUM
dpc-1651	41	3	]	]	PUNCT
dpc-1651	41	4	.	.	PUNCT
dpc-1651	42	1	marasf	marasf	PROPN
dpc-1651	42	2	is	be	AUX
dpc-1651	42	3	a	a	DET
dpc-1651	42	4	severe	severe	ADJ
dpc-1651	42	5	form	form	NOUN
dpc-1651	42	6	of	of	ADP
dpc-1651	42	7	ras	ras	PROPN
dpc-1651	42	8	that	that	PRON
dpc-1651	42	9	can	can	AUX
dpc-1651	42	10	be	be	AUX
dpc-1651	42	11	observed	observe	VERB
dpc-1651	42	12	in	in	ADP
dpc-1651	42	13	about	about	ADV
dpc-1651	42	14	10	10	NUM
dpc-1651	42	15	%	%	NOUN
dpc-1651	42	16	of	of	ADP
dpc-1651	42	17	patients	patient	NOUN
dpc-1651	42	18	with	with	ADP
dpc-1651	42	19	ras	ras	PROPN
dpc-1651	42	20	.	.	PROPN
dpc-1651	42	21	ulcers	ulcer	NOUN
dpc-1651	42	22	caused	cause	VERB
dpc-1651	42	23	by	by	ADP
dpc-1651	42	24	maras	mara	NOUN
dpc-1651	42	25	can	can	AUX
dpc-1651	42	26	be	be	AUX
dpc-1651	42	27	larger	large	ADJ
dpc-1651	42	28	than	than	ADP
dpc-1651	42	29	1	1	NUM
dpc-1651	42	30	cm	cm	NOUN
dpc-1651	42	31	and	and	CCONJ
dpc-1651	42	32	often	often	ADV
dpc-1651	42	33	develop	develop	VERB
dpc-1651	42	34	on	on	ADP
dpc-1651	42	35	the	the	DET
dpc-1651	42	36	lips	lip	NOUN
dpc-1651	42	37	,	,	PUNCT
dpc-1651	42	38	soft	soft	ADJ
dpc-1651	42	39	palate	palate	NOUN
dpc-1651	42	40	and	and	CCONJ
dpc-1651	42	41	fauces	fauce	NOUN
dpc-1651	42	42	.	.	PUNCT
dpc-1651	43	1	they	they	PRON
dpc-1651	43	2	persist	persist	VERB
dpc-1651	43	3	for	for	ADP
dpc-1651	43	4	figure	figure	NOUN
dpc-1651	43	5	1	1	NUM
dpc-1651	43	6	.	.	PUNCT
dpc-1651	43	7	recurrent	recurrent	ADJ
dpc-1651	43	8	aphthous	aphthous	ADJ
dpc-1651	43	9	stomatitis	stomatitis	NOUN
dpc-1651	43	10	in	in	ADP
dpc-1651	43	11	a	a	DET
dpc-1651	43	12	patient	patient	NOUN
dpc-1651	43	13	with	with	ADP
dpc-1651	43	14	adamantiades	adamantiade	NOUN
dpc-1651	43	15	-	-	PUNCT
dpc-1651	43	16	behçet	behçet	ADJ
dpc-1651	43	17	disease	disease	NOUN
dpc-1651	43	18	.	.	PUNCT
dpc-1651	44	1	up	up	ADP
dpc-1651	44	2	to	to	PART
dpc-1651	44	3	6	6	NUM
dpc-1651	44	4	weeks	week	NOUN
dpc-1651	45	1	.	.	PUNCT
dpc-1651	46	1	maras	mara	NOUN
dpc-1651	46	2	frequently	frequently	ADV
dpc-1651	46	3	has	have	VERB
dpc-1651	46	4	its	its	PRON
dpc-1651	46	5	onset	onset	NOUN
dpc-1651	46	6	after	after	ADP
dpc-1651	46	7	adolescence	adolescence	NOUN
dpc-1651	46	8	,	,	PUNCT
dpc-1651	46	9	is	be	AUX
dpc-1651	46	10	chronic	chronic	ADJ
dpc-1651	46	11	,	,	PUNCT
dpc-1651	46	12	and	and	CCONJ
dpc-1651	46	13	lasts	last	VERB
dpc-1651	46	14	for	for	ADP
dpc-1651	46	15	up	up	ADV
dpc-1651	46	16	20	20	NUM
dpc-1651	46	17	years	year	NOUN
dpc-1651	46	18	or	or	CCONJ
dpc-1651	46	19	more	more	ADJ
dpc-1651	46	20	[	[	X
dpc-1651	46	21	12,13	12,13	NUM
dpc-1651	46	22	]	]	PUNCT
dpc-1651	46	23	.	.	PUNCT
dpc-1651	47	1	herpetiformis	herpetiformis	ADJ
dpc-1651	47	2	ulcers	ulcer	NOUN
dpc-1651	47	3	affect	affect	VERB
dpc-1651	47	4	about	about	ADP
dpc-1651	47	5	1%-10	1%-10	NUM
dpc-1651	47	6	%	%	NOUN
dpc-1651	47	7	of	of	ADP
dpc-1651	47	8	patients	patient	NOUN
dpc-1651	47	9	with	with	ADP
dpc-1651	47	10	ras	ras	PROPN
dpc-1651	47	11	.	.	PROPN
dpc-1651	47	12	up	up	ADP
dpc-1651	47	13	to	to	PART
dpc-1651	47	14	100	100	NUM
dpc-1651	47	15	ulcers	ulcer	NOUN
dpc-1651	47	16	may	may	AUX
dpc-1651	47	17	be	be	AUX
dpc-1651	47	18	present	present	ADJ
dpc-1651	47	19	at	at	ADP
dpc-1651	47	20	the	the	DET
dpc-1651	47	21	same	same	ADJ
dpc-1651	47	22	time	time	NOUN
dpc-1651	47	23	,	,	PUNCT
dpc-1651	47	24	and	and	CCONJ
dpc-1651	47	25	while	while	SCONJ
dpc-1651	47	26	single	single	ADJ
dpc-1651	47	27	lesions	lesion	NOUN
dpc-1651	47	28	measure	measure	VERB
dpc-1651	47	29	only	only	ADV
dpc-1651	47	30	few	few	ADJ
dpc-1651	47	31	millimeters	millimeter	NOUN
dpc-1651	47	32	,	,	PUNCT
dpc-1651	47	33	they	they	PRON
dpc-1651	47	34	tend	tend	VERB
dpc-1651	47	35	to	to	PART
dpc-1651	47	36	coalesce	coalesce	VERB
dpc-1651	47	37	to	to	PART
dpc-1651	47	38	become	become	VERB
dpc-1651	47	39	large	large	ADJ
dpc-1651	47	40	and	and	CCONJ
dpc-1651	47	41	irregular	irregular	ADJ
dpc-1651	47	42	.	.	PUNCT
dpc-1651	48	1	hu	hu	PROPN
dpc-1651	48	2	are	be	AUX
dpc-1651	48	3	more	more	ADV
dpc-1651	48	4	frequent	frequent	ADJ
dpc-1651	48	5	in	in	ADP
dpc-1651	48	6	women	woman	NOUN
dpc-1651	48	7	.	.	PUNCT
dpc-1651	49	1	despite	despite	SCONJ
dpc-1651	49	2	its	its	PRON
dpc-1651	49	3	name	name	NOUN
dpc-1651	49	4	,	,	PUNCT
dpc-1651	49	5	no	no	DET
dpc-1651	49	6	association	association	NOUN
dpc-1651	49	7	with	with	ADP
dpc-1651	49	8	herpesvirus	herpesvirus	NOUN
dpc-1651	49	9	has	have	AUX
dpc-1651	49	10	been	be	AUX
dpc-1651	49	11	found	find	VERB
dpc-1651	49	12	[	[	X
dpc-1651	49	13	12,13	12,13	NUM
dpc-1651	49	14	]	]	PUNCT
dpc-1651	49	15	.	.	PUNCT
dpc-1651	50	1	behçet	behçet	PROPN
dpc-1651	50	2	disease	disease	NOUN
dpc-1651	50	3	(	(	PUNCT
dpc-1651	50	4	adamantiades	adamantiades	PROPN
dpc-1651	50	5	-	-	PUNCT
dpc-1651	50	6	behçet	behçet	ADJ
dpc-1651	50	7	disease	disease	NOUN
dpc-1651	50	8	[	[	X
dpc-1651	50	9	abd	abd	NOUN
dpc-1651	50	10	]	]	X
dpc-1651	50	11	)	)	PUNCT
dpc-1651	51	1	[	[	X
dpc-1651	51	2	14,15	14,15	NUM
dpc-1651	51	3	]	]	PUNCT
dpc-1651	51	4	is	be	AUX
dpc-1651	51	5	a	a	DET
dpc-1651	51	6	chronic	chronic	ADJ
dpc-1651	51	7	and	and	CCONJ
dpc-1651	51	8	multisystemic	multisystemic	ADJ
dpc-1651	51	9	inflammatory	inflammatory	ADJ
dpc-1651	51	10	disease	disease	NOUN
dpc-1651	51	11	,	,	PUNCT
dpc-1651	51	12	characterized	characterize	VERB
dpc-1651	51	13	by	by	ADP
dpc-1651	51	14	oral	oral	ADJ
dpc-1651	51	15	aphthae	aphthae	NOUN
dpc-1651	51	16	at	at	ADP
dpc-1651	51	17	its	its	PRON
dpc-1651	51	18	onset	onset	NOUN
dpc-1651	51	19	,	,	PUNCT
dpc-1651	51	20	with	with	ADP
dpc-1651	51	21	the	the	DET
dpc-1651	51	22	successive	successive	ADJ
dpc-1651	51	23	appearance	appearance	NOUN
dpc-1651	51	24	of	of	ADP
dpc-1651	51	25	ocular	ocular	ADJ
dpc-1651	51	26	,	,	PUNCT
dpc-1651	51	27	vascular	vascular	ADJ
dpc-1651	51	28	,	,	PUNCT
dpc-1651	51	29	gastrointestinal	gastrointestinal	ADJ
dpc-1651	51	30	,	,	PUNCT
dpc-1651	51	31	nervous	nervous	ADJ
dpc-1651	51	32	and	and	CCONJ
dpc-1651	51	33	mucocutaneous	mucocutaneous	ADJ
dpc-1651	51	34	lesions	lesion	NOUN
dpc-1651	51	35	(	(	PUNCT
dpc-1651	51	36	figure	figure	NOUN
dpc-1651	51	37	1	1	NUM
dpc-1651	51	38	)	)	PUNCT
dpc-1651	51	39	.	.	PUNCT
dpc-1651	52	1	abd	abd	PROPN
dpc-1651	52	2	mainly	mainly	ADV
dpc-1651	52	3	affects	affect	VERB
dpc-1651	52	4	young	young	ADJ
dpc-1651	52	5	(	(	PUNCT
dpc-1651	52	6	20to	20to	ADJ
dpc-1651	52	7	40	40	NUM
dpc-1651	52	8	-	-	PUNCT
dpc-1651	52	9	year	year	NOUN
dpc-1651	52	10	-	-	PUNCT
dpc-1651	52	11	old	old	ADJ
dpc-1651	52	12	)	)	PUNCT
dpc-1651	52	13	males	male	NOUN
dpc-1651	52	14	,	,	PUNCT
dpc-1651	52	15	but	but	CCONJ
dpc-1651	52	16	no	no	DET
dpc-1651	52	17	age	age	NOUN
dpc-1651	52	18	is	be	AUX
dpc-1651	52	19	spared	spare	VERB
dpc-1651	52	20	[	[	X
dpc-1651	52	21	14,15	14,15	NUM
dpc-1651	52	22	]	]	PUNCT
dpc-1651	52	23	.	.	PUNCT
dpc-1651	53	1	the	the	DET
dpc-1651	53	2	male	male	NOUN
dpc-1651	53	3	:	:	PUNCT
dpc-1651	53	4	female	female	ADJ
dpc-1651	53	5	ratio	ratio	NOUN
dpc-1651	53	6	is	be	AUX
dpc-1651	53	7	reported	report	VERB
dpc-1651	53	8	to	to	PART
dpc-1651	53	9	be	be	AUX
dpc-1651	53	10	from	from	ADP
dpc-1651	53	11	3.1	3.1	NUM
dpc-1651	53	12	to	to	ADP
dpc-1651	53	13	1.1	1.1	NUM
dpc-1651	53	14	,	,	PUNCT
dpc-1651	53	15	with	with	ADP
dpc-1651	53	16	the	the	DET
dpc-1651	53	17	same	same	ADJ
dpc-1651	53	18	values	value	NOUN
dpc-1651	53	19	being	be	AUX
dpc-1651	53	20	reported	report	VERB
dpc-1651	53	21	in	in	ADP
dpc-1651	53	22	the	the	DET
dpc-1651	53	23	us	us	PROPN
dpc-1651	53	24	and	and	CCONJ
dpc-1651	53	25	europe	europe	PROPN
dpc-1651	54	1	[	[	X
dpc-1651	54	2	14,15	14,15	NUM
dpc-1651	54	3	]	]	PUNCT
dpc-1651	54	4	.	.	PUNCT
dpc-1651	55	1	the	the	DET
dpc-1651	55	2	etiology	etiology	NOUN
dpc-1651	55	3	of	of	ADP
dpc-1651	55	4	abd	abd	PROPN
dpc-1651	55	5	is	be	AUX
dpc-1651	55	6	unknown	unknown	ADJ
dpc-1651	55	7	but	but	CCONJ
dpc-1651	55	8	is	be	AUX
dpc-1651	55	9	most	most	ADV
dpc-1651	55	10	probably	probably	ADV
dpc-1651	55	11	caused	cause	VERB
dpc-1651	55	12	by	by	ADP
dpc-1651	55	13	an	an	DET
dpc-1651	55	14	interplay	interplay	NOUN
dpc-1651	55	15	of	of	ADP
dpc-1651	55	16	genetic	genetic	ADJ
dpc-1651	55	17	and	and	CCONJ
dpc-1651	55	18	environmental	environmental	ADJ
dpc-1651	55	19	factors	factor	NOUN
dpc-1651	55	20	[	[	X
dpc-1651	55	21	14	14	NUM
dpc-1651	55	22	-	-	SYM
dpc-1651	55	23	16	16	NUM
dpc-1651	55	24	]	]	PUNCT
dpc-1651	55	25	.	.	PUNCT
dpc-1651	56	1	multiple	multiple	ADJ
dpc-1651	56	2	oral	oral	ADJ
dpc-1651	56	3	aphthae	aphthae	NOUN
dpc-1651	56	4	and	and	CCONJ
dpc-1651	56	5	ulcers	ulcer	NOUN
dpc-1651	56	6	can	can	AUX
dpc-1651	56	7	be	be	AUX
dpc-1651	56	8	observed	observe	VERB
dpc-1651	56	9	in	in	ADP
dpc-1651	56	10	association	association	NOUN
dpc-1651	56	11	with	with	ADP
dpc-1651	56	12	several	several	ADJ
dpc-1651	56	13	other	other	ADJ
dpc-1651	56	14	clinical	clinical	ADJ
dpc-1651	56	15	findings	finding	NOUN
dpc-1651	56	16	in	in	ADP
dpc-1651	56	17	many	many	ADJ
dpc-1651	56	18	autoimmune	autoimmune	ADJ
dpc-1651	56	19	diseases	disease	NOUN
dpc-1651	57	1	[	[	X
dpc-1651	57	2	3,17	3,17	X
dpc-1651	57	3	]	]	PUNCT
dpc-1651	57	4	or	or	CCONJ
dpc-1651	57	5	be	be	AUX
dpc-1651	57	6	induced	induce	VERB
dpc-1651	57	7	by	by	ADP
dpc-1651	57	8	medications	medication	NOUN
dpc-1651	58	1	[	[	X
dpc-1651	58	2	18	18	NUM
dpc-1651	58	3	]	]	PUNCT
dpc-1651	58	4	,	,	PUNCT
dpc-1651	58	5	genetic	genetic	ADJ
dpc-1651	58	6	disease	disease	NOUN
dpc-1651	58	7	[	[	X
dpc-1651	58	8	19,20	19,20	X
dpc-1651	58	9	]	]	PUNCT
dpc-1651	58	10	,	,	PUNCT
dpc-1651	58	11	and	and	CCONJ
dpc-1651	58	12	other	other	ADJ
dpc-1651	58	13	complex	complex	ADJ
dpc-1651	58	14	inflammatory	inflammatory	ADJ
dpc-1651	58	15	syndromes	syndrome	NOUN
dpc-1651	58	16	,	,	PUNCT
dpc-1651	58	17	such	such	ADJ
dpc-1651	58	18	as	as	ADP
dpc-1651	58	19	mouth	mouth	NOUN
dpc-1651	58	20	and	and	CCONJ
dpc-1651	58	21	genital	genital	ADJ
dpc-1651	58	22	ulcers	ulcer	NOUN
dpc-1651	58	23	with	with	ADP
dpc-1651	58	24	inflamed	inflamed	ADJ
dpc-1651	58	25	cartilage	cartilage	NOUN
dpc-1651	58	26	(	(	PUNCT
dpc-1651	58	27	magic	magic	NOUN
dpc-1651	58	28	)	)	PUNCT
dpc-1651	58	29	syndrome	syndrome	NOUN
dpc-1651	59	1	[	[	X
dpc-1651	59	2	21	21	NUM
dpc-1651	59	3	]	]	PUNCT
dpc-1651	59	4	,	,	PUNCT
dpc-1651	59	5	sweet	sweet	ADJ
dpc-1651	59	6	syndrome	syndrome	NOUN
dpc-1651	60	1	[	[	X
dpc-1651	60	2	22	22	NUM
dpc-1651	60	3	-	-	SYM
dpc-1651	60	4	28	28	NUM
dpc-1651	60	5	]	]	PUNCT
dpc-1651	60	6	,	,	PUNCT
dpc-1651	60	7	cyclic	cyclic	ADJ
dpc-1651	60	8	neutropenia	neutropenia	NOUN
dpc-1651	60	9	[	[	X
dpc-1651	60	10	29	29	NUM
dpc-1651	60	11	-	-	SYM
dpc-1651	60	12	32	32	NUM
dpc-1651	60	13	]	]	PUNCT
dpc-1651	60	14	,	,	PUNCT
dpc-1651	60	15	periodic	periodic	ADJ
dpc-1651	60	16	fever	fever	NOUN
dpc-1651	60	17	with	with	ADP
dpc-1651	60	18	aphthae	aphthae	NOUN
dpc-1651	60	19	,	,	PUNCT
dpc-1651	60	20	pharyngitis	pharyngitis	NOUN
dpc-1651	60	21	and	and	CCONJ
dpc-1651	60	22	adenitis	adenitis	PROPN
dpc-1651	60	23	(	(	PUNCT
dpc-1651	60	24	sometimes	sometimes	ADV
dpc-1651	60	25	termed	term	VERB
dpc-1651	60	26	pfapa	pfapa	ADJ
dpc-1651	60	27	syndrome	syndrome	NOUN
dpc-1651	60	28	)	)	PUNCT
dpc-1651	61	1	[	[	X
dpc-1651	61	2	33–35	33–35	NUM
dpc-1651	61	3	]	]	PUNCT
dpc-1651	61	4	,	,	PUNCT
dpc-1651	61	5	nutritional	nutritional	ADJ
dpc-1651	61	6	deficiencies	deficiency	NOUN
dpc-1651	61	7	[	[	X
dpc-1651	61	8	36,37	36,37	X
dpc-1651	61	9	]	]	X
dpc-1651	61	10	,	,	PUNCT
dpc-1651	61	11	gluten	gluten	NOUN
dpc-1651	61	12	-	-	PUNCT
dpc-1651	61	13	sensitive	sensitive	ADJ
dpc-1651	61	14	enteropathy	enteropathy	NOUN
dpc-1651	61	15	(	(	PUNCT
dpc-1651	61	16	celiac	celiac	ADJ
dpc-1651	61	17	disease	disease	NOUN
dpc-1651	61	18	)	)	PUNCT
dpc-1651	61	19	,	,	PUNCT
dpc-1651	61	20	inflammatory	inflammatory	ADJ
dpc-1651	61	21	review	review	NOUN
dpc-1651	61	22	|	|	ADV
dpc-1651	61	23	dermatol	dermatol	ADJ
dpc-1651	61	24	pract	pract	NOUN
dpc-1651	61	25	concept	concept	NOUN
dpc-1651	61	26	.	.	PUNCT
dpc-1651	62	1	2021;11(4):e2021099	2021;11(4):e2021099	NUM
dpc-1651	62	2	3	3	NUM
dpc-1651	62	3	bowel	bowel	NOUN
dpc-1651	62	4	disease	disease	NOUN
dpc-1651	62	5	,	,	PUNCT
dpc-1651	62	6	and	and	CCONJ
dpc-1651	62	7	immunodeficiencies	immunodeficiency	NOUN
dpc-1651	63	1	[	[	X
dpc-1651	63	2	38,39	38,39	NOUN
dpc-1651	63	3	]	]	PUNCT
dpc-1651	63	4	including	include	VERB
dpc-1651	63	5	hiv	hiv	PROPN
dpc-1651	63	6	infection	infection	NOUN
dpc-1651	64	1	[	[	X
dpc-1651	64	2	40,41	40,41	NOUN
dpc-1651	64	3	]	]	PUNCT
dpc-1651	64	4	.	.	PUNCT
dpc-1651	65	1	recurrent	recurrent	ADJ
dpc-1651	65	2	ulcerative	ulcerative	ADJ
dpc-1651	65	3	lesions	lesion	NOUN
dpc-1651	65	4	of	of	ADP
dpc-1651	65	5	the	the	DET
dpc-1651	65	6	oropharyngeal	oropharyngeal	ADJ
dpc-1651	65	7	mucosa	mucosa	NOUN
dpc-1651	65	8	can	can	AUX
dpc-1651	65	9	be	be	AUX
dpc-1651	65	10	associated	associate	VERB
dpc-1651	65	11	with	with	ADP
dpc-1651	65	12	many	many	ADJ
dpc-1651	65	13	viral	viral	ADJ
dpc-1651	65	14	or	or	CCONJ
dpc-1651	65	15	bacterial	bacterial	ADJ
dpc-1651	65	16	infections	infection	NOUN
dpc-1651	65	17	[	[	X
dpc-1651	65	18	40,42	40,42	NUM
dpc-1651	65	19	-	-	NUM
dpc-1651	65	20	44	44	NUM
dpc-1651	65	21	]	]	PUNCT
dpc-1651	65	22	;	;	PUNCT
dpc-1651	65	23	therefore	therefore	ADV
dpc-1651	65	24	,	,	PUNCT
dpc-1651	65	25	it	it	PRON
dpc-1651	65	26	is	be	AUX
dpc-1651	65	27	important	important	ADJ
dpc-1651	65	28	to	to	PART
dpc-1651	65	29	exclude	exclude	VERB
dpc-1651	65	30	an	an	DET
dpc-1651	65	31	infectious	infectious	ADJ
dpc-1651	65	32	etiology	etiology	NOUN
dpc-1651	65	33	before	before	ADP
dpc-1651	65	34	initiating	initiate	VERB
dpc-1651	65	35	immunosuppressive	immunosuppressive	ADJ
dpc-1651	65	36	or	or	CCONJ
dpc-1651	65	37	an	an	DET
dpc-1651	65	38	immunomodulatory	immunomodulatory	ADJ
dpc-1651	65	39	therapy	therapy	NOUN
dpc-1651	65	40	.	.	PUNCT
dpc-1651	66	1	aids	aids	PROPN
dpc-1651	66	2	is	be	AUX
dpc-1651	66	3	a	a	DET
dpc-1651	66	4	progressive	progressive	ADJ
dpc-1651	66	5	viral	viral	ADJ
dpc-1651	66	6	infection	infection	NOUN
dpc-1651	66	7	caused	cause	VERB
dpc-1651	66	8	by	by	ADP
dpc-1651	66	9	hiv-1/2	hiv-1/2	NUM
dpc-1651	66	10	viruses	virus	NOUN
dpc-1651	66	11	,	,	PUNCT
dpc-1651	66	12	with	with	ADP
dpc-1651	66	13	ulcerative	ulcerative	ADJ
dpc-1651	66	14	oral	oral	ADJ
dpc-1651	66	15	manifestations	manifestation	NOUN
dpc-1651	66	16	in	in	ADP
dpc-1651	66	17	8	8	NUM
dpc-1651	66	18	%	%	NOUN
dpc-1651	66	19	of	of	ADP
dpc-1651	66	20	the	the	DET
dpc-1651	66	21	cases	case	NOUN
dpc-1651	66	22	[	[	X
dpc-1651	66	23	45	45	NUM
dpc-1651	66	24	]	]	PUNCT
dpc-1651	66	25	.	.	PUNCT
dpc-1651	67	1	another	another	DET
dpc-1651	67	2	cause	cause	NOUN
dpc-1651	67	3	of	of	ADP
dpc-1651	67	4	ulcerative	ulcerative	ADJ
dpc-1651	67	5	lesions	lesion	NOUN
dpc-1651	67	6	can	can	AUX
dpc-1651	67	7	be	be	AUX
dpc-1651	67	8	the	the	DET
dpc-1651	67	9	herpes	herpe	NOUN
dpc-1651	67	10	simplex	simplex	NOUN
dpc-1651	67	11	virus	virus	NOUN
dpc-1651	67	12	infection	infection	NOUN
dpc-1651	67	13	(	(	PUNCT
dpc-1651	67	14	hsv-1/2	hsv-1/2	PROPN
dpc-1651	67	15	)	)	PUNCT
dpc-1651	67	16	when	when	SCONJ
dpc-1651	67	17	oral	oral	ADJ
dpc-1651	67	18	and	and	CCONJ
dpc-1651	67	19	perioral	perioral	ADJ
dpc-1651	67	20	ulcers	ulcer	NOUN
dpc-1651	67	21	are	be	AUX
dpc-1651	67	22	frequent	frequent	ADJ
dpc-1651	67	23	symptoms	symptom	NOUN
dpc-1651	67	24	.	.	PUNCT
dpc-1651	68	1	[	[	X
dpc-1651	68	2	43	43	NUM
dpc-1651	68	3	]	]	PUNCT
dpc-1651	68	4	.	.	PUNCT
dpc-1651	69	1	recurrent	recurrent	ADJ
dpc-1651	69	2	oropharyngeal	oropharyngeal	ADJ
dpc-1651	69	3	ulcers	ulcer	NOUN
dpc-1651	69	4	have	have	AUX
dpc-1651	69	5	been	be	AUX
dpc-1651	69	6	described	describe	VERB
dpc-1651	69	7	in	in	ADP
dpc-1651	69	8	several	several	ADJ
dpc-1651	69	9	infectious	infectious	ADJ
dpc-1651	69	10	diseases	disease	NOUN
dpc-1651	69	11	as	as	ADV
dpc-1651	69	12	such	such	ADJ
dpc-1651	69	13	as	as	ADP
dpc-1651	69	14	:	:	PUNCT
dpc-1651	69	15	secondary	secondary	ADJ
dpc-1651	69	16	syphilis	syphili	NOUN
dpc-1651	69	17	,	,	PUNCT
dpc-1651	69	18	tuberculosis	tuberculosis	NOUN
dpc-1651	69	19	,	,	PUNCT
dpc-1651	69	20	histoplasmosis	histoplasmosis	NOUN
dpc-1651	69	21	,	,	PUNCT
dpc-1651	69	22	lyme	lyme	NOUN
dpc-1651	69	23	disease	disease	NOUN
dpc-1651	69	24	,	,	PUNCT
dpc-1651	69	25	covid-19	covid-19	PROPN
dpc-1651	69	26	,	,	PUNCT
dpc-1651	69	27	epstein	epstein	PROPN
dpc-1651	69	28	-	-	PUNCT
dpc-1651	69	29	barr	barr	PROPN
dpc-1651	69	30	virus	virus	PROPN
dpc-1651	69	31	,	,	PUNCT
dpc-1651	69	32	and	and	CCONJ
dpc-1651	69	33	cytomegalovirus	cytomegalovirus	NOUN
dpc-1651	69	34	infection	infection	NOUN
dpc-1651	69	35	[	[	X
dpc-1651	69	36	44	44	NUM
dpc-1651	69	37	]	]	PUNCT
dpc-1651	69	38	.	.	PUNCT
dpc-1651	70	1	the	the	DET
dpc-1651	70	2	role	role	NOUN
dpc-1651	70	3	of	of	ADP
dpc-1651	70	4	helicobacter	helicobacter	NOUN
dpc-1651	70	5	pylori	pylori	NOUN
dpc-1651	70	6	as	as	ADP
dpc-1651	70	7	an	an	DET
dpc-1651	70	8	etiology	etiology	NOUN
dpc-1651	70	9	of	of	ADP
dpc-1651	70	10	ulcerative	ulcerative	ADJ
dpc-1651	70	11	lesions	lesion	NOUN
dpc-1651	70	12	of	of	ADP
dpc-1651	70	13	the	the	DET
dpc-1651	70	14	oral	oral	ADJ
dpc-1651	70	15	cavity	cavity	NOUN
dpc-1651	70	16	is	be	AUX
dpc-1651	70	17	still	still	ADV
dpc-1651	70	18	a	a	DET
dpc-1651	70	19	matter	matter	NOUN
dpc-1651	70	20	of	of	ADP
dpc-1651	70	21	debate	debate	NOUN
dpc-1651	70	22	[	[	X
dpc-1651	70	23	42	42	NUM
dpc-1651	70	24	]	]	PUNCT
dpc-1651	70	25	.	.	PUNCT
dpc-1651	71	1	prevention	prevention	NOUN
dpc-1651	71	2	and	and	CCONJ
dpc-1651	71	3	therapy	therapy	NOUN
dpc-1651	71	4	several	several	ADJ
dpc-1651	71	5	therapies	therapy	NOUN
dpc-1651	71	6	,	,	PUNCT
dpc-1651	71	7	with	with	ADP
dpc-1651	71	8	variable	variable	ADJ
dpc-1651	71	9	degrees	degree	NOUN
dpc-1651	71	10	of	of	ADP
dpc-1651	71	11	supporting	support	VERB
dpc-1651	71	12	evidences	evidence	NOUN
dpc-1651	71	13	,	,	PUNCT
dpc-1651	71	14	are	be	AUX
dpc-1651	71	15	available	available	ADJ
dpc-1651	71	16	for	for	ADP
dpc-1651	71	17	the	the	DET
dpc-1651	71	18	treatment	treatment	NOUN
dpc-1651	71	19	of	of	ADP
dpc-1651	71	20	aphthous	aphthous	ADJ
dpc-1651	71	21	stomatitis	stomatitis	NOUN
dpc-1651	72	1	[	[	X
dpc-1651	72	2	11	11	NUM
dpc-1651	72	3	]	]	PUNCT
dpc-1651	72	4	.	.	PUNCT
dpc-1651	73	1	treatment	treatment	NOUN
dpc-1651	73	2	for	for	ADP
dpc-1651	73	3	recurrent	recurrent	ADJ
dpc-1651	73	4	aphthous	aphthous	ADJ
dpc-1651	73	5	ulcers	ulcer	NOUN
dpc-1651	73	6	is	be	AUX
dpc-1651	73	7	aimed	aim	VERB
dpc-1651	73	8	at	at	ADP
dpc-1651	73	9	mitigating	mitigate	VERB
dpc-1651	73	10	symptoms	symptom	NOUN
dpc-1651	73	11	,	,	PUNCT
dpc-1651	73	12	shortening	shorten	VERB
dpc-1651	73	13	the	the	DET
dpc-1651	73	14	healing	healing	NOUN
dpc-1651	73	15	time	time	NOUN
dpc-1651	73	16	,	,	PUNCT
dpc-1651	73	17	and	and	CCONJ
dpc-1651	73	18	is	be	AUX
dpc-1651	73	19	used	use	VERB
dpc-1651	73	20	as	as	ADP
dpc-1651	73	21	a	a	DET
dpc-1651	73	22	prophylaxis	prophylaxis	NOUN
dpc-1651	73	23	against	against	ADP
dpc-1651	73	24	recurrence	recurrence	NOUN
dpc-1651	73	25	.	.	PUNCT
dpc-1651	74	1	most	most	ADJ
dpc-1651	74	2	of	of	ADP
dpc-1651	74	3	the	the	DET
dpc-1651	74	4	treatments	treatment	NOUN
dpc-1651	74	5	are	be	AUX
dpc-1651	74	6	prescribed	prescribe	VERB
dpc-1651	74	7	without	without	ADP
dpc-1651	74	8	studies	study	NOUN
dpc-1651	74	9	demonstrating	demonstrate	VERB
dpc-1651	74	10	therapeutic	therapeutic	ADJ
dpc-1651	74	11	efficacy	efficacy	NOUN
dpc-1651	74	12	with	with	ADP
dpc-1651	74	13	respect	respect	NOUN
dpc-1651	74	14	to	to	ADP
dpc-1651	74	15	aphthous	aphthous	ADJ
dpc-1651	74	16	stomatitis	stomatitis	NOUN
dpc-1651	74	17	.	.	PUNCT
dpc-1651	75	1	topical	topical	ADJ
dpc-1651	75	2	regimens	regimen	NOUN
dpc-1651	75	3	are	be	AUX
dpc-1651	75	4	considered	consider	VERB
dpc-1651	75	5	to	to	PART
dpc-1651	75	6	be	be	AUX
dpc-1651	75	7	the	the	DET
dpc-1651	75	8	standard	standard	ADJ
dpc-1651	75	9	treatment	treatment	NOUN
dpc-1651	75	10	in	in	ADP
dpc-1651	75	11	mild	mild	ADJ
dpc-1651	75	12	cases	case	NOUN
dpc-1651	75	13	of	of	ADP
dpc-1651	75	14	ras	ras	NOUN
dpc-1651	76	1	[	[	X
dpc-1651	76	2	2,11,46	2,11,46	NUM
dpc-1651	76	3	]	]	PUNCT
dpc-1651	76	4	.	.	PUNCT
dpc-1651	77	1	in	in	ADP
dpc-1651	77	2	more	more	ADV
dpc-1651	77	3	compromised	compromised	ADJ
dpc-1651	77	4	cases	case	NOUN
dpc-1651	77	5	,	,	PUNCT
dpc-1651	77	6	topical	topical	ADJ
dpc-1651	77	7	treatments	treatment	NOUN
dpc-1651	77	8	are	be	AUX
dpc-1651	77	9	likewise	likewise	ADV
dpc-1651	77	10	very	very	ADV
dpc-1651	77	11	helpful	helpful	ADJ
dpc-1651	77	12	in	in	ADP
dpc-1651	77	13	inducing	induce	VERB
dpc-1651	77	14	lesion	lesion	NOUN
dpc-1651	77	15	recovery	recovery	NOUN
dpc-1651	77	16	,	,	PUNCT
dpc-1651	77	17	but	but	CCONJ
dpc-1651	77	18	they	they	PRON
dpc-1651	77	19	are	be	AUX
dpc-1651	77	20	often	often	ADV
dpc-1651	77	21	ineffective	ineffective	ADJ
dpc-1651	77	22	at	at	ADP
dpc-1651	77	23	prolonging	prolong	VERB
dpc-1651	77	24	disease	disease	NOUN
dpc-1651	77	25	-	-	PUNCT
dpc-1651	77	26	free	free	ADJ
dpc-1651	77	27	intervals	interval	NOUN
dpc-1651	77	28	.	.	PUNCT
dpc-1651	78	1	medical	medical	ADJ
dpc-1651	78	2	care	care	NOUN
dpc-1651	78	3	topical	topical	ADJ
dpc-1651	78	4	therapies	therapy	NOUN
dpc-1651	78	5	can	can	AUX
dpc-1651	78	6	include	include	VERB
dpc-1651	78	7	the	the	DET
dpc-1651	78	8	following	follow	VERB
dpc-1651	78	9	:	:	PUNCT
dpc-1651	78	10	corticosteroids	corticosteroid	NOUN
dpc-1651	78	11	,	,	PUNCT
dpc-1651	78	12	cyclosporine	cyclosporine	NOUN
dpc-1651	78	13	,	,	PUNCT
dpc-1651	78	14	retinoids	retinoid	NOUN
dpc-1651	78	15	,	,	PUNCT
dpc-1651	78	16	antimicrobials	antimicrobial	NOUN
dpc-1651	78	17	,	,	PUNCT
dpc-1651	78	18	anesthetics	anesthetic	NOUN
dpc-1651	78	19	[	[	X
dpc-1651	78	20	47	47	NUM
dpc-1651	78	21	]	]	PUNCT
dpc-1651	78	22	.	.	PUNCT
dpc-1651	79	1	topical	topical	ADJ
dpc-1651	79	2	corticosteroids	corticosteroid	NOUN
dpc-1651	79	3	are	be	AUX
dpc-1651	79	4	the	the	DET
dpc-1651	79	5	first	first	ADJ
dpc-1651	79	6	-	-	PUNCT
dpc-1651	79	7	line	line	NOUN
dpc-1651	79	8	treatment	treatment	NOUN
dpc-1651	79	9	,	,	PUNCT
dpc-1651	79	10	and	and	CCONJ
dpc-1651	79	11	they	they	PRON
dpc-1651	79	12	are	be	AUX
dpc-1651	79	13	used	use	VERB
dpc-1651	79	14	to	to	PART
dpc-1651	79	15	reduce	reduce	VERB
dpc-1651	79	16	the	the	DET
dpc-1651	79	17	local	local	ADJ
dpc-1651	79	18	inflammation	inflammation	NOUN
dpc-1651	79	19	that	that	PRON
dpc-1651	79	20	induces	induce	VERB
dpc-1651	79	21	ulceration	ulceration	NOUN
dpc-1651	79	22	.	.	PUNCT
dpc-1651	80	1	they	they	PRON
dpc-1651	80	2	include	include	VERB
dpc-1651	80	3	dexamethasone	dexamethasone	NOUN
dpc-1651	80	4	(	(	PUNCT
dpc-1651	80	5	0.5	0.5	NUM
dpc-1651	80	6	mg/5ml	mg/5ml	NUM
dpc-1651	80	7	)	)	PUNCT
dpc-1651	80	8	,	,	PUNCT
dpc-1651	80	9	triamcinolone	triamcinolone	NOUN
dpc-1651	80	10	(	(	PUNCT
dpc-1651	80	11	.0,1	.0,1	NOUN
dpc-1651	80	12	%	%	NOUN
dpc-1651	80	13	gel	gel	NOUN
dpc-1651	80	14	)	)	PUNCT
dpc-1651	80	15	,	,	PUNCT
dpc-1651	80	16	fluocinonide	fluocinonide	INTJ
dpc-1651	80	17	(	(	PUNCT
dpc-1651	80	18	0.05	0.05	NUM
dpc-1651	80	19	%	%	NOUN
dpc-1651	80	20	gel	gel	NOUN
dpc-1651	80	21	)	)	PUNCT
dpc-1651	80	22	and	and	CCONJ
dpc-1651	80	23	clobetasol	clobetasol	NOUN
dpc-1651	80	24	(	(	PUNCT
dpc-1651	80	25	0.05	0.05	NUM
dpc-1651	80	26	%	%	NOUN
dpc-1651	80	27	gel	gel	NOUN
dpc-1651	80	28	)	)	PUNCT
dpc-1651	80	29	.	.	PUNCT
dpc-1651	81	1	clobetasol	clobetasol	NOUN
dpc-1651	81	2	is	be	AUX
dpc-1651	81	3	a	a	DET
dpc-1651	81	4	class	class	NOUN
dpc-1651	81	5	1	1	NUM
dpc-1651	81	6	superpotent	superpotent	NOUN
dpc-1651	81	7	steroid	steroid	NOUN
dpc-1651	81	8	,	,	PUNCT
dpc-1651	81	9	and	and	CCONJ
dpc-1651	81	10	is	be	AUX
dpc-1651	81	11	showing	show	VERB
dpc-1651	81	12	better	well	ADJ
dpc-1651	81	13	results	result	NOUN
dpc-1651	81	14	[	[	X
dpc-1651	81	15	2,46,47	2,46,47	NUM
dpc-1651	81	16	]	]	PUNCT
dpc-1651	81	17	.	.	PUNCT
dpc-1651	82	1	immunomodulatory	immunomodulatory	ADJ
dpc-1651	82	2	agents	agent	NOUN
dpc-1651	82	3	,	,	PUNCT
dpc-1651	82	4	include	include	VERB
dpc-1651	82	5	cyclosporine	cyclosporine	NOUN
dpc-1651	82	6	and	and	CCONJ
dpc-1651	82	7	retinoids	retinoid	NOUN
dpc-1651	82	8	.	.	PUNCT
dpc-1651	83	1	cyclosporine	cyclosporine	PROPN
dpc-1651	83	2	has	have	AUX
dpc-1651	83	3	been	be	AUX
dpc-1651	83	4	prescribed	prescribe	VERB
dpc-1651	83	5	as	as	ADP
dpc-1651	83	6	a	a	DET
dpc-1651	83	7	systemic	systemic	ADJ
dpc-1651	83	8	agent	agent	NOUN
dpc-1651	83	9	and	and	CCONJ
dpc-1651	83	10	a	a	DET
dpc-1651	83	11	topical	topical	ADJ
dpc-1651	83	12	paste	paste	NOUN
dpc-1651	83	13	with	with	ADP
dpc-1651	83	14	variable	variable	ADJ
dpc-1651	83	15	reported	report	VERB
dpc-1651	83	16	efficacy	efficacy	NOUN
dpc-1651	83	17	,	,	PUNCT
dpc-1651	83	18	but	but	CCONJ
dpc-1651	83	19	it	it	PRON
dpc-1651	83	20	is	be	AUX
dpc-1651	83	21	now	now	ADV
dpc-1651	83	22	frequently	frequently	ADV
dpc-1651	83	23	used	use	VERB
dpc-1651	83	24	effectively	effectively	ADV
dpc-1651	83	25	as	as	ADP
dpc-1651	83	26	an	an	DET
dpc-1651	83	27	oral	oral	ADJ
dpc-1651	83	28	rinse	rinse	NOUN
dpc-1651	83	29	.	.	PUNCT
dpc-1651	84	1	isotretinoin	isotretinoin	PROPN
dpc-1651	84	2	(	(	PUNCT
dpc-1651	84	3	0.1	0.1	NUM
dpc-1651	84	4	%	%	NOUN
dpc-1651	84	5	gel	gel	NOUN
dpc-1651	84	6	)	)	PUNCT
dpc-1651	84	7	and	and	CCONJ
dpc-1651	84	8	tretinoin	tretinoin	VERB
dpc-1651	84	9	in	in	ADP
dpc-1651	84	10	an	an	DET
dpc-1651	84	11	adhesive	adhesive	ADJ
dpc-1651	84	12	base	base	NOUN
dpc-1651	84	13	(	(	PUNCT
dpc-1651	84	14	0.1	0.1	NUM
dpc-1651	84	15	%	%	NOUN
dpc-1651	84	16	)	)	PUNCT
dpc-1651	84	17	,	,	PUNCT
dpc-1651	84	18	and	and	CCONJ
dpc-1651	84	19	retinoic	retinoic	PROPN
dpc-1651	84	20	acid	acid	NOUN
dpc-1651	84	21	in	in	ADP
dpc-1651	84	22	an	an	DET
dpc-1651	84	23	oral	oral	ADJ
dpc-1651	84	24	base	base	NOUN
dpc-1651	84	25	(	(	PUNCT
dpc-1651	84	26	.05	.05	NUM
dpc-1651	84	27	%	%	NOUN
dpc-1651	84	28	)	)	PUNCT
dpc-1651	84	29	have	have	AUX
dpc-1651	84	30	been	be	AUX
dpc-1651	84	31	prescribed	prescribe	VERB
dpc-1651	84	32	for	for	ADP
dpc-1651	84	33	the	the	DET
dpc-1651	84	34	management	management	NOUN
dpc-1651	84	35	of	of	ADP
dpc-1651	84	36	ras	ras	PROPN
dpc-1651	85	1	[	[	X
dpc-1651	85	2	2,47,48	2,47,48	NUM
dpc-1651	85	3	]	]	PUNCT
dpc-1651	85	4	.	.	PUNCT
dpc-1651	86	1	also	also	ADV
dpc-1651	86	2	,	,	PUNCT
dpc-1651	86	3	systemic	systemic	ADJ
dpc-1651	86	4	isotretinoin	isotretinoin	PROPN
dpc-1651	86	5	has	have	AUX
dpc-1651	86	6	been	be	AUX
dpc-1651	86	7	reported	report	VERB
dpc-1651	86	8	to	to	PART
dpc-1651	86	9	be	be	AUX
dpc-1651	86	10	an	an	DET
dpc-1651	86	11	effective	effective	ADJ
dpc-1651	86	12	therapy	therapy	NOUN
dpc-1651	86	13	for	for	ADP
dpc-1651	86	14	recurrent	recurrent	ADJ
dpc-1651	86	15	aphthosis	aphthosis	NOUN
dpc-1651	87	1	[	[	X
dpc-1651	87	2	49,50	49,50	X
dpc-1651	87	3	]	]	X
dpc-1651	87	4	.	.	PUNCT
dpc-1651	88	1	antimicrobials	antimicrobial	NOUN
dpc-1651	88	2	,	,	PUNCT
dpc-1651	88	3	including	include	VERB
dpc-1651	88	4	tetracycline	tetracycline	NOUN
dpc-1651	88	5	,	,	PUNCT
dpc-1651	88	6	chlorhexidine	chlorhexidine	NOUN
dpc-1651	88	7	gluconate	gluconate	NOUN
dpc-1651	88	8	,	,	PUNCT
dpc-1651	88	9	and	and	CCONJ
dpc-1651	88	10	diluted	dilute	VERB
dpc-1651	88	11	hydrogen	hydrogen	NOUN
dpc-1651	88	12	peroxide	peroxide	NOUN
dpc-1651	88	13	have	have	AUX
dpc-1651	88	14	shown	show	VERB
dpc-1651	88	15	to	to	PART
dpc-1651	88	16	reduce	reduce	VERB
dpc-1651	88	17	the	the	DET
dpc-1651	88	18	duration	duration	NOUN
dpc-1651	88	19	and	and	CCONJ
dpc-1651	88	20	pain	pain	NOUN
dpc-1651	88	21	of	of	ADP
dpc-1651	88	22	oral	oral	ADJ
dpc-1651	88	23	aphthae	aphthae	NOUN
dpc-1651	88	24	[	[	X
dpc-1651	88	25	2,13	2,13	NUM
dpc-1651	88	26	]	]	PUNCT
dpc-1651	88	27	.	.	PUNCT
dpc-1651	89	1	anesthetics	anesthetic	NOUN
dpc-1651	89	2	such	such	ADJ
dpc-1651	89	3	as	as	ADP
dpc-1651	89	4	topical	topical	ADJ
dpc-1651	89	5	lidocaine	lidocaine	NOUN
dpc-1651	89	6	(	(	PUNCT
dpc-1651	89	7	2	2	NUM
dpc-1651	89	8	%	%	NOUN
dpc-1651	89	9	viscous	viscous	ADJ
dpc-1651	89	10	solution	solution	NOUN
dpc-1651	89	11	,	,	PUNCT
dpc-1651	89	12	gel	gel	NOUN
dpc-1651	89	13	,	,	PUNCT
dpc-1651	89	14	or	or	CCONJ
dpc-1651	89	15	spray	spray	NOUN
dpc-1651	89	16	)	)	PUNCT
dpc-1651	89	17	or	or	CCONJ
dpc-1651	89	18	benzocaine	benzocaine	NOUN
dpc-1651	89	19	have	have	AUX
dpc-1651	89	20	been	be	AUX
dpc-1651	89	21	used	use	VERB
dpc-1651	89	22	to	to	PART
dpc-1651	89	23	reduce	reduce	VERB
dpc-1651	89	24	the	the	DET
dpc-1651	89	25	pain	pain	NOUN
dpc-1651	89	26	associated	associate	VERB
dpc-1651	89	27	to	to	ADP
dpc-1651	89	28	ras	ras	PROPN
dpc-1651	90	1	[	[	X
dpc-1651	90	2	13	13	NUM
dpc-1651	90	3	]	]	PUNCT
dpc-1651	90	4	.	.	PUNCT
dpc-1651	91	1	occlusive	occlusive	PROPN
dpc-1651	91	2	and	and	CCONJ
dpc-1651	91	3	bioadherent	bioadherent	ADJ
dpc-1651	91	4	agents	agent	NOUN
dpc-1651	91	5	,	,	PUNCT
dpc-1651	91	6	such	such	ADJ
dpc-1651	91	7	as	as	ADP
dpc-1651	91	8	gelclair	gelclair	NOUN
dpc-1651	91	9	,	,	PUNCT
dpc-1651	91	10	sucralfate	sucralfate	ADJ
dpc-1651	91	11	,	,	PUNCT
dpc-1651	91	12	bismuth	bismuth	NOUN
dpc-1651	91	13	subsalicylate	subsalicylate	NOUN
dpc-1651	91	14	,	,	PUNCT
dpc-1651	91	15	and	and	CCONJ
dpc-1651	91	16	2	2	NUM
dpc-1651	91	17	-	-	PUNCT
dpc-1651	91	18	octyl	octyl	NOUN
dpc-1651	91	19	cyanoacrylate	cyanoacrylate	NOUN
dpc-1651	91	20	have	have	AUX
dpc-1651	91	21	been	be	AUX
dpc-1651	91	22	successfully	successfully	ADV
dpc-1651	91	23	used	use	VERB
dpc-1651	91	24	in	in	ADP
dpc-1651	91	25	ras	ras	PROPN
dpc-1651	91	26	management	management	NOUN
dpc-1651	91	27	,	,	PUNCT
dpc-1651	91	28	because	because	SCONJ
dpc-1651	91	29	they	they	PRON
dpc-1651	91	30	can	can	AUX
dpc-1651	91	31	generate	generate	VERB
dpc-1651	91	32	a	a	DET
dpc-1651	91	33	protective	protective	ADJ
dpc-1651	91	34	coating	coating	NOUN
dpc-1651	91	35	that	that	SCONJ
dpc-1651	91	36	shields	shield	NOUN
dpc-1651	91	37	exposed	expose	VERB
dpc-1651	91	38	and	and	CCONJ
dpc-1651	91	39	overstimulated	overstimulate	VERB
dpc-1651	91	40	nerve	nerve	NOUN
dpc-1651	91	41	endings	ending	NOUN
dpc-1651	92	1	[	[	X
dpc-1651	92	2	11	11	NUM
dpc-1651	92	3	]	]	PUNCT
dpc-1651	92	4	.	.	PUNCT
dpc-1651	93	1	systemic	systemic	ADJ
dpc-1651	93	2	agents	agent	NOUN
dpc-1651	93	3	systemic	systemic	ADJ
dpc-1651	93	4	therapy	therapy	NOUN
dpc-1651	93	5	includes	include	VERB
dpc-1651	93	6	the	the	DET
dpc-1651	93	7	following	follow	VERB
dpc-1651	93	8	drugs	drug	NOUN
dpc-1651	93	9	:	:	PUNCT
dpc-1651	93	10	colchicine	colchicine	PROPN
dpc-1651	93	11	,	,	PUNCT
dpc-1651	93	12	pentoxifylline	pentoxifylline	PROPN
dpc-1651	93	13	,	,	PUNCT
dpc-1651	93	14	steroids	steroid	NOUN
dpc-1651	93	15	,	,	PUNCT
dpc-1651	93	16	dapsone	dapsone	NOUN
dpc-1651	93	17	,	,	PUNCT
dpc-1651	93	18	thalidomide	thalidomide	NOUN
dpc-1651	93	19	,	,	PUNCT
dpc-1651	93	20	pidotimod	pidotimod	VERB
dpc-1651	93	21	[	[	X
dpc-1651	93	22	16,51,52	16,51,52	NUM
dpc-1651	93	23	]	]	PUNCT
dpc-1651	93	24	.	.	PUNCT
dpc-1651	94	1	colchicine	colchicine	PROPN
dpc-1651	94	2	was	be	AUX
dpc-1651	94	3	reported	report	VERB
dpc-1651	94	4	to	to	PART
dpc-1651	94	5	reduce	reduce	VERB
dpc-1651	94	6	the	the	DET
dpc-1651	94	7	amount	amount	NOUN
dpc-1651	94	8	and	and	CCONJ
dpc-1651	94	9	duration	duration	NOUN
dpc-1651	94	10	of	of	ADP
dpc-1651	94	11	aphthae	aphthae	NOUN
dpc-1651	94	12	in	in	ADP
dpc-1651	94	13	up	up	ADP
dpc-1651	94	14	to	to	PART
dpc-1651	94	15	63	63	NUM
dpc-1651	94	16	%	%	NOUN
dpc-1651	94	17	of	of	ADP
dpc-1651	94	18	patients	patient	NOUN
dpc-1651	94	19	with	with	ADP
dpc-1651	94	20	ras	ras	PROPN
dpc-1651	94	21	.	.	PROPN
dpc-1651	94	22	treatment	treatment	NOUN
dpc-1651	94	23	over	over	ADP
dpc-1651	94	24	6	6	NUM
dpc-1651	94	25	weeks	week	NOUN
dpc-1651	94	26	,	,	PUNCT
dpc-1651	94	27	followed	follow	VERB
dpc-1651	94	28	by	by	ADP
dpc-1651	94	29	long	long	ADJ
dpc-1651	94	30	-	-	PUNCT
dpc-1651	94	31	term	term	NOUN
dpc-1651	94	32	(	(	PUNCT
dpc-1651	94	33	years	year	NOUN
dpc-1651	94	34	)	)	PUNCT
dpc-1651	94	35	therapy	therapy	NOUN
dpc-1651	94	36	(	(	PUNCT
dpc-1651	94	37	1	1	NUM
dpc-1651	94	38	-	-	SYM
dpc-1651	94	39	2	2	NUM
dpc-1651	94	40	mg	mg	NOUN
dpc-1651	94	41	daily	daily	ADV
dpc-1651	94	42	)	)	PUNCT
dpc-1651	94	43	is	be	AUX
dpc-1651	94	44	recommended	recommend	VERB
dpc-1651	94	45	[	[	PUNCT
dpc-1651	94	46	53	53	NUM
dpc-1651	94	47	]	]	PUNCT
dpc-1651	94	48	.	.	PUNCT
dpc-1651	95	1	combination	combination	NOUN
dpc-1651	95	2	therapy	therapy	NOUN
dpc-1651	95	3	with	with	ADP
dpc-1651	95	4	colchicine	colchicine	PROPN
dpc-1651	95	5	and	and	CCONJ
dpc-1651	95	6	pentoxifylline	pentoxifylline	PROPN
dpc-1651	95	7	,	,	PUNCT
dpc-1651	95	8	benzathine	benzathine	ADJ
dpc-1651	95	9	penicillin	penicillin	NOUN
dpc-1651	95	10	,	,	PUNCT
dpc-1651	95	11	immunosuppressants	immunosuppressant	NOUN
dpc-1651	95	12	,	,	PUNCT
dpc-1651	95	13	or	or	CCONJ
dpc-1651	95	14	interferon	interferon	ADJ
dpc-1651	95	15	-	-	PUNCT
dpc-1651	95	16	alfa	alfa	NOUN
dpc-1651	95	17	is	be	AUX
dpc-1651	95	18	possible	possible	ADJ
dpc-1651	95	19	[	[	X
dpc-1651	95	20	52	52	NUM
dpc-1651	95	21	]	]	PUNCT
dpc-1651	95	22	.	.	PUNCT
dpc-1651	96	1	systemic	systemic	ADJ
dpc-1651	96	2	corticosteroids	corticosteroid	NOUN
dpc-1651	96	3	are	be	AUX
dpc-1651	96	4	prescribed	prescribe	VERB
dpc-1651	96	5	as	as	ADP
dpc-1651	96	6	rescue	rescue	NOUN
dpc-1651	96	7	therapy	therapy	NOUN
dpc-1651	96	8	in	in	ADP
dpc-1651	96	9	patients	patient	NOUN
dpc-1651	96	10	with	with	ADP
dpc-1651	96	11	acute	acute	ADJ
dpc-1651	96	12	flares	flare	NOUN
dpc-1651	96	13	and	and	CCONJ
dpc-1651	96	14	in	in	ADP
dpc-1651	96	15	those	those	PRON
dpc-1651	96	16	who	who	PRON
dpc-1651	96	17	inadequately	inadequately	ADV
dpc-1651	96	18	respond	respond	VERB
dpc-1651	96	19	to	to	ADP
dpc-1651	96	20	therapy	therapy	NOUN
dpc-1651	96	21	with	with	ADP
dpc-1651	96	22	colchicine	colchicine	PROPN
dpc-1651	96	23	and	and	CCONJ
dpc-1651	96	24	pentoxifylline	pentoxifylline	PROPN
dpc-1651	96	25	.	.	PUNCT
dpc-1651	97	1	oral	oral	ADJ
dpc-1651	97	2	prednisolone	prednisolone	PROPN
dpc-1651	97	3	or	or	CCONJ
dpc-1651	97	4	its	its	PRON
dpc-1651	97	5	equivalents	equivalent	NOUN
dpc-1651	97	6	,	,	PUNCT
dpc-1651	97	7	at	at	ADP
dpc-1651	97	8	10	10	NUM
dpc-1651	97	9	-	-	SYM
dpc-1651	97	10	30	30	NUM
dpc-1651	97	11	mg	mg	NOUN
dpc-1651	97	12	daily	daily	ADV
dpc-1651	97	13	for	for	ADP
dpc-1651	97	14	up	up	ADP
dpc-1651	97	15	to	to	PART
dpc-1651	97	16	1	1	NUM
dpc-1651	97	17	month	month	NOUN
dpc-1651	97	18	can	can	AUX
dpc-1651	97	19	be	be	AUX
dpc-1651	97	20	prescribed	prescribe	VERB
dpc-1651	97	21	during	during	ADP
dpc-1651	97	22	a	a	DET
dpc-1651	97	23	ras	ras	NOUN
dpc-1651	97	24	exacerbation	exacerbation	NOUN
dpc-1651	97	25	.	.	PUNCT
dpc-1651	98	1	intravenous	intravenous	ADJ
dpc-1651	98	2	pulse	pulse	NOUN
dpc-1651	98	3	therapy	therapy	NOUN
dpc-1651	98	4	at	at	ADP
dpc-1651	98	5	100	100	NUM
dpc-1651	98	6	mg	mg	NOUN
dpc-1651	98	7	daily	daily	ADV
dpc-1651	98	8	for	for	ADP
dpc-1651	98	9	3	3	NUM
dpc-1651	98	10	days	day	NOUN
dpc-1651	98	11	results	result	NOUN
dpc-1651	98	12	in	in	ADP
dpc-1651	98	13	quick	quick	ADJ
dpc-1651	98	14	improvement	improvement	NOUN
dpc-1651	98	15	for	for	ADP
dpc-1651	98	16	severe	severe	ADJ
dpc-1651	98	17	cases	case	NOUN
dpc-1651	98	18	of	of	ADP
dpc-1651	98	19	ras	ras	NOUN
dpc-1651	98	20	[	[	X
dpc-1651	98	21	2	2	NUM
dpc-1651	98	22	]	]	PUNCT
dpc-1651	98	23	.	.	PUNCT
dpc-1651	99	1	dapsone	dapsone	PROPN
dpc-1651	99	2	(	(	PUNCT
dpc-1651	99	3	100	100	NUM
dpc-1651	99	4	mg	mg	NOUN
dpc-1651	99	5	daily	daily	ADV
dpc-1651	99	6	)	)	PUNCT
dpc-1651	99	7	can	can	AUX
dpc-1651	99	8	be	be	AUX
dpc-1651	99	9	prescribed	prescribe	VERB
dpc-1651	99	10	for	for	ADP
dpc-1651	99	11	oral	oral	ADJ
dpc-1651	99	12	and	and	CCONJ
dpc-1651	99	13	genital	genital	ADJ
dpc-1651	99	14	aphthae	aphthae	NOUN
dpc-1651	99	15	;	;	PUNCT
dpc-1651	99	16	however	however	ADV
dpc-1651	99	17	,	,	PUNCT
dpc-1651	99	18	rapid	rapid	ADJ
dpc-1651	99	19	relapses	relapse	NOUN
dpc-1651	99	20	can	can	AUX
dpc-1651	99	21	occur	occur	VERB
dpc-1651	99	22	after	after	ADP
dpc-1651	99	23	discontinuation	discontinuation	NOUN
dpc-1651	99	24	of	of	ADP
dpc-1651	99	25	therapy	therapy	NOUN
dpc-1651	99	26	.	.	PUNCT
dpc-1651	100	1	thalidomide	thalidomide	VERB
dpc-1651	100	2	at	at	ADP
dpc-1651	100	3	standard	standard	ADJ
dpc-1651	100	4	(	(	PUNCT
dpc-1651	100	5	100	100	NUM
dpc-1651	100	6	-	-	SYM
dpc-1651	100	7	300	300	NUM
dpc-1651	100	8	mg	mg	NOUN
dpc-1651	100	9	daily	daily	ADV
dpc-1651	100	10	)	)	PUNCT
dpc-1651	100	11	or	or	CCONJ
dpc-1651	100	12	low	low	ADJ
dpc-1651	100	13	(	(	PUNCT
dpc-1651	100	14	50	50	NUM
dpc-1651	100	15	mg	mg	NOUN
dpc-1651	100	16	daily	daily	ADV
dpc-1651	100	17	)	)	PUNCT
dpc-1651	100	18	dosing	dose	VERB
dpc-1651	100	19	levels	level	NOUN
dpc-1651	100	20	was	be	AUX
dpc-1651	100	21	shown	show	VERB
dpc-1651	100	22	to	to	PART
dpc-1651	100	23	be	be	AUX
dpc-1651	100	24	effective	effective	ADJ
dpc-1651	100	25	within	within	ADP
dpc-1651	100	26	7	7	NUM
dpc-1651	100	27	-	-	SYM
dpc-1651	100	28	10	10	NUM
dpc-1651	100	29	weeks	week	NOUN
dpc-1651	100	30	following	follow	VERB
dpc-1651	100	31	administration	administration	NOUN
dpc-1651	101	1	[	[	X
dpc-1651	101	2	54	54	NUM
dpc-1651	101	3	]	]	PUNCT
dpc-1651	101	4	.	.	PUNCT
dpc-1651	102	1	in	in	ADP
dpc-1651	102	2	a	a	DET
dpc-1651	102	3	recent	recent	ADJ
dpc-1651	102	4	study	study	NOUN
dpc-1651	102	5	a	a	DET
dpc-1651	102	6	new	new	ADJ
dpc-1651	102	7	therapeutic	therapeutic	ADJ
dpc-1651	102	8	high	high	ADJ
dpc-1651	102	9	dosage	dosage	NOUN
dpc-1651	102	10	of	of	ADP
dpc-1651	102	11	pidotimod	pidotimod	NOUN
dpc-1651	102	12	in	in	ADP
dpc-1651	102	13	children	child	NOUN
dpc-1651	102	14	with	with	ADP
dpc-1651	102	15	pfapa	pfapa	ADJ
dpc-1651	102	16	(	(	PUNCT
dpc-1651	102	17	including	include	VERB
dpc-1651	102	18	ras	ras	NOUN
dpc-1651	102	19	)	)	PUNCT
dpc-1651	102	20	showed	show	VERB
dpc-1651	102	21	promising	promising	ADJ
dpc-1651	102	22	results	result	NOUN
dpc-1651	102	23	.	.	PUNCT
dpc-1651	103	1	pidotimod	pidotimod	NOUN
dpc-1651	103	2	is	be	AUX
dpc-1651	103	3	an	an	DET
dpc-1651	103	4	immunomodulatory	immunomodulatory	ADJ
dpc-1651	103	5	agent	agent	NOUN
dpc-1651	103	6	that	that	PRON
dpc-1651	103	7	increases	increase	VERB
dpc-1651	103	8	antigen	antigen	ADJ
dpc-1651	103	9	presentation	presentation	NOUN
dpc-1651	103	10	and	and	CCONJ
dpc-1651	103	11	promotes	promote	VERB
dpc-1651	103	12	adaptive	adaptive	ADJ
dpc-1651	103	13	th1	th1	PROPN
dpc-1651	103	14	-	-	PUNCT
dpc-1651	103	15	mediated	mediate	VERB
dpc-1651	103	16	immunity	immunity	NOUN
dpc-1651	103	17	[	[	X
dpc-1651	103	18	55	55	NUM
dpc-1651	103	19	]	]	PUNCT
dpc-1651	103	20	.	.	PUNCT
dpc-1651	104	1	low	low	ADJ
dpc-1651	104	2	laser	laser	NOUN
dpc-1651	104	3	therapy	therapy	NOUN
dpc-1651	104	4	four	four	NUM
dpc-1651	104	5	types	type	NOUN
dpc-1651	104	6	of	of	ADP
dpc-1651	104	7	lasers	laser	NOUN
dpc-1651	104	8	have	have	AUX
dpc-1651	104	9	been	be	AUX
dpc-1651	104	10	described	describe	VERB
dpc-1651	104	11	in	in	ADP
dpc-1651	104	12	aphthae	aphthae	ADJ
dpc-1651	104	13	treatment	treatment	NOUN
dpc-1651	104	14	:	:	PUNCT
dpc-1651	104	15	co2	co2	NOUN
dpc-1651	104	16	,	,	PUNCT
dpc-1651	104	17	nd	nd	PRON
dpc-1651	104	18	:	:	PUNCT
dpc-1651	104	19	yag	yag	NOUN
dpc-1651	104	20	,	,	PUNCT
dpc-1651	104	21	diode	diode	NOUN
dpc-1651	104	22	,	,	PUNCT
dpc-1651	104	23	and	and	CCONJ
dpc-1651	104	24	ga1as	ga1as	NOUN
dpc-1651	105	1	[	[	X
dpc-1651	105	2	56	56	NUM
dpc-1651	105	3	]	]	PUNCT
dpc-1651	105	4	.	.	PUNCT
dpc-1651	106	1	the	the	DET
dpc-1651	106	2	main	main	ADJ
dpc-1651	106	3	goal	goal	NOUN
dpc-1651	106	4	of	of	ADP
dpc-1651	106	5	treatment	treatment	NOUN
dpc-1651	106	6	is	be	AUX
dpc-1651	106	7	to	to	PART
dpc-1651	106	8	decrease	decrease	VERB
dpc-1651	106	9	pain	pain	NOUN
dpc-1651	106	10	,	,	PUNCT
dpc-1651	106	11	healing	healing	NOUN
dpc-1651	106	12	time	time	NOUN
dpc-1651	106	13	,	,	PUNCT
dpc-1651	106	14	number	number	NOUN
dpc-1651	106	15	,	,	PUNCT
dpc-1651	106	16	and	and	CCONJ
dpc-1651	106	17	size	size	NOUN
dpc-1651	106	18	of	of	ADP
dpc-1651	106	19	ulcers	ulcer	NOUN
dpc-1651	106	20	.	.	PUNCT
dpc-1651	107	1	the	the	DET
dpc-1651	107	2	main	main	ADJ
dpc-1651	107	3	advantage	advantage	NOUN
dpc-1651	107	4	of	of	ADP
dpc-1651	107	5	laser	laser	NOUN
dpc-1651	107	6	therapy	therapy	NOUN
dpc-1651	107	7	over	over	ADP
dpc-1651	107	8	other	other	ADJ
dpc-1651	107	9	treatments	treatment	NOUN
dpc-1651	107	10	is	be	AUX
dpc-1651	107	11	that	that	SCONJ
dpc-1651	107	12	it	it	PRON
dpc-1651	107	13	can	can	AUX
dpc-1651	107	14	be	be	AUX
dpc-1651	107	15	used	use	VERB
dpc-1651	107	16	for	for	ADP
dpc-1651	107	17	all	all	DET
dpc-1651	107	18	the	the	DET
dpc-1651	107	19	causes	cause	NOUN
dpc-1651	107	20	of	of	ADP
dpc-1651	107	21	the	the	DET
dpc-1651	107	22	disease	disease	NOUN
dpc-1651	107	23	without	without	ADP
dpc-1651	107	24	systemic	systemic	ADJ
dpc-1651	107	25	side	side	NOUN
dpc-1651	107	26	effects	effect	NOUN
dpc-1651	107	27	.	.	PUNCT
dpc-1651	108	1	adamantiades	adamantiade	NOUN
dpc-1651	108	2	-	-	PUNCT
dpc-1651	108	3	behçet	behçet	ADJ
dpc-1651	108	4	disease	disease	NOUN
dpc-1651	108	5	systemic	systemic	ADJ
dpc-1651	108	6	glucocorticoids	glucocorticoid	NOUN
dpc-1651	108	7	are	be	AUX
dpc-1651	108	8	effective	effective	ADJ
dpc-1651	108	9	for	for	ADP
dpc-1651	108	10	most	most	ADJ
dpc-1651	108	11	manifestations	manifestation	NOUN
dpc-1651	108	12	of	of	ADP
dpc-1651	108	13	abd	abd	PROPN
dpc-1651	108	14	.	.	PUNCT
dpc-1651	109	1	they	they	PRON
dpc-1651	109	2	are	be	AUX
dpc-1651	109	3	administered	administer	VERB
dpc-1651	109	4	at	at	ADP
dpc-1651	109	5	doses	dose	NOUN
dpc-1651	109	6	of	of	ADP
dpc-1651	109	7	50	50	NUM
dpc-1651	109	8	-	-	SYM
dpc-1651	109	9	60	60	NUM
dpc-1651	109	10	mg	mg	NOUN
dpc-1651	109	11	of	of	ADP
dpc-1651	109	12	prednisone	prednisone	NOUN
dpc-1651	109	13	per	per	ADP
dpc-1651	109	14	day	day	NOUN
dpc-1651	109	15	,	,	PUNCT
dpc-1651	109	16	or	or	CCONJ
dpc-1651	109	17	the	the	DET
dpc-1651	109	18	equivalent	equivalent	NOUN
dpc-1651	109	19	,	,	PUNCT
dpc-1651	109	20	with	with	ADP
dpc-1651	109	21	a	a	DET
dpc-1651	109	22	tapering	taper	VERB
dpc-1651	109	23	scheme	scheme	NOUN
dpc-1651	109	24	[	[	X
dpc-1651	109	25	14,15	14,15	NUM
dpc-1651	109	26	]	]	X
dpc-1651	109	27	.	.	PUNCT
dpc-1651	110	1	therefore	therefore	ADV
dpc-1651	110	2	,	,	PUNCT
dpc-1651	110	3	other	other	ADJ
dpc-1651	110	4	therapies	therapy	NOUN
dpc-1651	110	5	are	be	AUX
dpc-1651	110	6	often	often	ADV
dpc-1651	110	7	used	use	VERB
dpc-1651	110	8	instead	instead	ADV
dpc-1651	110	9	of	of	ADP
dpc-1651	110	10	,	,	PUNCT
dpc-1651	110	11	or	or	CCONJ
dpc-1651	110	12	as	as	ADP
dpc-1651	110	13	an	an	DET
dpc-1651	110	14	adjunct	adjunct	ADJ
dpc-1651	110	15	to	to	ADP
dpc-1651	110	16	systemic	systemic	ADJ
dpc-1651	110	17	glucocorticoid	glucocorticoid	ADJ
dpc-1651	110	18	therapy	therapy	NOUN
dpc-1651	110	19	,	,	PUNCT
dpc-1651	110	20	such	such	ADJ
dpc-1651	110	21	as	as	ADP
dpc-1651	110	22	4	4	NUM
dpc-1651	110	23	review	review	NOUN
dpc-1651	110	24	|	|	ADV
dpc-1651	110	25	dermatol	dermatol	ADJ
dpc-1651	110	26	pract	pract	NOUN
dpc-1651	110	27	concept	concept	NOUN
dpc-1651	110	28	.	.	PUNCT
dpc-1651	111	1	2021;11(4):e2021099	2021;11(4):e2021099	NUM
dpc-1651	111	2	cyclosporine	cyclosporine	NOUN
dpc-1651	111	3	,	,	PUNCT
dpc-1651	111	4	colchicine	colchicine	PROPN
dpc-1651	111	5	,	,	PUNCT
dpc-1651	111	6	cyclophosphamide	cyclophosphamide	NOUN
dpc-1651	111	7	,	,	PUNCT
dpc-1651	111	8	dapsone	dapsone	PROPN
dpc-1651	111	9	,	,	PUNCT
dpc-1651	111	10	infliximab	infliximab	NOUN
dpc-1651	111	11	,	,	PUNCT
dpc-1651	111	12	interferon	interferon	ADJ
dpc-1651	111	13	alfa-2a	alfa-2a	NOUN
dpc-1651	111	14	,	,	PUNCT
dpc-1651	111	15	and	and	CCONJ
dpc-1651	111	16	thalidomide	thalidomide	VERB
dpc-1651	111	17	[	[	PUNCT
dpc-1651	111	18	14	14	NUM
dpc-1651	111	19	-	-	SYM
dpc-1651	111	20	16,49,52	16,49,52	NUM
dpc-1651	111	21	]	]	PUNCT
dpc-1651	111	22	.	.	PUNCT
dpc-1651	112	1	when	when	SCONJ
dpc-1651	112	2	mucocutaneous	mucocutaneous	ADJ
dpc-1651	112	3	lesions	lesion	NOUN
dpc-1651	112	4	are	be	AUX
dpc-1651	112	5	the	the	DET
dpc-1651	112	6	main	main	ADJ
dpc-1651	112	7	concern	concern	NOUN
dpc-1651	112	8	in	in	ADP
dpc-1651	112	9	patients	patient	NOUN
dpc-1651	112	10	with	with	ADP
dpc-1651	112	11	mild	mild	ADJ
dpc-1651	112	12	-	-	PUNCT
dpc-1651	112	13	to	to	ADP
dpc-1651	112	14	-	-	PUNCT
dpc-1651	112	15	moderate	moderate	ADJ
dpc-1651	112	16	aphthosis	aphthosis	NOUN
dpc-1651	112	17	,	,	PUNCT
dpc-1651	112	18	the	the	DET
dpc-1651	112	19	application	application	NOUN
dpc-1651	112	20	of	of	ADP
dpc-1651	112	21	topical	topical	ADJ
dpc-1651	112	22	steroids	steroid	NOUN
dpc-1651	112	23	may	may	AUX
dpc-1651	112	24	obviate	obviate	VERB
dpc-1651	112	25	the	the	DET
dpc-1651	112	26	need	need	NOUN
dpc-1651	112	27	for	for	ADP
dpc-1651	112	28	systemic	systemic	ADJ
dpc-1651	112	29	therapy	therapy	NOUN
dpc-1651	112	30	,	,	PUNCT
dpc-1651	112	31	mild	mild	ADJ
dpc-1651	112	32	aphthosis	aphthosis	NOUN
dpc-1651	112	33	may	may	AUX
dpc-1651	112	34	also	also	ADV
dpc-1651	112	35	benefit	benefit	VERB
dpc-1651	112	36	from	from	ADP
dpc-1651	112	37	the	the	DET
dpc-1651	112	38	applications	application	NOUN
dpc-1651	112	39	of	of	ADP
dpc-1651	112	40	topical	topical	ADJ
dpc-1651	112	41	sucralfate	sucralfate	NOUN
dpc-1651	112	42	,	,	PUNCT
dpc-1651	112	43	topical	topical	ADJ
dpc-1651	112	44	tetracycline	tetracycline	NOUN
dpc-1651	112	45	,	,	PUNCT
dpc-1651	112	46	or	or	CCONJ
dpc-1651	112	47	a	a	DET
dpc-1651	112	48	course	course	NOUN
dpc-1651	112	49	of	of	ADP
dpc-1651	112	50	zinc	zinc	NOUN
dpc-1651	112	51	sulfate	sulfate	NOUN
dpc-1651	112	52	(	(	PUNCT
dpc-1651	112	53	100	100	NUM
dpc-1651	112	54	mg	mg	ADV
dpc-1651	112	55	orally	orally	ADV
dpc-1651	112	56	twice	twice	ADV
dpc-1651	112	57	daily	daily	ADV
dpc-1651	112	58	)	)	PUNCT
dpc-1651	112	59	or	or	CCONJ
dpc-1651	112	60	azithromycin	azithromycin	PROPN
dpc-1651	112	61	(	(	PUNCT
dpc-1651	112	62	500	500	NUM
dpc-1651	112	63	mg	mg	NOUN
dpc-1651	112	64	orally	orally	ADV
dpc-1651	112	65	3	3	NUM
dpc-1651	112	66	times	time	NOUN
dpc-1651	112	67	weekly	weekly	ADJ
dpc-1651	112	68	)	)	PUNCT
dpc-1651	113	1	[	[	X
dpc-1651	113	2	51	51	NUM
dpc-1651	113	3	]	]	PUNCT
dpc-1651	113	4	.	.	PUNCT
dpc-1651	114	1	azathioprine	azathioprine	PROPN
dpc-1651	114	2	also	also	ADV
dpc-1651	114	3	proved	prove	VERB
dpc-1651	114	4	to	to	PART
dpc-1651	114	5	be	be	AUX
dpc-1651	114	6	effective	effective	ADJ
dpc-1651	114	7	in	in	ADP
dpc-1651	114	8	a	a	DET
dpc-1651	114	9	randomized	randomized	ADJ
dpc-1651	114	10	clinical	clinical	ADJ
dpc-1651	114	11	trial	trial	NOUN
dpc-1651	114	12	for	for	ADP
dpc-1651	114	13	the	the	DET
dpc-1651	114	14	prevention	prevention	NOUN
dpc-1651	114	15	of	of	ADP
dpc-1651	114	16	both	both	CCONJ
dpc-1651	114	17	oral	oral	ADJ
dpc-1651	114	18	and	and	CCONJ
dpc-1651	114	19	genital	genital	ADJ
dpc-1651	114	20	ulcers	ulcer	NOUN
dpc-1651	114	21	.	.	PUNCT
dpc-1651	115	1	in	in	ADP
dpc-1651	115	2	patients	patient	NOUN
dpc-1651	115	3	with	with	ADP
dpc-1651	115	4	more	more	ADV
dpc-1651	115	5	severe	severe	ADJ
dpc-1651	115	6	,	,	PUNCT
dpc-1651	115	7	recalcitrant	recalcitrant	ADJ
dpc-1651	115	8	mucocutaneous	mucocutaneous	ADJ
dpc-1651	115	9	lesions	lesion	NOUN
dpc-1651	115	10	,	,	PUNCT
dpc-1651	115	11	dapsone	dapsone	X
dpc-1651	115	12	(	(	PUNCT
dpc-1651	115	13	100	100	NUM
dpc-1651	115	14	mg	mg	NOUN
dpc-1651	115	15	daily	daily	ADV
dpc-1651	115	16	)	)	PUNCT
dpc-1651	115	17	and	and	CCONJ
dpc-1651	115	18	thalidomide	thalidomide	NOUN
dpc-1651	115	19	(	(	PUNCT
dpc-1651	115	20	100	100	NUM
dpc-1651	115	21	mg	mg	NOUN
dpc-1651	115	22	daily	daily	ADV
dpc-1651	115	23	)	)	PUNCT
dpc-1651	115	24	are	be	AUX
dpc-1651	115	25	considered	consider	VERB
dpc-1651	115	26	particularly	particularly	ADV
dpc-1651	115	27	effective	effective	ADJ
dpc-1651	115	28	.	.	PUNCT
dpc-1651	116	1	conclusions	conclusion	NOUN
dpc-1651	116	2	recurrent	recurrent	VERB
dpc-1651	116	3	aphthous	aphthous	ADJ
dpc-1651	116	4	stomatitis	stomatitis	NOUN
dpc-1651	116	5	is	be	AUX
dpc-1651	116	6	a	a	DET
dpc-1651	116	7	common	common	ADJ
dpc-1651	116	8	disorder	disorder	NOUN
dpc-1651	116	9	affecting	affect	VERB
dpc-1651	116	10	the	the	DET
dpc-1651	116	11	oral	oral	ADJ
dpc-1651	116	12	cavity	cavity	NOUN
dpc-1651	116	13	with	with	ADP
dpc-1651	116	14	3	3	NUM
dpc-1651	116	15	main	main	ADJ
dpc-1651	116	16	presentations	presentation	NOUN
dpc-1651	116	17	:	:	PUNCT
dpc-1651	116	18	minor	minor	ADJ
dpc-1651	116	19	,	,	PUNCT
dpc-1651	116	20	major	major	ADJ
dpc-1651	116	21	or	or	CCONJ
dpc-1651	116	22	herpetiformis	herpetiformis	ADJ
dpc-1651	116	23	ulcers	ulcer	NOUN
dpc-1651	116	24	.	.	PUNCT
dpc-1651	117	1	an	an	DET
dpc-1651	117	2	ras	ras	NOUN
dpc-1651	117	3	diagnosis	diagnosis	NOUN
dpc-1651	117	4	is	be	AUX
dpc-1651	117	5	often	often	ADV
dpc-1651	117	6	based	base	VERB
dpc-1651	117	7	on	on	ADP
dpc-1651	117	8	history	history	NOUN
dpc-1651	117	9	and	and	CCONJ
dpc-1651	117	10	clinical	clinical	ADJ
dpc-1651	117	11	findings	finding	NOUN
dpc-1651	117	12	.	.	PUNCT
dpc-1651	118	1	recurrent	recurrent	ADJ
dpc-1651	118	2	oral	oral	ADJ
dpc-1651	118	3	ulcerative	ulcerative	ADJ
dpc-1651	118	4	lesions	lesion	NOUN
dpc-1651	118	5	are	be	AUX
dpc-1651	118	6	rarely	rarely	ADV
dpc-1651	118	7	associated	associate	VERB
dpc-1651	118	8	with	with	ADP
dpc-1651	118	9	several	several	ADJ
dpc-1651	118	10	complex	complex	ADJ
dpc-1651	118	11	inflammatory	inflammatory	ADJ
dpc-1651	118	12	syndromes	syndrome	NOUN
dpc-1651	118	13	and	and	CCONJ
dpc-1651	118	14	to	to	ADP
dpc-1651	118	15	viral	viral	ADJ
dpc-1651	118	16	or	or	CCONJ
dpc-1651	118	17	bacterial	bacterial	ADJ
dpc-1651	118	18	infections	infection	NOUN
dpc-1651	118	19	.	.	PUNCT
dpc-1651	119	1	therefore	therefore	ADV
dpc-1651	119	2	,	,	PUNCT
dpc-1651	119	3	it	it	PRON
dpc-1651	119	4	is	be	AUX
dpc-1651	119	5	always	always	ADV
dpc-1651	119	6	important	important	ADJ
dpc-1651	119	7	to	to	PART
dpc-1651	119	8	exclude	exclude	VERB
dpc-1651	119	9	the	the	DET
dpc-1651	119	10	presence	presence	NOUN
dpc-1651	119	11	of	of	ADP
dpc-1651	119	12	a	a	DET
dpc-1651	119	13	systemic	systemic	ADJ
dpc-1651	119	14	or	or	CCONJ
dpc-1651	119	15	an	an	DET
dpc-1651	119	16	infectious	infectious	ADJ
dpc-1651	119	17	disease	disease	NOUN
dpc-1651	119	18	before	before	ADP
dpc-1651	119	19	starting	start	VERB
dpc-1651	119	20	an	an	DET
dpc-1651	119	21	immunosuppressive	immunosuppressive	ADJ
dpc-1651	119	22	or	or	CCONJ
dpc-1651	119	23	an	an	DET
dpc-1651	119	24	immunomodulatory	immunomodulatory	ADJ
dpc-1651	119	25	therapy	therapy	NOUN
dpc-1651	119	26	.	.	PUNCT
dpc-1651	120	1	references	reference	NOUN
dpc-1651	120	2	1	1	NUM
dpc-1651	120	3	.	.	PUNCT
dpc-1651	121	1	giannetti	giannetti	PROPN
dpc-1651	121	2	l	l	PROPN
dpc-1651	121	3	,	,	PUNCT
dpc-1651	121	4	murri	murri	PROPN
dpc-1651	121	5	dello	dello	PROPN
dpc-1651	121	6	diago	diago	PROPN
dpc-1651	122	1	a	a	X
dpc-1651	122	2	,	,	PUNCT
dpc-1651	122	3	lo	lo	PROPN
dpc-1651	122	4	muzio	muzio	PROPN
dpc-1651	122	5	l.	l.	PROPN
dpc-1651	122	6	recurrent	recurrent	PROPN
dpc-1651	122	7	aphtous	aphtous	ADJ
dpc-1651	122	8	stomatitis	stomatitis	PROPN
dpc-1651	122	9	.	.	PUNCT
dpc-1651	123	1	minerva	minerva	PROPN
dpc-1651	123	2	stomatol	stomatol	PROPN
dpc-1651	123	3	.	.	PUNCT
dpc-1651	124	1	2018;67(3):125–128	2018;67(3):125–128	X
dpc-1651	124	2	.	.	PUNCT
dpc-1651	125	1	doi	doi	NOUN
dpc-1651	125	2	:	:	PUNCT
dpc-1651	125	3	10.23736	10.23736	NUM
dpc-1651	125	4	/	/	SYM
dpc-1651	125	5	s0026	s0026	PROPN
dpc-1651	125	6	-	-	PUNCT
dpc-1651	125	7	4970.18.04137	4970.18.04137	NOUN
dpc-1651	125	8	-	-	PUNCT
dpc-1651	125	9	7	7	NUM
dpc-1651	125	10	.	.	PUNCT
dpc-1651	126	1	pmid	pmid	NOUN
dpc-1651	126	2	:	:	PUNCT
dpc-1651	126	3	29332375	29332375	NUM
dpc-1651	126	4	.	.	PUNCT
dpc-1651	127	1	2	2	X
dpc-1651	127	2	.	.	X
dpc-1651	127	3	edgar	edgar	PROPN
dpc-1651	127	4	nr	nr	PROPN
dpc-1651	127	5	,	,	PUNCT
dpc-1651	127	6	saleh	saleh	PROPN
dpc-1651	127	7	d	d	PROPN
dpc-1651	127	8	,	,	PUNCT
dpc-1651	127	9	miller	miller	PROPN
dpc-1651	127	10	ra	ra	PROPN
dpc-1651	127	11	.	.	PUNCT
dpc-1651	128	1	recurrent	recurrent	ADJ
dpc-1651	128	2	aphthous	aphthous	ADJ
dpc-1651	128	3	stomatitis	stomatitis	NOUN
dpc-1651	128	4	:	:	PUNCT
dpc-1651	128	5	a	a	DET
dpc-1651	128	6	review	review	NOUN
dpc-1651	128	7	.	.	PUNCT
dpc-1651	129	1	j	j	PROPN
dpc-1651	129	2	clin	clin	PROPN
dpc-1651	129	3	aesthetic	aesthetic	ADJ
dpc-1651	129	4	dermatol	dermatol	NOUN
dpc-1651	129	5	.	.	PUNCT
dpc-1651	130	1	2017;10(3):26–36	2017;10(3):26–36	NUM
dpc-1651	130	2	.	.	PUNCT
dpc-1651	131	1	3	3	X
dpc-1651	131	2	.	.	PUNCT
dpc-1651	131	3	giannetti	giannetti	PROPN
dpc-1651	131	4	l	l	PROPN
dpc-1651	131	5	,	,	PUNCT
dpc-1651	131	6	generali	generali	PROPN
dpc-1651	131	7	l	l	PROPN
dpc-1651	131	8	,	,	PUNCT
dpc-1651	131	9	bertoldi	bertoldi	PROPN
dpc-1651	131	10	c.	c.	PROPN
dpc-1651	131	11	oral	oral	PROPN
dpc-1651	131	12	pemphigus	pemphigus	PROPN
dpc-1651	131	13	.	.	PUNCT
dpc-1651	132	1	g	g	PROPN
dpc-1651	132	2	ital	ital	ADJ
dpc-1651	132	3	dermatol	dermatol	NOUN
dpc-1651	132	4	venereol	venereol	NOUN
dpc-1651	132	5	.	.	PUNCT
dpc-1651	133	1	2018;153(3):383–388	2018;153(3):383–388	NUM
dpc-1651	133	2	.	.	X
dpc-1651	133	3	doi	doi	NOUN
dpc-1651	133	4	:	:	PUNCT
dpc-1651	133	5	10.23736	10.23736	NUM
dpc-1651	133	6	/	/	SYM
dpc-1651	133	7	s03920488.18.05887	s03920488.18.05887	PROPN
dpc-1651	133	8	-	-	PUNCT
dpc-1651	133	9	x.	x.	NOUN
dpc-1651	133	10	pmid	pmid	PROPN
dpc-1651	133	11	:	:	PUNCT
dpc-1651	133	12	29512980	29512980	NUM
dpc-1651	133	13	.	.	PUNCT
dpc-1651	134	1	4	4	X
dpc-1651	134	2	.	.	X
dpc-1651	134	3	schmidt	schmidt	PROPN
dpc-1651	134	4	e	e	PROPN
dpc-1651	134	5	,	,	PUNCT
dpc-1651	134	6	kasperkiewicz	kasperkiewicz	PROPN
dpc-1651	134	7	m	m	PROPN
dpc-1651	134	8	,	,	PUNCT
dpc-1651	134	9	joly	joly	PROPN
dpc-1651	134	10	p.	p.	PROPN
dpc-1651	134	11	pemphigus	pemphigus	PROPN
dpc-1651	134	12	.	.	PUNCT
dpc-1651	134	13	lancet	lancet	PROPN
dpc-1651	134	14	.	.	PUNCT
dpc-1651	135	1	2019	2019	NUM
dpc-1651	135	2	;	;	PUNCT
dpc-1651	135	3	394(10201):882–894	394(10201):882–894	NUM
dpc-1651	135	4	.	.	PUNCT
dpc-1651	135	5	doi	doi	PROPN
dpc-1651	135	6	:	:	PUNCT
dpc-1651	135	7	10.1016	10.1016	NUM
dpc-1651	135	8	/	/	SYM
dpc-1651	135	9	s0140	s0140	PROPN
dpc-1651	135	10	-	-	PUNCT
dpc-1651	135	11	6736(19)31778	6736(19)31778	NUM
dpc-1651	135	12	-	-	SYM
dpc-1651	135	13	7	7	NUM
dpc-1651	135	14	.	.	NOUN
dpc-1651	135	15	5	5	NUM
dpc-1651	135	16	.	.	PUNCT
dpc-1651	135	17	alrashdan	alrashdan	PROPN
dpc-1651	135	18	ms	ms	PROPN
dpc-1651	135	19	,	,	PUNCT
dpc-1651	135	20	cirillo	cirillo	PROPN
dpc-1651	135	21	n	n	PROPN
dpc-1651	135	22	,	,	PUNCT
dpc-1651	135	23	mccullough	mccullough	PROPN
dpc-1651	135	24	m.	m.	NOUN
dpc-1651	135	25	oral	oral	ADJ
dpc-1651	135	26	lichen	lichen	NOUN
dpc-1651	135	27	planus	planus	PROPN
dpc-1651	135	28	:	:	PUNCT
dpc-1651	135	29	a	a	DET
dpc-1651	135	30	literature	literature	NOUN
dpc-1651	135	31	review	review	NOUN
dpc-1651	135	32	and	and	CCONJ
dpc-1651	135	33	update	update	VERB
dpc-1651	135	34	.	.	PUNCT
dpc-1651	136	1	arch	arch	ADJ
dpc-1651	136	2	dermatol	dermatol	NOUN
dpc-1651	136	3	res	re	NOUN
dpc-1651	136	4	.	.	PUNCT
dpc-1651	137	1	2016;308(8):539	2016;308(8):539	NUM
dpc-1651	137	2	–	–	PUNCT
dpc-1651	137	3	551	551	NUM
dpc-1651	137	4	.	.	PUNCT
dpc-1651	138	1	doi	doi	NOUN
dpc-1651	138	2	:	:	PUNCT
dpc-1651	138	3	10.1007	10.1007	NUM
dpc-1651	138	4	/	/	SYM
dpc-1651	138	5	s00403	s00403	NOUN
dpc-1651	138	6	-	-	PUNCT
dpc-1651	138	7	016	016	NUM
dpc-1651	138	8	-	-	PUNCT
dpc-1651	138	9	1667	1667	NUM
dpc-1651	138	10	-	-	SYM
dpc-1651	138	11	2	2	NUM
dpc-1651	138	12	.	.	PUNCT
dpc-1651	139	1	pmid	pmid	NOUN
dpc-1651	139	2	:	:	PUNCT
dpc-1651	139	3	27349424	27349424	NUM
dpc-1651	139	4	.	.	PUNCT
dpc-1651	140	1	6	6	X
dpc-1651	140	2	.	.	PUNCT
dpc-1651	140	3	giannetti	giannetti	PROPN
dpc-1651	140	4	l	l	PROPN
dpc-1651	140	5	,	,	PUNCT
dpc-1651	140	6	dello	dello	PROPN
dpc-1651	140	7	diago	diago	PROPN
dpc-1651	140	8	am	be	AUX
dpc-1651	140	9	,	,	PUNCT
dpc-1651	140	10	spinas	spinas	PROPN
dpc-1651	140	11	e.	e.	PROPN
dpc-1651	140	12	oral	oral	PROPN
dpc-1651	140	13	lichen	lichen	PROPN
dpc-1651	140	14	planus	planus	NOUN
dpc-1651	140	15	.	.	PUNCT
dpc-1651	141	1	j	j	PROPN
dpc-1651	141	2	biol	biol	PROPN
dpc-1651	141	3	regul	regul	PROPN
dpc-1651	141	4	homeost	homeost	ADJ
dpc-1651	141	5	agents	agent	NOUN
dpc-1651	141	6	.	.	PUNCT
dpc-1651	142	1	2018;32(2):391–395	2018;32(2):391–395	X
dpc-1651	142	2	.	.	PUNCT
dpc-1651	143	1	pmid	pmid	NOUN
dpc-1651	143	2	:	:	PUNCT
dpc-1651	143	3	29685024	29685024	NUM
dpc-1651	143	4	.	.	PUNCT
dpc-1651	144	1	7	7	X
dpc-1651	144	2	.	.	X
dpc-1651	144	3	adamski	adamski	PROPN
dpc-1651	144	4	z	z	PROPN
dpc-1651	144	5	,	,	PUNCT
dpc-1651	144	6	burchardt	burchardt	PROPN
dpc-1651	144	7	d	d	PROPN
dpc-1651	144	8	,	,	PUNCT
dpc-1651	144	9	pawlaczyk	pawlaczyk	NOUN
dpc-1651	144	10	-	-	PUNCT
dpc-1651	144	11	kamieńska	kamieńska	NOUN
dpc-1651	144	12	t	t	PROPN
dpc-1651	144	13	,	,	PUNCT
dpc-1651	144	14	borysewicz	borysewicz	NOUN
dpc-1651	144	15	-	-	PUNCT
dpc-1651	144	16	lewicka	lewicka	NOUN
dpc-1651	144	17	m	m	NOUN
dpc-1651	144	18	,	,	PUNCT
dpc-1651	144	19	wyganowska	wyganowska	NOUN
dpc-1651	144	20	-	-	PUNCT
dpc-1651	144	21	świątkowska	świątkowska	NOUN
dpc-1651	144	22	m.	m.	NOUN
dpc-1651	144	23	diagnosis	diagnosis	NOUN
dpc-1651	144	24	of	of	ADP
dpc-1651	144	25	papillon	papillon	NOUN
dpc-1651	144	26	-	-	PUNCT
dpc-1651	144	27	lefèvre	lefèvre	NOUN
dpc-1651	144	28	syndrome	syndrome	NOUN
dpc-1651	144	29	:	:	PUNCT
dpc-1651	144	30	review	review	NOUN
dpc-1651	144	31	of	of	ADP
dpc-1651	144	32	the	the	DET
dpc-1651	144	33	literature	literature	NOUN
dpc-1651	144	34	and	and	CCONJ
dpc-1651	144	35	a	a	DET
dpc-1651	144	36	case	case	NOUN
dpc-1651	144	37	report	report	NOUN
dpc-1651	144	38	.	.	PUNCT
dpc-1651	145	1	postepy	postepy	ADJ
dpc-1651	145	2	dermatol	dermatol	NOUN
dpc-1651	145	3	alergol	alergol	NOUN
dpc-1651	145	4	.	.	PUNCT
dpc-1651	146	1	2020;37(5):671–676	2020;37(5):671–676	NUM
dpc-1651	146	2	.	.	X
dpc-1651	147	1	doi	doi	NOUN
dpc-1651	147	2	:	:	PUNCT
dpc-1651	147	3	10.5114	10.5114	NUM
dpc-1651	147	4	/	/	SYM
dpc-1651	147	5	ada.2020.100480	ada.2020.100480	NOUN
dpc-1651	147	6	.	.	PUNCT
dpc-1651	148	1	pmid	pmid	NOUN
dpc-1651	148	2	:	:	PUNCT
dpc-1651	148	3	33240004	33240004	NUM
dpc-1651	148	4	.	.	PUNCT
dpc-1651	149	1	8	8	X
dpc-1651	149	2	.	.	X
dpc-1651	150	1	ferreli	ferreli	VERB
dpc-1651	150	2	c	c	NOUN
dpc-1651	150	3	,	,	PUNCT
dpc-1651	150	4	giannetti	giannetti	PROPN
dpc-1651	150	5	l	l	NOUN
dpc-1651	150	6	,	,	PUNCT
dpc-1651	150	7	robustelli	robustelli	NOUN
dpc-1651	150	8	test	test	NOUN
dpc-1651	150	9	e	e	NOUN
dpc-1651	150	10	,	,	PUNCT
dpc-1651	150	11	atzori	atzori	PROPN
dpc-1651	150	12	l	l	PROPN
dpc-1651	150	13	,	,	PUNCT
dpc-1651	150	14	rongioletti	rongioletti	PROPN
dpc-1651	150	15	f.	f.	PROPN
dpc-1651	150	16	linear	linear	PROPN
dpc-1651	150	17	white	white	ADJ
dpc-1651	150	18	lesion	lesion	NOUN
dpc-1651	150	19	in	in	ADP
dpc-1651	150	20	the	the	DET
dpc-1651	150	21	oral	oral	ADJ
dpc-1651	150	22	mucosa	mucosa	NOUN
dpc-1651	150	23	.	.	PUNCT
dpc-1651	151	1	jaad	jaad	NOUN
dpc-1651	151	2	case	case	NOUN
dpc-1651	151	3	rep	rep	PROPN
dpc-1651	151	4	.	.	PROPN
dpc-1651	151	5	2019;5(8):694–696	2019;5(8):694–696	NUM
dpc-1651	151	6	.	.	PUNCT
dpc-1651	152	1	doi	doi	NOUN
dpc-1651	152	2	:	:	PUNCT
dpc-1651	152	3	10.1016	10.1016	NUM
dpc-1651	152	4	/	/	SYM
dpc-1651	152	5	j.jdcr.2019.05.009	j.jdcr.2019.05.009	PROPN
dpc-1651	152	6	.	.	PUNCT
dpc-1651	153	1	pmid	pmid	NOUN
dpc-1651	153	2	:	:	PUNCT
dpc-1651	153	3	31440559	31440559	NUM
dpc-1651	153	4	.	.	PUNCT
dpc-1651	154	1	9	9	X
dpc-1651	154	2	.	.	X
dpc-1651	154	3	castori	castori	PROPN
dpc-1651	154	4	m	m	PROPN
dpc-1651	154	5	,	,	PUNCT
dpc-1651	154	6	madonna	madonna	PROPN
dpc-1651	154	7	s	s	PROPN
dpc-1651	154	8	,	,	PUNCT
dpc-1651	154	9	giannetti	giannetti	PROPN
dpc-1651	154	10	l	l	NOUN
dpc-1651	154	11	,	,	PUNCT
dpc-1651	154	12	et	et	PROPN
dpc-1651	154	13	al	al	PROPN
dpc-1651	154	14	.	.	PROPN
dpc-1651	154	15	novel	novel	ADJ
dpc-1651	154	16	ctsc	ctsc	NOUN
dpc-1651	154	17	mutations	mutation	NOUN
dpc-1651	154	18	in	in	ADP
dpc-1651	154	19	a	a	DET
dpc-1651	154	20	patient	patient	NOUN
dpc-1651	154	21	with	with	ADP
dpc-1651	154	22	papillon	papillon	NOUN
dpc-1651	154	23	-	-	PUNCT
dpc-1651	154	24	lefèvre	lefèvre	NOUN
dpc-1651	154	25	syndrome	syndrome	NOUN
dpc-1651	154	26	with	with	ADP
dpc-1651	154	27	recurrent	recurrent	ADJ
dpc-1651	154	28	pyoderma	pyoderma	NOUN
dpc-1651	154	29	and	and	CCONJ
dpc-1651	154	30	minimal	minimal	ADJ
dpc-1651	154	31	oral	oral	ADJ
dpc-1651	154	32	and	and	CCONJ
dpc-1651	154	33	palmoplantar	palmoplantar	NOUN
dpc-1651	154	34	involvement	involvement	NOUN
dpc-1651	154	35	.	.	PUNCT
dpc-1651	155	1	br	br	PROPN
dpc-1651	155	2	j	j	PROPN
dpc-1651	155	3	dermatol	dermatol	NOUN
dpc-1651	155	4	.	.	PUNCT
dpc-1651	156	1	2009;160(4):881–883	2009;160(4):881–883	X
dpc-1651	156	2	.	.	PUNCT
dpc-1651	156	3	doi	doi	NOUN
dpc-1651	156	4	:	:	PUNCT
dpc-1651	156	5	10.1111	10.1111	NUM
dpc-1651	156	6	/	/	SYM
dpc-1651	156	7	j.13652133.2008.08878.x	j.13652133.2008.08878.x	PROPN
dpc-1651	156	8	.	.	PUNCT
dpc-1651	157	1	pmid	pmid	NOUN
dpc-1651	157	2	:	:	PUNCT
dpc-1651	157	3	18945301	18945301	NUM
dpc-1651	157	4	.	.	PUNCT
dpc-1651	158	1	10	10	NUM
dpc-1651	158	2	.	.	PUNCT
dpc-1651	159	1	giannetti	giannetti	NOUN
dpc-1651	159	2	l	l	NOUN
dpc-1651	159	3	,	,	PUNCT
dpc-1651	159	4	apponi	apponi	PROPN
dpc-1651	159	5	r	r	PROPN
dpc-1651	159	6	,	,	PUNCT
dpc-1651	159	7	dello	dello	PROPN
dpc-1651	159	8	diago	diago	PROPN
dpc-1651	159	9	am	be	AUX
dpc-1651	159	10	,	,	PUNCT
dpc-1651	159	11	jafferany	jafferany	NOUN
dpc-1651	159	12	m	m	PROPN
dpc-1651	159	13	,	,	PUNCT
dpc-1651	159	14	goldust	goldust	PROPN
dpc-1651	159	15	m	m	PROPN
dpc-1651	159	16	,	,	PUNCT
dpc-1651	159	17	sadoughifar	sadoughifar	ADV
dpc-1651	159	18	r.	r.	PROPN
dpc-1651	159	19	papillon	papillon	NOUN
dpc-1651	159	20	-	-	PUNCT
dpc-1651	159	21	lefèvre	lefèvre	NOUN
dpc-1651	159	22	syndrome	syndrome	NOUN
dpc-1651	159	23	:	:	PUNCT
dpc-1651	159	24	oral	oral	ADJ
dpc-1651	159	25	aspects	aspect	NOUN
dpc-1651	159	26	and	and	CCONJ
dpc-1651	159	27	treatment	treatment	NOUN
dpc-1651	159	28	.	.	PUNCT
dpc-1651	160	1	dermatol	dermatol	NOUN
dpc-1651	160	2	ther	ther	ADV
dpc-1651	160	3	.	.	PUNCT
dpc-1651	161	1	2020;33(3):e13336	2020;33(3):e13336	NUM
dpc-1651	161	2	.	.	PUNCT
dpc-1651	162	1	doi	doi	NOUN
dpc-1651	162	2	:	:	PUNCT
dpc-1651	162	3	10.1111/	10.1111/	NUM
dpc-1651	162	4	dth.13336	dth.13336	PROPN
dpc-1651	162	5	.	.	PUNCT
dpc-1651	163	1	pmid	pmid	NOUN
dpc-1651	163	2	:	:	PUNCT
dpc-1651	163	3	32222110	32222110	NUM
dpc-1651	163	4	.	.	PUNCT
dpc-1651	164	1	11	11	NUM
dpc-1651	164	2	.	.	X
dpc-1651	164	3	altenburg	altenburg	PROPN
dpc-1651	164	4	a	a	PRON
dpc-1651	164	5	,	,	PUNCT
dpc-1651	164	6	zouboulis	zouboulis	PROPN
dpc-1651	164	7	cc	cc	PROPN
dpc-1651	164	8	.	.	PUNCT
dpc-1651	164	9	current	current	ADJ
dpc-1651	164	10	concepts	concept	NOUN
dpc-1651	164	11	in	in	ADP
dpc-1651	164	12	the	the	DET
dpc-1651	164	13	treatment	treatment	NOUN
dpc-1651	164	14	of	of	ADP
dpc-1651	164	15	recurrent	recurrent	ADJ
dpc-1651	164	16	aphthous	aphthous	ADJ
dpc-1651	164	17	stomatitis	stomatitis	NOUN
dpc-1651	164	18	.	.	PUNCT
dpc-1651	165	1	skin	skin	NOUN
dpc-1651	165	2	ther	ther	PROPN
dpc-1651	165	3	lett	lett	PROPN
dpc-1651	165	4	.	.	PUNCT
dpc-1651	166	1	2008;13(7):1–4	2008;13(7):1–4	NUM
dpc-1651	166	2	.	.	PUNCT
dpc-1651	167	1	pmid	pmid	NOUN
dpc-1651	167	2	:	:	PUNCT
dpc-1651	167	3	18839042	18839042	NUM
dpc-1651	167	4	.	.	PUNCT
dpc-1651	168	1	12	12	NUM
dpc-1651	168	2	.	.	PUNCT
dpc-1651	168	3	yasui	yasui	PROPN
dpc-1651	168	4	k	k	PROPN
dpc-1651	168	5	,	,	PUNCT
dpc-1651	168	6	kurata	kurata	PROPN
dpc-1651	168	7	t	t	PROPN
dpc-1651	168	8	,	,	PUNCT
dpc-1651	168	9	yashiro	yashiro	PROPN
dpc-1651	168	10	m	m	NOUN
dpc-1651	168	11	,	,	PUNCT
dpc-1651	168	12	tsuge	tsuge	NOUN
dpc-1651	168	13	m	m	PROPN
dpc-1651	168	14	,	,	PUNCT
dpc-1651	168	15	ohtsuki	ohtsuki	PROPN
dpc-1651	168	16	s	s	PROPN
dpc-1651	168	17	,	,	PUNCT
dpc-1651	168	18	morishima	morishima	PROPN
dpc-1651	168	19	t.	t.	PROPN
dpc-1651	168	20	the	the	DET
dpc-1651	168	21	effect	effect	NOUN
dpc-1651	168	22	of	of	ADP
dpc-1651	168	23	ascorbate	ascorbate	NOUN
dpc-1651	168	24	on	on	ADP
dpc-1651	168	25	minor	minor	ADJ
dpc-1651	168	26	recurrent	recurrent	ADJ
dpc-1651	168	27	aphthous	aphthous	ADJ
dpc-1651	168	28	stomatitis	stomatitis	NOUN
dpc-1651	168	29	.	.	PUNCT
dpc-1651	169	1	acta	acta	PROPN
dpc-1651	169	2	paediatr	paediatr	NOUN
dpc-1651	169	3	.	.	PUNCT
dpc-1651	170	1	1992	1992	NUM
dpc-1651	170	2	.	.	PUNCT
dpc-1651	171	1	2010;99(3):442–445	2010;99(3):442–445	X
dpc-1651	171	2	.	.	PUNCT
dpc-1651	172	1	doi	doi	NOUN
dpc-1651	172	2	:	:	PUNCT
dpc-1651	172	3	10.1111	10.1111	NUM
dpc-1651	172	4	/	/	SYM
dpc-1651	172	5	j.16512227.2009.01628.x	j.16512227.2009.01628.x	NOUN
dpc-1651	172	6	.	.	PUNCT
dpc-1651	173	1	pmid	pmid	NOUN
dpc-1651	173	2	:	:	PUNCT
dpc-1651	173	3	20003102	20003102	NUM
dpc-1651	173	4	.	.	PUNCT
dpc-1651	174	1	13	13	NUM
dpc-1651	174	2	.	.	PUNCT
dpc-1651	175	1	montgomery	montgomery	PROPN
dpc-1651	175	2	-	-	PUNCT
dpc-1651	175	3	cranny	cranny	PROPN
dpc-1651	175	4	ja	ja	PROPN
dpc-1651	175	5	,	,	PUNCT
dpc-1651	175	6	wallace	wallace	PROPN
dpc-1651	175	7	a	a	X
dpc-1651	175	8	,	,	PUNCT
dpc-1651	175	9	rogers	rogers	PROPN
dpc-1651	175	10	hj	hj	PROPN
dpc-1651	175	11	,	,	PUNCT
dpc-1651	175	12	hughes	hughes	PROPN
dpc-1651	175	13	sc	sc	PROPN
dpc-1651	175	14	,	,	PUNCT
dpc-1651	175	15	hegarty	hegarty	PROPN
dpc-1651	175	16	am	am	PROPN
dpc-1651	175	17	,	,	PUNCT
dpc-1651	175	18	zaitoun	zaitoun	PROPN
dpc-1651	175	19	h.	h.	PROPN
dpc-1651	175	20	management	management	PROPN
dpc-1651	175	21	of	of	ADP
dpc-1651	175	22	recurrent	recurrent	ADJ
dpc-1651	175	23	aphthous	aphthous	ADJ
dpc-1651	175	24	stomatitis	stomatitis	NOUN
dpc-1651	175	25	in	in	ADP
dpc-1651	175	26	children	child	NOUN
dpc-1651	175	27	.	.	PUNCT
dpc-1651	176	1	dent	dent	NOUN
dpc-1651	176	2	update	update	NOUN
dpc-1651	176	3	.	.	PUNCT
dpc-1651	177	1	2015;42(6):564–566	2015;42(6):564–566	NUM
dpc-1651	177	2	,	,	PUNCT
dpc-1651	177	3	569–572	569–572	NUM
dpc-1651	177	4	.	.	PUNCT
dpc-1651	177	5	doi	doi	NOUN
dpc-1651	177	6	:	:	PUNCT
dpc-1651	177	7	10.12968	10.12968	NUM
dpc-1651	177	8	/	/	SYM
dpc-1651	177	9	denu.2015.42.6.564	denu.2015.42.6.564	PROPN
dpc-1651	177	10	.	.	PUNCT
dpc-1651	178	1	pmid	pmid	NOUN
dpc-1651	178	2	:	:	PUNCT
dpc-1651	178	3	26506812	26506812	NUM
dpc-1651	178	4	.	.	PUNCT
dpc-1651	179	1	14	14	NUM
dpc-1651	179	2	.	.	PUNCT
dpc-1651	180	1	bulur	bulur	PROPN
dpc-1651	180	2	i	i	PRON
dpc-1651	180	3	,	,	PUNCT
dpc-1651	180	4	onder	onder	PROPN
dpc-1651	180	5	m.	m.	PROPN
dpc-1651	180	6	behçet	behçet	PROPN
dpc-1651	180	7	disease	disease	PROPN
dpc-1651	180	8	:	:	PUNCT
dpc-1651	180	9	new	new	ADJ
dpc-1651	180	10	aspects	aspect	NOUN
dpc-1651	180	11	.	.	PUNCT
dpc-1651	181	1	clin	clin	PROPN
dpc-1651	181	2	dermatol	dermatol	NOUN
dpc-1651	181	3	.	.	PUNCT
dpc-1651	182	1	2017;35(5):421–434	2017;35(5):421–434	NUM
dpc-1651	182	2	.	.	PUNCT
dpc-1651	183	1	doi	doi	NOUN
dpc-1651	183	2	:	:	PUNCT
dpc-1651	183	3	10.1016	10.1016	NUM
dpc-1651	183	4	/	/	SYM
dpc-1651	183	5	j.clindermatol.2017.06.004	j.clindermatol.2017.06.004	PROPN
dpc-1651	183	6	.	.	PUNCT
dpc-1651	184	1	pmid	pmid	NOUN
dpc-1651	184	2	:	:	PUNCT
dpc-1651	184	3	28916023	28916023	NUM
dpc-1651	184	4	.	.	PUNCT
dpc-1651	185	1	15	15	NUM
dpc-1651	185	2	.	.	PUNCT
dpc-1651	186	1	giannetti	giannetti	NOUN
dpc-1651	186	2	l	l	PROPN
dpc-1651	186	3	,	,	PUNCT
dpc-1651	186	4	murri	murri	PROPN
dpc-1651	186	5	dello	dello	PROPN
dpc-1651	186	6	diago	diago	PROPN
dpc-1651	187	1	a	a	X
dpc-1651	187	2	,	,	PUNCT
dpc-1651	187	3	lo	lo	PROPN
dpc-1651	187	4	muzio	muzio	PROPN
dpc-1651	187	5	l.	l.	PROPN
dpc-1651	187	6	behçet	behçet	PROPN
dpc-1651	187	7	’s	’s	PART
dpc-1651	187	8	disease	disease	NOUN
dpc-1651	187	9	:	:	PUNCT
dpc-1651	187	10	minireview	minireview	NOUN
dpc-1651	187	11	with	with	ADP
dpc-1651	187	12	emphasis	emphasis	NOUN
dpc-1651	187	13	on	on	ADP
dpc-1651	187	14	oral	oral	ADJ
dpc-1651	187	15	aspects	aspect	NOUN
dpc-1651	187	16	.	.	PUNCT
dpc-1651	188	1	minerva	minerva	PROPN
dpc-1651	188	2	stomatol	stomatol	PROPN
dpc-1651	188	3	.	.	PUNCT
dpc-1651	189	1	2018;67(6):246–249	2018;67(6):246–249	X
dpc-1651	189	2	.	.	PUNCT
dpc-1651	189	3	doi	doi	NOUN
dpc-1651	189	4	:	:	PUNCT
dpc-1651	189	5	10.23736	10.23736	NUM
dpc-1651	189	6	/	/	SYM
dpc-1651	189	7	s00264970.18.04135	s00264970.18.04135	NOUN
dpc-1651	189	8	-	-	PUNCT
dpc-1651	189	9	3	3	NUM
dpc-1651	189	10	.	.	NOUN
dpc-1651	189	11	16	16	NUM
dpc-1651	189	12	.	.	PUNCT
dpc-1651	190	1	arida	arida	PROPN
dpc-1651	190	2	a	a	PRON
dpc-1651	190	3	,	,	PUNCT
dpc-1651	190	4	fragiadaki	fragiadaki	PROPN
dpc-1651	190	5	k	k	NOUN
dpc-1651	190	6	,	,	PUNCT
dpc-1651	190	7	giavri	giavri	NOUN
dpc-1651	190	8	e	e	NOUN
dpc-1651	190	9	,	,	PUNCT
dpc-1651	190	10	sfikakis	sfikakis	PROPN
dpc-1651	190	11	pp	pp	X
dpc-1651	190	12	.	.	PUNCT
dpc-1651	191	1	anti	anti	ADJ
dpc-1651	191	2	-	-	ADJ
dpc-1651	191	3	tnf	tnf	ADJ
dpc-1651	191	4	agents	agent	NOUN
dpc-1651	191	5	for	for	ADP
dpc-1651	191	6	behçet	behçet	PROPN
dpc-1651	191	7	’s	’s	PART
dpc-1651	191	8	disease	disease	NOUN
dpc-1651	191	9	:	:	PUNCT
dpc-1651	191	10	analysis	analysis	NOUN
dpc-1651	191	11	of	of	ADP
dpc-1651	191	12	published	publish	VERB
dpc-1651	191	13	data	datum	NOUN
dpc-1651	191	14	on	on	ADP
dpc-1651	191	15	369	369	NUM
dpc-1651	191	16	patients	patient	NOUN
dpc-1651	191	17	.	.	PUNCT
dpc-1651	192	1	semin	semin	PROPN
dpc-1651	192	2	arthritis	arthritis	PROPN
dpc-1651	192	3	rheum	rheum	PROPN
dpc-1651	192	4	.	.	PUNCT
dpc-1651	193	1	2011;41(1):61–70	2011;41(1):61–70	PROPN
dpc-1651	193	2	.	.	PUNCT
dpc-1651	194	1	doi	doi	NOUN
dpc-1651	194	2	:	:	PUNCT
dpc-1651	194	3	10.1016	10.1016	NUM
dpc-1651	194	4	/	/	SYM
dpc-1651	194	5	j.	j.	PROPN
dpc-1651	194	6	semarthrit.2010.09.002	semarthrit.2010.09.002	PROPN
dpc-1651	194	7	.	.	PUNCT
dpc-1651	195	1	pmid	pmid	PROPN
dpc-1651	195	2	:	:	PUNCT
dpc-1651	195	3	21168186	21168186	NUM
dpc-1651	195	4	.	.	PUNCT
dpc-1651	196	1	17	17	NUM
dpc-1651	196	2	.	.	PUNCT
dpc-1651	196	3	mandel	mandel	PROPN
dpc-1651	196	4	vd	vd	PROPN
dpc-1651	196	5	,	,	PUNCT
dpc-1651	196	6	farnetani	farnetani	PROPN
dpc-1651	196	7	f	f	X
dpc-1651	196	8	,	,	PUNCT
dpc-1651	196	9	vaschieri	vaschieri	PROPN
dpc-1651	196	10	c	c	PROPN
dpc-1651	196	11	,	,	PUNCT
dpc-1651	196	12	et	et	PROPN
dpc-1651	196	13	al	al	PROPN
dpc-1651	196	14	.	.	PROPN
dpc-1651	196	15	pemphigus	pemphigus	PROPN
dpc-1651	196	16	with	with	ADP
dpc-1651	196	17	features	feature	NOUN
dpc-1651	196	18	of	of	ADP
dpc-1651	196	19	both	both	DET
dpc-1651	196	20	vulgaris	vulgaris	NOUN
dpc-1651	196	21	and	and	CCONJ
dpc-1651	196	22	foliaceus	foliaceus	ADJ
dpc-1651	196	23	variants	variant	NOUN
dpc-1651	196	24	localized	localize	VERB
dpc-1651	196	25	to	to	ADP
dpc-1651	196	26	the	the	DET
dpc-1651	196	27	nose	nose	NOUN
dpc-1651	196	28	.	.	PUNCT
dpc-1651	197	1	j	j	PROPN
dpc-1651	197	2	dermatol	dermatol	NOUN
dpc-1651	197	3	.	.	PUNCT
dpc-1651	198	1	2016;43(8):940–943	2016;43(8):940–943	X
dpc-1651	198	2	.	.	PUNCT
dpc-1651	198	3	doi	doi	NOUN
dpc-1651	198	4	:	:	PUNCT
dpc-1651	198	5	10.1111/13468138.13314	10.1111/13468138.13314	NUM
dpc-1651	198	6	.	.	PUNCT
dpc-1651	199	1	pmid	pmid	NOUN
dpc-1651	199	2	:	:	PUNCT
dpc-1651	199	3	26945696	26945696	NUM
dpc-1651	199	4	.	.	PUNCT
dpc-1651	200	1	18	18	NUM
dpc-1651	200	2	.	.	X
dpc-1651	201	1	celentano	celentano	PROPN
dpc-1651	201	2	a	a	X
dpc-1651	201	3	,	,	PUNCT
dpc-1651	201	4	tovaru	tovaru	PROPN
dpc-1651	201	5	s	s	PROPN
dpc-1651	201	6	,	,	PUNCT
dpc-1651	201	7	yap	yap	PROPN
dpc-1651	201	8	t	t	PROPN
dpc-1651	201	9	,	,	PUNCT
dpc-1651	201	10	adamo	adamo	PROPN
dpc-1651	201	11	d	d	PROPN
dpc-1651	201	12	,	,	PUNCT
dpc-1651	201	13	aria	aria	PROPN
dpc-1651	201	14	m	m	PROPN
dpc-1651	201	15	,	,	PUNCT
dpc-1651	201	16	mignogna	mignogna	PROPN
dpc-1651	201	17	md	md	PROPN
dpc-1651	201	18	.	.	PROPN
dpc-1651	201	19	oral	oral	ADJ
dpc-1651	201	20	erythema	erythema	ADJ
dpc-1651	201	21	multiforme	multiforme	NOUN
dpc-1651	201	22	:	:	PUNCT
dpc-1651	201	23	trends	trend	NOUN
dpc-1651	201	24	and	and	CCONJ
dpc-1651	201	25	clinical	clinical	ADJ
dpc-1651	201	26	findings	finding	NOUN
dpc-1651	201	27	of	of	ADP
dpc-1651	201	28	a	a	DET
dpc-1651	201	29	large	large	ADJ
dpc-1651	201	30	retrospective	retrospective	ADJ
dpc-1651	201	31	european	european	ADJ
dpc-1651	201	32	case	case	NOUN
dpc-1651	201	33	series	series	NOUN
dpc-1651	201	34	.	.	PUNCT
dpc-1651	202	1	oral	oral	ADJ
dpc-1651	202	2	surg	surg	NOUN
dpc-1651	202	3	oral	oral	ADJ
dpc-1651	202	4	med	med	ADJ
dpc-1651	202	5	oral	oral	ADJ
dpc-1651	202	6	pathol	pathol	NOUN
dpc-1651	202	7	oral	oral	ADJ
dpc-1651	202	8	radiol	radiol	NOUN
dpc-1651	202	9	.	.	PUNCT
dpc-1651	203	1	2015;120(6):707–716	2015;120(6):707–716	X
dpc-1651	203	2	.	.	PUNCT
dpc-1651	203	3	doi	doi	NOUN
dpc-1651	203	4	:	:	PUNCT
dpc-1651	203	5	10.1016	10.1016	NUM
dpc-1651	203	6	/	/	SYM
dpc-1651	203	7	j.	j.	PROPN
dpc-1651	203	8	oooo.2015.08.010	oooo.2015.08.010	PROPN
dpc-1651	203	9	.	.	PUNCT
dpc-1651	204	1	pmid	pmid	NOUN
dpc-1651	204	2	:	:	PUNCT
dpc-1651	204	3	26455287	26455287	NUM
dpc-1651	204	4	.	.	PUNCT
dpc-1651	205	1	19	19	NUM
dpc-1651	205	2	.	.	PUNCT
dpc-1651	206	1	ponti	ponti	PROPN
dpc-1651	206	2	g	g	PROPN
dpc-1651	206	3	,	,	PUNCT
dpc-1651	206	4	tomasi	tomasi	PROPN
dpc-1651	206	5	a	a	PRON
dpc-1651	206	6	,	,	PUNCT
dpc-1651	206	7	manfredini	manfredini	PROPN
dpc-1651	206	8	m	m	PROPN
dpc-1651	206	9	,	,	PUNCT
dpc-1651	206	10	pellacani	pellacani	PROPN
dpc-1651	206	11	g.	g.	PROPN
dpc-1651	206	12	oral	oral	ADJ
dpc-1651	206	13	mucosal	mucosal	NOUN
dpc-1651	206	14	stigmata	stigmata	NOUN
dpc-1651	206	15	in	in	ADP
dpc-1651	206	16	hereditary	hereditary	ADJ
dpc-1651	206	17	-	-	PUNCT
dpc-1651	206	18	cancer	cancer	NOUN
dpc-1651	206	19	syndromes	syndrome	NOUN
dpc-1651	206	20	:	:	PUNCT
dpc-1651	206	21	from	from	ADP
dpc-1651	206	22	germline	germline	NOUN
dpc-1651	206	23	mutations	mutation	NOUN
dpc-1651	206	24	to	to	ADP
dpc-1651	206	25	distinctive	distinctive	ADJ
dpc-1651	206	26	clinical	clinical	ADJ
dpc-1651	206	27	phenotypes	phenotype	NOUN
dpc-1651	206	28	and	and	CCONJ
dpc-1651	206	29	tailored	tailor	VERB
dpc-1651	206	30	therapies	therapy	NOUN
dpc-1651	206	31	.	.	PUNCT
dpc-1651	207	1	gene	gene	NOUN
dpc-1651	207	2	.	.	PUNCT
dpc-1651	208	1	2016;582(1):23–32	2016;582(1):23–32	X
dpc-1651	208	2	.	.	PUNCT
dpc-1651	209	1	doi	doi	NOUN
dpc-1651	209	2	:	:	PUNCT
dpc-1651	209	3	10.1016	10.1016	NUM
dpc-1651	209	4	/	/	SYM
dpc-1651	209	5	j.gene.2016.01.053	j.gene.2016.01.053	NOUN
dpc-1651	209	6	.	.	PUNCT
dpc-1651	210	1	pmid	pmid	NOUN
dpc-1651	210	2	:	:	PUNCT
dpc-1651	210	3	26850131	26850131	NUM
dpc-1651	210	4	.	.	PUNCT
dpc-1651	211	1	20	20	NUM
dpc-1651	211	2	.	.	PUNCT
dpc-1651	212	1	ponti	ponti	PROPN
dpc-1651	212	2	g	g	PROPN
dpc-1651	212	3	,	,	PUNCT
dpc-1651	212	4	meschieri	meschieri	VERB
dpc-1651	212	5	a	a	PRON
dpc-1651	212	6	,	,	PUNCT
dpc-1651	212	7	pollio	pollio	NOUN
dpc-1651	212	8	a	a	NOUN
dpc-1651	212	9	,	,	PUNCT
dpc-1651	212	10	et	et	PROPN
dpc-1651	212	11	al	al	PROPN
dpc-1651	212	12	.	.	PUNCT
dpc-1651	213	1	fordyce	fordyce	PROPN
dpc-1651	213	2	granules	granule	NOUN
dpc-1651	213	3	and	and	CCONJ
dpc-1651	213	4	hyperplastic	hyperplastic	ADJ
dpc-1651	213	5	mucosal	mucosal	ADJ
dpc-1651	213	6	sebaceous	sebaceous	ADJ
dpc-1651	213	7	glands	gland	NOUN
dpc-1651	213	8	as	as	ADP
dpc-1651	213	9	distinctive	distinctive	ADJ
dpc-1651	213	10	stigmata	stigmata	NOUN
dpc-1651	213	11	in	in	ADP
dpc-1651	213	12	muir	muir	PROPN
dpc-1651	213	13	-	-	PUNCT
dpc-1651	213	14	torre	torre	PROPN
dpc-1651	213	15	syndrome	syndrome	NOUN
dpc-1651	213	16	patients	patient	NOUN
dpc-1651	213	17	:	:	PUNCT
dpc-1651	213	18	characterization	characterization	NOUN
dpc-1651	213	19	with	with	ADP
dpc-1651	213	20	reflectance	reflectance	NOUN
dpc-1651	213	21	confocal	confocal	ADJ
dpc-1651	213	22	microscopy	microscopy	NOUN
dpc-1651	213	23	.	.	PUNCT
dpc-1651	214	1	j	j	PROPN
dpc-1651	214	2	oral	oral	ADJ
dpc-1651	214	3	pathol	pathol	NOUN
dpc-1651	214	4	med	me	VERB
dpc-1651	214	5	.	.	PUNCT
dpc-1651	215	1	2015;44(7):552–557	2015;44(7):552–557	X
dpc-1651	215	2	.	.	PUNCT
dpc-1651	215	3	doi	doi	NOUN
dpc-1651	215	4	:	:	PUNCT
dpc-1651	215	5	10.1111	10.1111	NUM
dpc-1651	215	6	/	/	SYM
dpc-1651	215	7	jop.12256	jop.12256	PROPN
dpc-1651	215	8	.	.	PUNCT
dpc-1651	216	1	pmid	pmid	NOUN
dpc-1651	216	2	:	:	PUNCT
dpc-1651	216	3	25213213	25213213	NUM
dpc-1651	216	4	.	.	PUNCT
dpc-1651	217	1	21	21	NUM
dpc-1651	217	2	.	.	PUNCT
dpc-1651	217	3	lê	lê	PROPN
dpc-1651	217	4	thi	thi	PROPN
dpc-1651	217	5	huong	huong	PROPN
dpc-1651	217	6	d	d	PROPN
dpc-1651	217	7	,	,	PUNCT
dpc-1651	217	8	wechsler	wechsler	PROPN
dpc-1651	217	9	b	b	PROPN
dpc-1651	217	10	,	,	PUNCT
dpc-1651	217	11	piette	piette	PROPN
dpc-1651	217	12	jc	jc	PROPN
dpc-1651	217	13	,	,	PUNCT
dpc-1651	217	14	et	et	PROPN
dpc-1651	217	15	al	al	PROPN
dpc-1651	217	16	.	.	PUNCT
dpc-1651	218	1	aortic	aortic	ADJ
dpc-1651	218	2	insufficiency	insufficiency	NOUN
dpc-1651	218	3	and	and	CCONJ
dpc-1651	218	4	recurrent	recurrent	ADJ
dpc-1651	218	5	valve	valve	NOUN
dpc-1651	218	6	prosthesis	prosthesis	NOUN
dpc-1651	218	7	dehiscence	dehiscence	NOUN
dpc-1651	218	8	in	in	ADP
dpc-1651	218	9	magic	magic	ADJ
dpc-1651	218	10	syndrome	syndrome	NOUN
dpc-1651	218	11	.	.	PUNCT
dpc-1651	219	1	j	j	PROPN
dpc-1651	219	2	rheumatol	rheumatol	NOUN
dpc-1651	219	3	.	.	PUNCT
dpc-1651	220	1	1993;20(2):397–398	1993;20(2):397–398	X
dpc-1651	220	2	.	.	NOUN
dpc-1651	220	3	22	22	NUM
dpc-1651	220	4	.	.	PUNCT
dpc-1651	221	1	delke	delke	PROPN
dpc-1651	221	2	i	i	PRON
dpc-1651	221	3	,	,	PUNCT
dpc-1651	221	4	veridiano	veridiano	PROPN
dpc-1651	221	5	np	np	PROPN
dpc-1651	221	6	,	,	PUNCT
dpc-1651	221	7	tancer	tancer	NOUN
dpc-1651	221	8	ml	ml	NOUN
dpc-1651	221	9	,	,	PUNCT
dpc-1651	221	10	gomez	gomez	PROPN
dpc-1651	221	11	l	l	PROPN
dpc-1651	221	12	,	,	PUNCT
dpc-1651	221	13	diamond	diamond	PROPN
dpc-1651	221	14	i.	i.	NOUN
dpc-1651	221	15	sweet	sweet	PROPN
dpc-1651	221	16	syndrome	syndrome	NOUN
dpc-1651	221	17	with	with	ADP
dpc-1651	221	18	involvement	involvement	NOUN
dpc-1651	221	19	of	of	ADP
dpc-1651	221	20	the	the	DET
dpc-1651	221	21	female	female	ADJ
dpc-1651	221	22	genital	genital	ADJ
dpc-1651	221	23	tract	tract	NOUN
dpc-1651	221	24	.	.	PUNCT
dpc-1651	222	1	obstet	obstet	PROPN
dpc-1651	222	2	gynecol	gynecol	PROPN
dpc-1651	222	3	.	.	PUNCT
dpc-1651	223	1	1981;58(3):394–396	1981;58(3):394–396	X
dpc-1651	223	2	.	.	PUNCT
dpc-1651	224	1	23	23	NUM
dpc-1651	224	2	.	.	PUNCT
dpc-1651	225	1	driban	driban	PROPN
dpc-1651	225	2	ne	ne	PROPN
dpc-1651	225	3	,	,	PUNCT
dpc-1651	225	4	alvarez	alvarez	PROPN
dpc-1651	225	5	ma	ma	PROPN
dpc-1651	225	6	.	.	PROPN
dpc-1651	225	7	oral	oral	ADJ
dpc-1651	225	8	manifestations	manifestation	NOUN
dpc-1651	225	9	of	of	ADP
dpc-1651	225	10	sweet	sweet	ADJ
dpc-1651	225	11	’s	’s	PART
dpc-1651	225	12	syndrome	syndrome	NOUN
dpc-1651	225	13	.	.	PUNCT
dpc-1651	226	1	dermatologica	dermatologica	PROPN
dpc-1651	226	2	.	.	PUNCT
dpc-1651	227	1	1984;169(2):102–103	1984;169(2):102–103	NUM
dpc-1651	227	2	.	.	PUNCT
dpc-1651	227	3	doi	doi	NOUN
dpc-1651	227	4	:	:	PUNCT
dpc-1651	227	5	10.1159/000249579	10.1159/000249579	NUM
dpc-1651	227	6	.	.	X
dpc-1651	228	1	24	24	NUM
dpc-1651	228	2	.	.	PUNCT
dpc-1651	229	1	mizoguchi	mizoguchi	PROPN
dpc-1651	229	2	m	m	PROPN
dpc-1651	229	3	,	,	PUNCT
dpc-1651	229	4	matsuki	matsuki	PROPN
dpc-1651	229	5	k	k	PROPN
dpc-1651	229	6	,	,	PUNCT
dpc-1651	229	7	mochizuki	mochizuki	PROPN
dpc-1651	229	8	m	m	PROPN
dpc-1651	229	9	,	,	PUNCT
dpc-1651	229	10	et	et	PROPN
dpc-1651	229	11	al	al	PROPN
dpc-1651	229	12	.	.	PUNCT
dpc-1651	230	1	human	human	ADJ
dpc-1651	230	2	leukocyte	leukocyte	NOUN
dpc-1651	230	3	antigen	antigen	NOUN
dpc-1651	230	4	in	in	ADP
dpc-1651	230	5	sweet	sweet	ADJ
dpc-1651	230	6	’s	’s	PART
dpc-1651	230	7	syndrome	syndrome	NOUN
dpc-1651	230	8	and	and	CCONJ
dpc-1651	230	9	its	its	PRON
dpc-1651	230	10	relationship	relationship	NOUN
dpc-1651	230	11	to	to	ADP
dpc-1651	230	12	behçet	behçet	PROPN
dpc-1651	230	13	’s	’s	PART
dpc-1651	230	14	disease	disease	NOUN
dpc-1651	230	15	.	.	PUNCT
dpc-1651	231	1	arch	arch	ADJ
dpc-1651	231	2	dermatol	dermatol	NOUN
dpc-1651	231	3	.	.	PUNCT
dpc-1651	232	1	1988;124(7):1069–1073	1988;124(7):1069–1073	NUM
dpc-1651	232	2	.	.	PUNCT
dpc-1651	233	1	doi	doi	NOUN
dpc-1651	233	2	:	:	PUNCT
dpc-1651	233	3	10.1001/	10.1001/	NUM
dpc-1651	233	4	archderm.1988.01670070057019	archderm.1988.01670070057019	X
dpc-1651	233	5	.	.	PUNCT
dpc-1651	234	1	pmid	pmid	NOUN
dpc-1651	234	2	:	:	PUNCT
dpc-1651	234	3	3389850	3389850	NUM
dpc-1651	234	4	.	.	PUNCT
dpc-1651	235	1	review	review	VERB
dpc-1651	235	2	|	|	ADV
dpc-1651	235	3	dermatol	dermatol	ADJ
dpc-1651	235	4	pract	pract	NOUN
dpc-1651	235	5	concept	concept	NOUN
dpc-1651	235	6	.	.	PUNCT
dpc-1651	236	1	2021;11(4):e2021099	2021;11(4):e2021099	NUM
dpc-1651	236	2	5	5	NUM
dpc-1651	236	3	25	25	NUM
dpc-1651	236	4	.	.	PUNCT
dpc-1651	237	1	von	von	PROPN
dpc-1651	237	2	den	den	PROPN
dpc-1651	237	3	driesch	driesch	PROPN
dpc-1651	237	4	p	p	NOUN
dpc-1651	237	5	,	,	PUNCT
dpc-1651	237	6	gomez	gomez	PROPN
dpc-1651	237	7	rs	rs	PROPN
dpc-1651	237	8	,	,	PUNCT
dpc-1651	237	9	kiesewetter	kiesewetter	NOUN
dpc-1651	237	10	f	f	PROPN
dpc-1651	237	11	,	,	PUNCT
dpc-1651	237	12	hornstein	hornstein	ADJ
dpc-1651	237	13	op	op	NOUN
dpc-1651	237	14	.	.	PUNCT
dpc-1651	238	1	sweet	sweet	ADJ
dpc-1651	238	2	’s	’s	PART
dpc-1651	238	3	syndrome	syndrome	NOUN
dpc-1651	238	4	:	:	PUNCT
dpc-1651	238	5	clinical	clinical	ADJ
dpc-1651	238	6	spectrum	spectrum	NOUN
dpc-1651	238	7	and	and	CCONJ
dpc-1651	238	8	associated	associated	ADJ
dpc-1651	238	9	conditions	condition	NOUN
dpc-1651	238	10	.	.	PUNCT
dpc-1651	239	1	cutis	cutis	NOUN
dpc-1651	239	2	.	.	PUNCT
dpc-1651	240	1	1989;44(3):193–200	1989;44(3):193–200	X
dpc-1651	240	2	.	.	NOUN
dpc-1651	240	3	26	26	NUM
dpc-1651	240	4	.	.	PUNCT
dpc-1651	240	5	bruyn	bruyn	PROPN
dpc-1651	240	6	ga	ga	PROPN
dpc-1651	240	7	,	,	PUNCT
dpc-1651	240	8	missier	missier	PROPN
dpc-1651	240	9	et	et	PROPN
dpc-1651	240	10	,	,	PUNCT
dpc-1651	240	11	toonstra	toonstra	PROPN
dpc-1651	240	12	j	j	PROPN
dpc-1651	240	13	,	,	PUNCT
dpc-1651	240	14	bijlsma	bijlsma	PROPN
dpc-1651	240	15	jw	jw	PROPN
dpc-1651	240	16	.	.	PROPN
dpc-1651	240	17	sweet	sweet	PROPN
dpc-1651	240	18	’s	’s	PART
dpc-1651	240	19	syndrome	syndrome	NOUN
dpc-1651	240	20	.	.	PUNCT
dpc-1651	241	1	neth	neth	PROPN
dpc-1651	241	2	j	j	PROPN
dpc-1651	241	3	med	med	PROPN
dpc-1651	241	4	.	.	PUNCT
dpc-1651	242	1	1990;36(1–2):62–68	1990;36(1–2):62–68	X
dpc-1651	242	2	.	.	PROPN
dpc-1651	243	1	27	27	NUM
dpc-1651	243	2	.	.	PUNCT
dpc-1651	244	1	von	von	PROPN
dpc-1651	244	2	den	den	PROPN
dpc-1651	244	3	driesch	driesch	PROPN
dpc-1651	244	4	p.	p.	PROPN
dpc-1651	244	5	sweet	sweet	PROPN
dpc-1651	244	6	’s	’s	PART
dpc-1651	244	7	syndrome	syndrome	NOUN
dpc-1651	244	8	(	(	PUNCT
dpc-1651	244	9	acute	acute	ADJ
dpc-1651	244	10	febrile	febrile	NOUN
dpc-1651	244	11	neutrophilic	neutrophilic	ADJ
dpc-1651	244	12	dermatosis	dermatosis	NOUN
dpc-1651	244	13	)	)	PUNCT
dpc-1651	244	14	.	.	PUNCT
dpc-1651	245	1	j	j	PROPN
dpc-1651	245	2	am	be	AUX
dpc-1651	245	3	acad	acad	ADJ
dpc-1651	245	4	dermatol	dermatol	NOUN
dpc-1651	245	5	.	.	PUNCT
dpc-1651	246	1	1994;31(4):535–56	1994;31(4):535–56	NUM
dpc-1651	246	2	.	.	PUNCT
dpc-1651	246	3	doi	doi	NOUN
dpc-1651	246	4	:	:	PUNCT
dpc-1651	246	5	10.1016	10.1016	NUM
dpc-1651	246	6	/	/	SYM
dpc-1651	246	7	s0190	s0190	VERB
dpc-1651	246	8	-	-	PUNCT
dpc-1651	246	9	9622(94)70215	9622(94)70215	NUM
dpc-1651	246	10	-	-	PUNCT
dpc-1651	246	11	2	2	NUM
dpc-1651	246	12	.	.	NOUN
dpc-1651	246	13	28	28	NUM
dpc-1651	246	14	.	.	PUNCT
dpc-1651	247	1	femiano	femiano	PROPN
dpc-1651	247	2	f	f	PROPN
dpc-1651	247	3	,	,	PUNCT
dpc-1651	247	4	gombos	gombos	PROPN
dpc-1651	247	5	f	f	PROPN
dpc-1651	247	6	,	,	PUNCT
dpc-1651	247	7	scully	scully	PROPN
dpc-1651	247	8	c.	c.	PROPN
dpc-1651	247	9	sweet	sweet	PROPN
dpc-1651	247	10	’s	’s	PART
dpc-1651	248	1	syndrome	syndrome	NOUN
dpc-1651	248	2	:	:	PUNCT
dpc-1651	248	3	recurrent	recurrent	ADJ
dpc-1651	248	4	oral	oral	ADJ
dpc-1651	248	5	ulceration	ulceration	NOUN
dpc-1651	248	6	,	,	PUNCT
dpc-1651	248	7	pyrexia	pyrexia	NOUN
dpc-1651	248	8	,	,	PUNCT
dpc-1651	248	9	thrombophlebitis	thrombophlebitis	NOUN
dpc-1651	248	10	,	,	PUNCT
dpc-1651	248	11	and	and	CCONJ
dpc-1651	248	12	cutaneous	cutaneous	ADJ
dpc-1651	248	13	lesions	lesion	NOUN
dpc-1651	248	14	.	.	PUNCT
dpc-1651	249	1	oral	oral	ADJ
dpc-1651	249	2	surg	surg	NOUN
dpc-1651	249	3	oral	oral	ADJ
dpc-1651	249	4	med	med	ADJ
dpc-1651	249	5	oral	oral	ADJ
dpc-1651	249	6	pathol	pathol	NOUN
dpc-1651	249	7	oral	oral	ADJ
dpc-1651	249	8	radiol	radiol	NOUN
dpc-1651	249	9	endod	endod	PROPN
dpc-1651	249	10	.	.	PUNCT
dpc-1651	250	1	2003	2003	NUM
dpc-1651	250	2	mar;95(3):324–327	mar;95(3):324–327	NOUN
dpc-1651	250	3	.	.	PUNCT
dpc-1651	251	1	doi	doi	NOUN
dpc-1651	251	2	:	:	PUNCT
dpc-1651	251	3	10.1067	10.1067	NUM
dpc-1651	251	4	/	/	SYM
dpc-1651	251	5	moe.2003.4	moe.2003.4	NOUN
dpc-1651	251	6	.	.	PUNCT
dpc-1651	252	1	pmid	pmid	NOUN
dpc-1651	252	2	:	:	PUNCT
dpc-1651	252	3	12627104	12627104	NUM
dpc-1651	252	4	.	.	PUNCT
dpc-1651	253	1	29	29	NUM
dpc-1651	253	2	.	.	PUNCT
dpc-1651	253	3	lange	lange	PROPN
dpc-1651	253	4	rd	rd	PROPN
dpc-1651	253	5	,	,	PUNCT
dpc-1651	253	6	jones	jones	PROPN
dpc-1651	253	7	jb	jb	PROPN
dpc-1651	253	8	.	.	PUNCT
dpc-1651	254	1	cyclic	cyclic	PROPN
dpc-1651	254	2	neutropenia	neutropenia	PROPN
dpc-1651	254	3	.	.	PUNCT
dpc-1651	255	1	review	review	NOUN
dpc-1651	255	2	of	of	ADP
dpc-1651	255	3	clinical	clinical	ADJ
dpc-1651	255	4	manifestations	manifestation	NOUN
dpc-1651	255	5	and	and	CCONJ
dpc-1651	255	6	management	management	NOUN
dpc-1651	255	7	.	.	PUNCT
dpc-1651	256	1	am	be	AUX
dpc-1651	256	2	j	j	PROPN
dpc-1651	256	3	pediatr	pediatr	PROPN
dpc-1651	256	4	hematol	hematol	NOUN
dpc-1651	256	5	oncol	oncol	ADJ
dpc-1651	256	6	.	.	PUNCT
dpc-1651	257	1	1981;3(4):363–367	1981;3(4):363–367	NUM
dpc-1651	257	2	.	.	NOUN
dpc-1651	257	3	30	30	NUM
dpc-1651	257	4	.	.	PUNCT
dpc-1651	258	1	scully	scully	PROPN
dpc-1651	258	2	c	c	PROPN
dpc-1651	258	3	,	,	PUNCT
dpc-1651	258	4	macfadyen	macfadyen	NOUN
dpc-1651	258	5	e	e	NOUN
dpc-1651	258	6	,	,	PUNCT
dpc-1651	258	7	campbell	campbell	PROPN
dpc-1651	258	8	a.	a.	PROPN
dpc-1651	258	9	oral	oral	PROPN
dpc-1651	258	10	manifestations	manifestation	NOUN
dpc-1651	258	11	in	in	ADP
dpc-1651	258	12	cyclic	cyclic	ADJ
dpc-1651	258	13	neutropenia	neutropenia	NOUN
dpc-1651	258	14	.	.	PUNCT
dpc-1651	259	1	br	br	PROPN
dpc-1651	259	2	j	j	PROPN
dpc-1651	259	3	oral	oral	ADJ
dpc-1651	259	4	surg	surg	NOUN
dpc-1651	259	5	.	.	PUNCT
dpc-1651	260	1	1982;20(2):96–101	1982;20(2):96–101	NUM
dpc-1651	260	2	.	.	PUNCT
dpc-1651	261	1	doi	doi	NOUN
dpc-1651	261	2	:	:	PUNCT
dpc-1651	261	3	10.1016/0007	10.1016/0007	NUM
dpc-1651	261	4	-	-	PUNCT
dpc-1651	261	5	117x(82)90015	117x(82)90015	NUM
dpc-1651	261	6	-	-	PUNCT
dpc-1651	261	7	4	4	NUM
dpc-1651	261	8	.	.	NUM
dpc-1651	261	9	31	31	NUM
dpc-1651	261	10	.	.	PUNCT
dpc-1651	262	1	sucker	sucker	NOUN
dpc-1651	262	2	c	c	PROPN
dpc-1651	262	3	,	,	PUNCT
dpc-1651	262	4	djawari	djawari	PROPN
dpc-1651	262	5	j.	j.	PROPN
dpc-1651	263	1	[	[	X
dpc-1651	263	2	recurrent	recurrent	ADJ
dpc-1651	263	3	episodes	episode	NOUN
dpc-1651	263	4	of	of	ADP
dpc-1651	263	5	ulcerative	ulcerative	ADJ
dpc-1651	263	6	gingivostomatitis	gingivostomatitis	NOUN
dpc-1651	263	7	associated	associate	VERB
dpc-1651	263	8	with	with	ADP
dpc-1651	263	9	cyclic	cyclic	PROPN
dpc-1651	263	10	neutropenia	neutropenia	PROPN
dpc-1651	263	11	]	]	X
dpc-1651	263	12	.	.	PUNCT
dpc-1651	264	1	hautarzt.1999;50(7):503–506	hautarzt.1999;50(7):503–506	PROPN
dpc-1651	264	2	.	.	PUNCT
dpc-1651	265	1	doi	doi	NOUN
dpc-1651	265	2	:	:	PUNCT
dpc-1651	265	3	/10.1007	/10.1007	PROPN
dpc-1651	265	4	/	/	SYM
dpc-1651	265	5	s001050050042	s001050050042	NOUN
dpc-1651	265	6	.	.	PROPN
dpc-1651	265	7	32	32	NUM
dpc-1651	265	8	.	.	PUNCT
dpc-1651	266	1	lubitz	lubitz	PROPN
dpc-1651	266	2	pa	pa	PROPN
dpc-1651	266	3	,	,	PUNCT
dpc-1651	266	4	dower	dower	NOUN
dpc-1651	266	5	n	n	CCONJ
dpc-1651	266	6	,	,	PUNCT
dpc-1651	266	7	krol	krol	PROPN
dpc-1651	266	8	al	al	PROPN
dpc-1651	266	9	.	.	PROPN
dpc-1651	266	10	cyclic	cyclic	PROPN
dpc-1651	266	11	neutropenia	neutropenia	PROPN
dpc-1651	266	12	:	:	PUNCT
dpc-1651	266	13	an	an	DET
dpc-1651	266	14	unusual	unusual	ADJ
dpc-1651	266	15	disorder	disorder	NOUN
dpc-1651	266	16	of	of	ADP
dpc-1651	266	17	granulopoiesis	granulopoiesis	NOUN
dpc-1651	266	18	effectively	effectively	ADV
dpc-1651	266	19	treated	treat	VERB
dpc-1651	266	20	with	with	ADP
dpc-1651	266	21	recombinant	recombinant	ADJ
dpc-1651	266	22	granulocyte	granulocyte	ADJ
dpc-1651	266	23	colony	colony	NOUN
dpc-1651	266	24	-	-	PUNCT
dpc-1651	266	25	stimulating	stimulate	VERB
dpc-1651	266	26	factor	factor	NOUN
dpc-1651	266	27	.	.	PUNCT
dpc-1651	267	1	pediatr	pediatr	ADJ
dpc-1651	267	2	dermatol	dermatol	NOUN
dpc-1651	267	3	.	.	PUNCT
dpc-1651	268	1	2001;18(5):426–432	2001;18(5):426–432	X
dpc-1651	268	2	.	.	PUNCT
dpc-1651	268	3	doi	doi	NOUN
dpc-1651	268	4	:	:	PUNCT
dpc-1651	268	5	10.1046	10.1046	NUM
dpc-1651	268	6	/	/	SYM
dpc-1651	268	7	j.1525	j.1525	NOUN
dpc-1651	268	8	-	-	PUNCT
dpc-1651	268	9	1470.2001.01974.x	1470.2001.01974.x	PROPN
dpc-1651	268	10	.	.	PUNCT
dpc-1651	269	1	pmid	pmid	NOUN
dpc-1651	269	2	:	:	PUNCT
dpc-1651	269	3	11737691	11737691	NUM
dpc-1651	269	4	.	.	PUNCT
dpc-1651	270	1	33	33	NUM
dpc-1651	270	2	.	.	PUNCT
dpc-1651	271	1	marshall	marshall	PROPN
dpc-1651	271	2	gs	gs	PROPN
dpc-1651	271	3	,	,	PUNCT
dpc-1651	271	4	edwards	edwards	PROPN
dpc-1651	271	5	km	km	PROPN
dpc-1651	271	6	,	,	PUNCT
dpc-1651	271	7	butler	butler	PROPN
dpc-1651	271	8	j	j	PROPN
dpc-1651	271	9	,	,	PUNCT
dpc-1651	271	10	lawton	lawton	PROPN
dpc-1651	271	11	ar	ar	PROPN
dpc-1651	271	12	.	.	PROPN
dpc-1651	271	13	syndrome	syndrome	PROPN
dpc-1651	271	14	of	of	ADP
dpc-1651	271	15	periodic	periodic	ADJ
dpc-1651	271	16	fever	fever	NOUN
dpc-1651	271	17	,	,	PUNCT
dpc-1651	271	18	pharyngitis	pharyngitis	NOUN
dpc-1651	271	19	,	,	PUNCT
dpc-1651	271	20	and	and	CCONJ
dpc-1651	271	21	aphthous	aphthous	ADJ
dpc-1651	271	22	stomatitis	stomatitis	NOUN
dpc-1651	271	23	.	.	PUNCT
dpc-1651	272	1	j	j	PROPN
dpc-1651	272	2	pediatr	pediatr	PROPN
dpc-1651	272	3	.	.	PUNCT
dpc-1651	273	1	1987;110(1):43–6	1987;110(1):43–6	NUM
dpc-1651	273	2	.	.	PUNCT
dpc-1651	274	1	34	34	NUM
dpc-1651	274	2	.	.	PUNCT
dpc-1651	275	1	feder	feder	PROPN
dpc-1651	275	2	hm	hm	INTJ
dpc-1651	275	3	.	.	PROPN
dpc-1651	275	4	periodic	periodic	ADJ
dpc-1651	275	5	fever	fever	NOUN
dpc-1651	275	6	,	,	PUNCT
dpc-1651	275	7	aphthous	aphthous	ADJ
dpc-1651	275	8	stomatitis	stomatitis	NOUN
dpc-1651	275	9	,	,	PUNCT
dpc-1651	275	10	pharyngitis	pharyngitis	NOUN
dpc-1651	275	11	,	,	PUNCT
dpc-1651	275	12	adenitis	adenitis	NOUN
dpc-1651	275	13	:	:	PUNCT
dpc-1651	275	14	a	a	DET
dpc-1651	275	15	clinical	clinical	ADJ
dpc-1651	275	16	review	review	NOUN
dpc-1651	275	17	of	of	ADP
dpc-1651	275	18	a	a	DET
dpc-1651	275	19	new	new	ADJ
dpc-1651	275	20	syndrome	syndrome	NOUN
dpc-1651	275	21	.	.	PUNCT
dpc-1651	276	1	curr	curr	PROPN
dpc-1651	276	2	opin	opin	NOUN
dpc-1651	276	3	pediatr	pediatr	NOUN
dpc-1651	276	4	.	.	PUNCT
dpc-1651	277	1	2000;12(3):253–256	2000;12(3):253–256	X
dpc-1651	277	2	.	.	PUNCT
dpc-1651	277	3	doi	doi	NOUN
dpc-1651	277	4	:	:	PUNCT
dpc-1651	277	5	10.1097/00008480	10.1097/00008480	NUM
dpc-1651	277	6	-	-	SYM
dpc-1651	277	7	20000600000014	20000600000014	NUM
dpc-1651	277	8	.	.	PUNCT
dpc-1651	278	1	pmid	pmid	NOUN
dpc-1651	278	2	:	:	PUNCT
dpc-1651	278	3	10836162	10836162	NUM
dpc-1651	278	4	.	.	PUNCT
dpc-1651	279	1	35	35	NUM
dpc-1651	279	2	.	.	PUNCT
dpc-1651	280	1	kawashima	kawashima	PROPN
dpc-1651	280	2	h	h	PROPN
dpc-1651	280	3	,	,	PUNCT
dpc-1651	280	4	nishimata	nishimata	PROPN
dpc-1651	280	5	s	s	PROPN
dpc-1651	280	6	,	,	PUNCT
dpc-1651	280	7	shimizu	shimizu	PROPN
dpc-1651	280	8	t	t	PROPN
dpc-1651	280	9	,	,	PUNCT
dpc-1651	280	10	kashiwagi	kashiwagi	PROPN
dpc-1651	280	11	y	y	PROPN
dpc-1651	280	12	,	,	PUNCT
dpc-1651	280	13	takekuma	takekuma	PROPN
dpc-1651	280	14	k	k	NOUN
dpc-1651	280	15	,	,	PUNCT
dpc-1651	280	16	hoshika	hoshika	PROPN
dpc-1651	280	17	a.	a.	NOUN
dpc-1651	280	18	highly	highly	ADV
dpc-1651	280	19	suspected	suspect	VERB
dpc-1651	280	20	case	case	NOUN
dpc-1651	280	21	of	of	ADP
dpc-1651	280	22	fapa	fapa	NOUN
dpc-1651	280	23	(	(	PUNCT
dpc-1651	280	24	periodic	periodic	ADJ
dpc-1651	280	25	fever	fever	NOUN
dpc-1651	280	26	,	,	PUNCT
dpc-1651	280	27	aphthous	aphthous	ADJ
dpc-1651	280	28	stomatitis	stomatitis	NOUN
dpc-1651	280	29	,	,	PUNCT
dpc-1651	280	30	pharyngitis	pharyngitis	NOUN
dpc-1651	280	31	and	and	CCONJ
dpc-1651	280	32	adenitis	adenitis	NOUN
dpc-1651	280	33	)	)	PUNCT
dpc-1651	280	34	syndrome	syndrome	NOUN
dpc-1651	280	35	.	.	PUNCT
dpc-1651	281	1	pediatr	pediatr	PROPN
dpc-1651	281	2	int	int	PROPN
dpc-1651	281	3	.	.	PUNCT
dpc-1651	282	1	2001;43(1):103–106	2001;43(1):103–106	X
dpc-1651	282	2	.	.	PUNCT
dpc-1651	283	1	doi	doi	NOUN
dpc-1651	283	2	:	:	PUNCT
dpc-1651	283	3	10.1046	10.1046	NUM
dpc-1651	283	4	/	/	SYM
dpc-1651	283	5	j.1442	j.1442	NUM
dpc-1651	283	6	-	-	PUNCT
dpc-1651	283	7	200x.2001.01331.x	200x.2001.01331.x	NOUN
dpc-1651	283	8	.	.	PUNCT
dpc-1651	284	1	pmid	pmid	NOUN
dpc-1651	284	2	:	:	PUNCT
dpc-1651	284	3	11208014	11208014	NUM
dpc-1651	284	4	.	.	PUNCT
dpc-1651	285	1	36	36	NUM
dpc-1651	285	2	.	.	X
dpc-1651	286	1	grattan	grattan	PROPN
dpc-1651	286	2	ce	ce	PROPN
dpc-1651	286	3	,	,	PUNCT
dpc-1651	286	4	scully	scully	PROPN
dpc-1651	286	5	c.	c.	PROPN
dpc-1651	286	6	oral	oral	ADJ
dpc-1651	286	7	ulceration	ulceration	NOUN
dpc-1651	286	8	:	:	PUNCT
dpc-1651	286	9	a	a	DET
dpc-1651	286	10	diagnostic	diagnostic	ADJ
dpc-1651	286	11	problem	problem	NOUN
dpc-1651	286	12	.	.	PUNCT
dpc-1651	287	1	br	br	PROPN
dpc-1651	287	2	med	med	PROPN
dpc-1651	287	3	j	j	PROPN
dpc-1651	287	4	(	(	PUNCT
dpc-1651	287	5	clin	clin	PROPN
dpc-1651	287	6	res	re	NOUN
dpc-1651	287	7	ed	ed	NOUN
dpc-1651	287	8	)	)	PUNCT
dpc-1651	287	9	.	.	PUNCT
dpc-1651	288	1	1986;292(6528):1093–1094	1986;292(6528):1093–1094	X
dpc-1651	288	2	.	.	PUNCT
dpc-1651	289	1	doi	doi	NOUN
dpc-1651	289	2	:	:	PUNCT
dpc-1651	289	3	10.1136/	10.1136/	NUM
dpc-1651	289	4	bmj.292.6528.1093	bmj.292.6528.1093	PROPN
dpc-1651	289	5	.	.	PUNCT
dpc-1651	290	1	pmid	pmid	NOUN
dpc-1651	290	2	:	:	PUNCT
dpc-1651	290	3	3084011	3084011	NUM
dpc-1651	290	4	.	.	PUNCT
dpc-1651	291	1	37	37	NUM
dpc-1651	291	2	.	.	PUNCT
dpc-1651	291	3	eversole	eversole	PROPN
dpc-1651	291	4	lr	lr	PROPN
dpc-1651	291	5	.	.	PROPN
dpc-1651	291	6	immunopathology	immunopathology	NOUN
dpc-1651	291	7	of	of	ADP
dpc-1651	291	8	oral	oral	ADJ
dpc-1651	291	9	mucosal	mucosal	NOUN
dpc-1651	291	10	ulcerative	ulcerative	NOUN
dpc-1651	291	11	,	,	PUNCT
dpc-1651	291	12	desquamative	desquamative	ADJ
dpc-1651	291	13	,	,	PUNCT
dpc-1651	291	14	and	and	CCONJ
dpc-1651	291	15	bullous	bullous	ADJ
dpc-1651	291	16	diseases	disease	NOUN
dpc-1651	291	17	.	.	PUNCT
dpc-1651	292	1	selective	selective	ADJ
dpc-1651	292	2	review	review	NOUN
dpc-1651	292	3	of	of	ADP
dpc-1651	292	4	the	the	DET
dpc-1651	292	5	literature	literature	NOUN
dpc-1651	292	6	.	.	PUNCT
dpc-1651	293	1	oral	oral	ADJ
dpc-1651	293	2	surg	surg	NOUN
dpc-1651	293	3	oral	oral	ADJ
dpc-1651	293	4	med	med	ADJ
dpc-1651	293	5	oral	oral	ADJ
dpc-1651	293	6	pathol	pathol	NOUN
dpc-1651	293	7	.	.	PUNCT
dpc-1651	294	1	1994;77(6):555–571	1994;77(6):555–571	NUM
dpc-1651	294	2	.	.	PUNCT
dpc-1651	294	3	doi	doi	NOUN
dpc-1651	294	4	:	:	PUNCT
dpc-1651	294	5	10.1016/0030	10.1016/0030	NUM
dpc-1651	294	6	-	-	SYM
dpc-1651	294	7	4220(94)90312	4220(94)90312	NUM
dpc-1651	294	8	-	-	PUNCT
dpc-1651	294	9	3	3	NUM
dpc-1651	294	10	.	.	NOUN
dpc-1651	294	11	38	38	NUM
dpc-1651	294	12	.	.	PUNCT
dpc-1651	295	1	porter	porter	PROPN
dpc-1651	295	2	sr	sr	PROPN
dpc-1651	295	3	,	,	PUNCT
dpc-1651	295	4	scully	scully	PROPN
dpc-1651	295	5	c	c	AUX
dpc-1651	295	6	,	,	PUNCT
dpc-1651	295	7	luker	luker	PROPN
dpc-1651	295	8	j.	j.	PROPN
dpc-1651	295	9	complications	complication	NOUN
dpc-1651	295	10	of	of	ADP
dpc-1651	295	11	dental	dental	ADJ
dpc-1651	295	12	surgery	surgery	NOUN
dpc-1651	295	13	in	in	ADP
dpc-1651	295	14	persons	person	NOUN
dpc-1651	295	15	with	with	ADP
dpc-1651	295	16	hiv	hiv	PROPN
dpc-1651	295	17	disease	disease	NOUN
dpc-1651	295	18	.	.	PUNCT
dpc-1651	296	1	oral	oral	ADJ
dpc-1651	296	2	surg	surg	NOUN
dpc-1651	296	3	oral	oral	ADJ
dpc-1651	296	4	med	med	ADJ
dpc-1651	296	5	oral	oral	ADJ
dpc-1651	296	6	pathol	pathol	NOUN
dpc-1651	296	7	.	.	PUNCT
dpc-1651	297	1	1993;75(2):165–167	1993;75(2):165–167	NUM
dpc-1651	297	2	.	.	PUNCT
dpc-1651	297	3	doi	doi	NOUN
dpc-1651	297	4	:	:	PUNCT
dpc-1651	297	5	10.1016/0030	10.1016/0030	NUM
dpc-1651	297	6	-	-	PUNCT
dpc-1651	297	7	4220(93)90087	4220(93)90087	PROPN
dpc-1651	297	8	-	-	PUNCT
dpc-1651	297	9	k.	k.	NOUN
dpc-1651	297	10	39	39	NUM
dpc-1651	297	11	.	.	PUNCT
dpc-1651	298	1	scully	scully	ADV
dpc-1651	298	2	c	c	PROPN
dpc-1651	298	3	,	,	PUNCT
dpc-1651	298	4	porter	porter	PROPN
dpc-1651	298	5	sr	sr	PROPN
dpc-1651	298	6	.	.	PUNCT
dpc-1651	299	1	oral	oral	ADJ
dpc-1651	299	2	mucosal	mucosal	NOUN
dpc-1651	299	3	disease	disease	NOUN
dpc-1651	299	4	:	:	PUNCT
dpc-1651	299	5	a	a	DET
dpc-1651	299	6	decade	decade	NOUN
dpc-1651	299	7	of	of	ADP
dpc-1651	299	8	new	new	ADJ
dpc-1651	299	9	entities	entity	NOUN
dpc-1651	299	10	,	,	PUNCT
dpc-1651	299	11	aetiologies	aetiology	NOUN
dpc-1651	299	12	and	and	CCONJ
dpc-1651	299	13	associations	association	NOUN
dpc-1651	299	14	.	.	PUNCT
dpc-1651	300	1	int	int	PROPN
dpc-1651	300	2	dent	dent	NOUN
dpc-1651	300	3	j.	j.	PROPN
dpc-1651	300	4	1994;44(1):33–43	1994;44(1):33–43	PROPN
dpc-1651	300	5	.	.	PUNCT
dpc-1651	301	1	pmid	pmid	NOUN
dpc-1651	301	2	:	:	PUNCT
dpc-1651	301	3	8021031	8021031	NUM
dpc-1651	301	4	.	.	PUNCT
dpc-1651	302	1	40	40	NUM
dpc-1651	302	2	.	.	PUNCT
dpc-1651	303	1	macphail	macphail	PROPN
dpc-1651	303	2	la	la	PROPN
dpc-1651	303	3	,	,	PUNCT
dpc-1651	303	4	greenspan	greenspan	PROPN
dpc-1651	303	5	js	js	PROPN
dpc-1651	303	6	.	.	PUNCT
dpc-1651	303	7	oral	oral	ADJ
dpc-1651	303	8	ulceration	ulceration	NOUN
dpc-1651	303	9	in	in	ADP
dpc-1651	303	10	hiv	hiv	PROPN
dpc-1651	303	11	infection	infection	NOUN
dpc-1651	303	12	:	:	PUNCT
dpc-1651	303	13	investigation	investigation	NOUN
dpc-1651	303	14	and	and	CCONJ
dpc-1651	303	15	pathogenesis	pathogenesis	NOUN
dpc-1651	303	16	.	.	PUNCT
dpc-1651	304	1	oral	oral	ADJ
dpc-1651	304	2	dis	dis	PROPN
dpc-1651	304	3	.	.	PUNCT
dpc-1651	305	1	1997;3	1997;3	NUM
dpc-1651	305	2	suppl	suppl	ADJ
dpc-1651	305	3	1	1	NUM
dpc-1651	305	4	:	:	PUNCT
dpc-1651	305	5	s190	s190	NUM
dpc-1651	305	6	-	-	PUNCT
dpc-1651	305	7	193	193	NUM
dpc-1651	305	8	.	.	PUNCT
dpc-1651	306	1	doi	doi	NOUN
dpc-1651	306	2	:	:	PUNCT
dpc-1651	306	3	10.1111	10.1111	NUM
dpc-1651	306	4	/	/	SYM
dpc-1651	306	5	j.1601	j.1601	PROPN
dpc-1651	306	6	-	-	PUNCT
dpc-1651	306	7	0825.1997.tb00358.x	0825.1997.tb00358.x	NOUN
dpc-1651	306	8	.	.	PUNCT
dpc-1651	307	1	pmid	pmid	NOUN
dpc-1651	307	2	:	:	PUNCT
dpc-1651	307	3	9456687	9456687	NUM
dpc-1651	307	4	.	.	PUNCT
dpc-1651	308	1	41	41	NUM
dpc-1651	308	2	.	.	PUNCT
dpc-1651	309	1	zakrzewska	zakrzewska	PROPN
dpc-1651	309	2	jm	jm	PROPN
dpc-1651	309	3	,	,	PUNCT
dpc-1651	309	4	robinson	robinson	PROPN
dpc-1651	309	5	p	p	PROPN
dpc-1651	309	6	,	,	PUNCT
dpc-1651	309	7	williams	williams	PROPN
dpc-1651	309	8	ig	ig	PROPN
dpc-1651	309	9	.	.	PUNCT
dpc-1651	310	1	severe	severe	ADJ
dpc-1651	310	2	oral	oral	ADJ
dpc-1651	310	3	ulceration	ulceration	NOUN
dpc-1651	310	4	in	in	ADP
dpc-1651	310	5	patients	patient	NOUN
dpc-1651	310	6	with	with	ADP
dpc-1651	310	7	hiv	hiv	PROPN
dpc-1651	310	8	infection	infection	NOUN
dpc-1651	310	9	:	:	PUNCT
dpc-1651	310	10	a	a	DET
dpc-1651	310	11	case	case	NOUN
dpc-1651	310	12	series	series	NOUN
dpc-1651	310	13	.	.	PUNCT
dpc-1651	311	1	oral	oral	ADJ
dpc-1651	311	2	dis	dis	PROPN
dpc-1651	311	3	.	.	PUNCT
dpc-1651	312	1	1997;3	1997;3	NUM
dpc-1651	312	2	suppl	suppl	ADJ
dpc-1651	313	1	1	1	NUM
dpc-1651	313	2	:	:	PUNCT
dpc-1651	313	3	s194	s194	PROPN
dpc-1651	313	4	-	-	PUNCT
dpc-1651	313	5	196	196	NUM
dpc-1651	313	6	.	.	PUNCT
dpc-1651	314	1	doi	doi	NOUN
dpc-1651	314	2	:	:	PUNCT
dpc-1651	314	3	10.1111	10.1111	NUM
dpc-1651	314	4	/	/	SYM
dpc-1651	314	5	j.1601	j.1601	PROPN
dpc-1651	314	6	-	-	PUNCT
dpc-1651	314	7	0825.1997.tb00359.x	0825.1997.tb00359.x	PROPN
dpc-1651	314	8	.	.	PUNCT
dpc-1651	315	1	pmid	pmid	NOUN
dpc-1651	315	2	:	:	PUNCT
dpc-1651	315	3	9456688	9456688	NUM
dpc-1651	315	4	.	.	X
dpc-1651	316	1	42	42	NUM
dpc-1651	316	2	.	.	PUNCT
dpc-1651	317	1	li	li	PROPN
dpc-1651	317	2	l	l	PROPN
dpc-1651	317	3	,	,	PUNCT
dpc-1651	317	4	gu	gu	NOUN
dpc-1651	317	5	h	h	PROPN
dpc-1651	317	6	,	,	PUNCT
dpc-1651	317	7	zhang	zhang	PROPN
dpc-1651	317	8	g.	g.	PROPN
dpc-1651	317	9	association	association	PROPN
dpc-1651	317	10	between	between	ADP
dpc-1651	317	11	recurrent	recurrent	ADJ
dpc-1651	317	12	aphthous	aphthous	ADJ
dpc-1651	317	13	stomatitis	stomatitis	NOUN
dpc-1651	317	14	and	and	CCONJ
dpc-1651	317	15	helicobacter	helicobacter	NOUN
dpc-1651	317	16	pylori	pylori	ADJ
dpc-1651	317	17	infection	infection	NOUN
dpc-1651	317	18	:	:	PUNCT
dpc-1651	317	19	a	a	DET
dpc-1651	317	20	meta	meta	ADJ
dpc-1651	317	21	-	-	PUNCT
dpc-1651	317	22	analysis	analysis	NOUN
dpc-1651	317	23	.	.	PUNCT
dpc-1651	318	1	clin	clin	PROPN
dpc-1651	318	2	oral	oral	PROPN
dpc-1651	318	3	investig	investig	PROPN
dpc-1651	318	4	.	.	PUNCT
dpc-1651	319	1	2014;18(6):1553–1560	2014;18(6):1553–1560	NUM
dpc-1651	319	2	.	.	PUNCT
dpc-1651	320	1	doi	doi	NOUN
dpc-1651	320	2	:	:	PUNCT
dpc-1651	320	3	10.1007	10.1007	NUM
dpc-1651	320	4	/	/	SYM
dpc-1651	320	5	s00784014	s00784014	NOUN
dpc-1651	320	6	-	-	PUNCT
dpc-1651	320	7	1230	1230	NUM
dpc-1651	320	8	-	-	SYM
dpc-1651	320	9	5	5	NUM
dpc-1651	320	10	.	.	PUNCT
dpc-1651	321	1	pmid	pmid	NOUN
dpc-1651	321	2	:	:	PUNCT
dpc-1651	321	3	24682540	24682540	NUM
dpc-1651	321	4	.	.	PUNCT
dpc-1651	322	1	43	43	NUM
dpc-1651	322	2	.	.	PUNCT
dpc-1651	323	1	arduino	arduino	PROPN
dpc-1651	323	2	pg	pg	PROPN
dpc-1651	323	3	,	,	PUNCT
dpc-1651	323	4	porter	porter	PROPN
dpc-1651	323	5	sr	sr	PROPN
dpc-1651	323	6	.	.	PUNCT
dpc-1651	324	1	oral	oral	ADJ
dpc-1651	324	2	and	and	CCONJ
dpc-1651	324	3	perioral	perioral	ADJ
dpc-1651	324	4	herpes	herpe	NOUN
dpc-1651	324	5	simplex	simplex	NOUN
dpc-1651	324	6	virus	virus	NOUN
dpc-1651	324	7	type	type	NOUN
dpc-1651	324	8	1	1	NUM
dpc-1651	324	9	(	(	PUNCT
dpc-1651	324	10	hsv-1	hsv-1	NOUN
dpc-1651	324	11	)	)	PUNCT
dpc-1651	324	12	infection	infection	NOUN
dpc-1651	324	13	:	:	PUNCT
dpc-1651	324	14	review	review	NOUN
dpc-1651	324	15	of	of	ADP
dpc-1651	324	16	its	its	PRON
dpc-1651	324	17	management	management	NOUN
dpc-1651	324	18	.	.	PUNCT
dpc-1651	325	1	oral	oral	ADJ
dpc-1651	325	2	dis	dis	PROPN
dpc-1651	325	3	.	.	PUNCT
dpc-1651	326	1	2006;12(3):254–270	2006;12(3):254–270	NUM
dpc-1651	326	2	.	.	PUNCT
dpc-1651	327	1	doi	doi	NOUN
dpc-1651	327	2	:	:	PUNCT
dpc-1651	327	3	10.1111	10.1111	NUM
dpc-1651	327	4	/	/	SYM
dpc-1651	327	5	j.1601	j.1601	PROPN
dpc-1651	327	6	-	-	PUNCT
dpc-1651	327	7	0825.2006.01202.x	0825.2006.01202.x	PROPN
dpc-1651	327	8	.	.	PUNCT
dpc-1651	328	1	pmid	pmid	NOUN
dpc-1651	328	2	:	:	PUNCT
dpc-1651	328	3	16700734	16700734	NUM
dpc-1651	328	4	.	.	PUNCT
dpc-1651	329	1	44	44	NUM
dpc-1651	329	2	.	.	PUNCT
dpc-1651	330	1	fitzpatrick	fitzpatrick	PROPN
dpc-1651	330	2	sg	sg	PROPN
dpc-1651	330	3	,	,	PUNCT
dpc-1651	330	4	cohen	cohen	PROPN
dpc-1651	330	5	dm	dm	PROPN
dpc-1651	330	6	,	,	PUNCT
dpc-1651	330	7	clark	clark	PROPN
dpc-1651	330	8	an	an	PROPN
dpc-1651	330	9	.	.	PUNCT
dpc-1651	330	10	ulcerated	ulcerated	ADJ
dpc-1651	330	11	lesions	lesion	NOUN
dpc-1651	330	12	of	of	ADP
dpc-1651	330	13	the	the	DET
dpc-1651	330	14	oral	oral	ADJ
dpc-1651	330	15	mucosa	mucosa	NOUN
dpc-1651	330	16	:	:	PUNCT
dpc-1651	330	17	clinical	clinical	ADJ
dpc-1651	330	18	and	and	CCONJ
dpc-1651	330	19	histologic	histologic	ADJ
dpc-1651	330	20	review	review	NOUN
dpc-1651	330	21	.	.	PUNCT
dpc-1651	331	1	head	head	NOUN
dpc-1651	331	2	neck	neck	NOUN
dpc-1651	331	3	pathol	pathol	NOUN
dpc-1651	331	4	.	.	PUNCT
dpc-1651	332	1	2019;13(1):91–102	2019;13(1):91–102	NUM
dpc-1651	332	2	.	.	PUNCT
dpc-1651	333	1	doi	doi	NOUN
dpc-1651	333	2	:	:	PUNCT
dpc-1651	333	3	10.1007	10.1007	NUM
dpc-1651	333	4	/	/	SYM
dpc-1651	333	5	s12105	s12105	NOUN
dpc-1651	333	6	-	-	PUNCT
dpc-1651	333	7	018	018	NUM
dpc-1651	333	8	-	-	PUNCT
dpc-1651	333	9	0981	0981	NUM
dpc-1651	333	10	-	-	PUNCT
dpc-1651	333	11	8	8	NUM
dpc-1651	333	12	.	.	PUNCT
dpc-1651	334	1	pmid	pmid	NOUN
dpc-1651	334	2	:	:	PUNCT
dpc-1651	334	3	30701449	30701449	NUM
dpc-1651	334	4	.	.	PUNCT
dpc-1651	335	1	45	45	NUM
dpc-1651	335	2	.	.	PUNCT
dpc-1651	336	1	patil	patil	PROPN
dpc-1651	336	2	n	n	CCONJ
dpc-1651	336	3	,	,	PUNCT
dpc-1651	336	4	chaurasia	chaurasia	PROPN
dpc-1651	336	5	vr	vr	PROPN
dpc-1651	336	6	,	,	PUNCT
dpc-1651	336	7	babaji	babaji	PROPN
dpc-1651	336	8	p	p	PROPN
dpc-1651	336	9	,	,	PUNCT
dpc-1651	336	10	ramesh	ramesh	PROPN
dpc-1651	336	11	d	d	PROPN
dpc-1651	336	12	,	,	PUNCT
dpc-1651	336	13	jhamb	jhamb	ADV
dpc-1651	336	14	k	k	PROPN
dpc-1651	336	15	,	,	PUNCT
dpc-1651	336	16	sharma	sharma	PROPN
dpc-1651	336	17	am	be	AUX
dpc-1651	336	18	.	.	PUNCT
dpc-1651	337	1	the	the	DET
dpc-1651	337	2	effect	effect	NOUN
dpc-1651	337	3	of	of	ADP
dpc-1651	337	4	highly	highly	ADV
dpc-1651	337	5	active	active	ADJ
dpc-1651	337	6	antiretroviral	antiretroviral	ADJ
dpc-1651	337	7	therapy	therapy	NOUN
dpc-1651	337	8	on	on	ADP
dpc-1651	337	9	the	the	DET
dpc-1651	337	10	prevalence	prevalence	NOUN
dpc-1651	337	11	of	of	ADP
dpc-1651	337	12	oral	oral	ADJ
dpc-1651	337	13	manifestation	manifestation	NOUN
dpc-1651	337	14	in	in	ADP
dpc-1651	337	15	human	human	ADJ
dpc-1651	337	16	immunodeficiency	immunodeficiency	NOUN
dpc-1651	337	17	virus	virus	NOUN
dpc-1651	337	18	-	-	PUNCT
dpc-1651	337	19	infected	infect	VERB
dpc-1651	337	20	patients	patient	NOUN
dpc-1651	337	21	in	in	ADP
dpc-1651	337	22	karnataka	karnataka	PROPN
dpc-1651	337	23	,	,	PUNCT
dpc-1651	337	24	india	india	PROPN
dpc-1651	337	25	.	.	PUNCT
dpc-1651	338	1	eur	eur	PROPN
dpc-1651	338	2	j	j	PROPN
dpc-1651	338	3	dent	dent	NOUN
dpc-1651	338	4	.	.	PUNCT
dpc-1651	339	1	2015;9(1):47–52	2015;9(1):47–52	NUM
dpc-1651	339	2	.	.	X
dpc-1651	340	1	46	46	NUM
dpc-1651	340	2	.	.	PUNCT
dpc-1651	341	1	giannetti	giannetti	PROPN
dpc-1651	341	2	l	l	PROPN
dpc-1651	341	3	,	,	PUNCT
dpc-1651	341	4	murri	murri	PROPN
dpc-1651	341	5	dello	dello	PROPN
dpc-1651	341	6	diago	diago	PROPN
dpc-1651	342	1	a	a	X
dpc-1651	342	2	,	,	PUNCT
dpc-1651	342	3	lo	lo	PROPN
dpc-1651	342	4	muzio	muzio	PROPN
dpc-1651	342	5	l.	l.	PROPN
dpc-1651	342	6	recurrent	recurrent	PROPN
dpc-1651	342	7	aphtous	aphtous	ADJ
dpc-1651	342	8	stomatitis	stomatitis	PROPN
dpc-1651	342	9	.	.	PUNCT
dpc-1651	343	1	minerva	minerva	PROPN
dpc-1651	343	2	stomatol	stomatol	PROPN
dpc-1651	343	3	.	.	PUNCT
dpc-1651	344	1	2018;67(3):125–8	2018;67(3):125–8	NUM
dpc-1651	344	2	.	.	PUNCT
dpc-1651	345	1	doi	doi	NOUN
dpc-1651	345	2	:	:	PUNCT
dpc-1651	345	3	10.23736/	10.23736/	NUM
dpc-1651	345	4	s0026	s0026	PROPN
dpc-1651	345	5	-	-	PUNCT
dpc-1651	345	6	4970.18.04137	4970.18.04137	NOUN
dpc-1651	345	7	-	-	PUNCT
dpc-1651	345	8	7	7	NUM
dpc-1651	345	9	.	.	PUNCT
dpc-1651	346	1	pmid	pmid	NOUN
dpc-1651	346	2	:	:	PUNCT
dpc-1651	346	3	29332375	29332375	NUM
dpc-1651	346	4	.	.	PUNCT
dpc-1651	347	1	47	47	NUM
dpc-1651	347	2	.	.	PUNCT
dpc-1651	348	1	dalessandri	dalessandri	PROPN
dpc-1651	348	2	d	d	PROPN
dpc-1651	348	3	,	,	PUNCT
dpc-1651	348	4	zotti	zotti	PROPN
dpc-1651	348	5	f	f	X
dpc-1651	348	6	,	,	PUNCT
dpc-1651	348	7	laffranchi	laffranchi	PROPN
dpc-1651	348	8	l	l	NOUN
dpc-1651	348	9	,	,	PUNCT
dpc-1651	348	10	migliorati	migliorati	PROPN
dpc-1651	348	11	m	m	PROPN
dpc-1651	348	12	,	,	PUNCT
dpc-1651	348	13	isola	isola	PROPN
dpc-1651	348	14	g	g	PROPN
dpc-1651	348	15	,	,	PUNCT
dpc-1651	348	16	bonetti	bonetti	PROPN
dpc-1651	348	17	s	s	PROPN
dpc-1651	348	18	,	,	PUNCT
dpc-1651	348	19	et	et	PROPN
dpc-1651	348	20	al	al	PROPN
dpc-1651	348	21	.	.	PUNCT
dpc-1651	349	1	treatment	treatment	NOUN
dpc-1651	349	2	of	of	ADP
dpc-1651	349	3	recurrent	recurrent	ADJ
dpc-1651	349	4	aphthous	aphthous	ADJ
dpc-1651	349	5	stomatitis	stomatitis	NOUN
dpc-1651	349	6	(	(	PUNCT
dpc-1651	349	7	ras	ras	NOUN
dpc-1651	349	8	;	;	PUNCT
dpc-1651	349	9	aphthae	aphthae	NOUN
dpc-1651	349	10	;	;	PUNCT
dpc-1651	349	11	canker	canker	NOUN
dpc-1651	349	12	sores	sore	NOUN
dpc-1651	349	13	)	)	PUNCT
dpc-1651	349	14	with	with	ADP
dpc-1651	349	15	a	a	DET
dpc-1651	349	16	barrier	barrier	NOUN
dpc-1651	349	17	forming	form	VERB
dpc-1651	349	18	mouth	mouth	NOUN
dpc-1651	349	19	rinse	rinse	NOUN
dpc-1651	349	20	or	or	CCONJ
dpc-1651	349	21	topical	topical	ADJ
dpc-1651	349	22	gel	gel	NOUN
dpc-1651	349	23	formulation	formulation	NOUN
dpc-1651	349	24	containing	contain	VERB
dpc-1651	349	25	hyaluronic	hyaluronic	ADJ
dpc-1651	349	26	acid	acid	NOUN
dpc-1651	349	27	:	:	PUNCT
dpc-1651	349	28	a	a	DET
dpc-1651	349	29	retrospective	retrospective	ADJ
dpc-1651	349	30	clinical	clinical	ADJ
dpc-1651	349	31	study	study	NOUN
dpc-1651	349	32	.	.	PUNCT
dpc-1651	350	1	bmc	bmc	PROPN
dpc-1651	350	2	oral	oral	ADJ
dpc-1651	350	3	health	health	NOUN
dpc-1651	350	4	.	.	PUNCT
dpc-1651	351	1	2019;19(1):153	2019;19(1):153	PROPN
dpc-1651	351	2	.	.	PUNCT
dpc-1651	352	1	doi	doi	PROPN
dpc-1651	352	2	:	:	PUNCT
dpc-1651	352	3	10.1186/	10.1186/	NUM
dpc-1651	352	4	s12903	s12903	NOUN
dpc-1651	352	5	-	-	PUNCT
dpc-1651	352	6	019	019	NUM
dpc-1651	352	7	-	-	PUNCT
dpc-1651	352	8	0850	0850	NUM
dpc-1651	352	9	-	-	PUNCT
dpc-1651	352	10	1	1	NUM
dpc-1651	352	11	.	.	PUNCT
dpc-1651	353	1	pmid	pmid	NOUN
dpc-1651	353	2	:	:	PUNCT
dpc-1651	353	3	31311529	31311529	NUM
dpc-1651	353	4	.	.	PUNCT
dpc-1651	354	1	48	48	NUM
dpc-1651	354	2	.	.	PUNCT
dpc-1651	355	1	carl	carl	PROPN
dpc-1651	355	2	w	w	PROPN
dpc-1651	355	3	,	,	PUNCT
dpc-1651	355	4	havens	haven	NOUN
dpc-1651	355	5	j.	j.	PROPN
dpc-1651	355	6	the	the	DET
dpc-1651	355	7	cancer	cancer	NOUN
dpc-1651	355	8	patient	patient	NOUN
dpc-1651	355	9	with	with	ADP
dpc-1651	355	10	severe	severe	ADJ
dpc-1651	355	11	mucositis	mucositis	NOUN
dpc-1651	355	12	.	.	PUNCT
dpc-1651	356	1	curr	curr	PROPN
dpc-1651	356	2	rev	rev	PROPN
dpc-1651	356	3	pain	pain	NOUN
dpc-1651	356	4	.	.	PUNCT
dpc-1651	357	1	2000;4(3):197–202	2000;4(3):197–202	X
dpc-1651	357	2	.	.	PUNCT
dpc-1651	357	3	doi	doi	NOUN
dpc-1651	357	4	:	:	PUNCT
dpc-1651	357	5	10.1007	10.1007	NUM
dpc-1651	357	6	/	/	SYM
dpc-1651	357	7	s11916	s11916	PROPN
dpc-1651	357	8	-	-	PUNCT
dpc-1651	357	9	0000079	0000079	NUM
dpc-1651	357	10	-	-	SYM
dpc-1651	357	11	2	2	NUM
dpc-1651	357	12	.	.	NUM
dpc-1651	357	13	49	49	NUM
dpc-1651	357	14	.	.	PUNCT
dpc-1651	358	1	sharquie	sharquie	PROPN
dpc-1651	358	2	ke	ke	PROPN
dpc-1651	358	3	,	,	PUNCT
dpc-1651	358	4	helmi	helmi	PROPN
dpc-1651	358	5	rma	rma	PROPN
dpc-1651	358	6	,	,	PUNCT
dpc-1651	358	7	noiami	noiami	NOUN
dpc-1651	358	8	aa	aa	PROPN
dpc-1651	358	9	,	,	PUNCT
dpc-1651	358	10	al	al	PROPN
dpc-1651	358	11	-	-	PUNCT
dpc-1651	358	12	hayani	hayani	PROPN
dpc-1651	358	13	rk	rk	PROPN
dpc-1651	358	14	,	,	PUNCT
dpc-1651	358	15	kadhom	kadhom	PROPN
dpc-1651	358	16	maa	maa	PROPN
dpc-1651	358	17	.	.	PUNCT
dpc-1651	359	1	the	the	DET
dpc-1651	359	2	therapeutic	therapeutic	ADJ
dpc-1651	359	3	role	role	NOUN
dpc-1651	359	4	of	of	ADP
dpc-1651	359	5	isotretinoin	isotretinoin	PROPN
dpc-1651	359	6	in	in	ADP
dpc-1651	359	7	the	the	DET
dpc-1651	359	8	management	management	NOUN
dpc-1651	359	9	of	of	ADP
dpc-1651	359	10	behçet	behçet	PROPN
dpc-1651	359	11	’s	’s	PART
dpc-1651	359	12	disease	disease	NOUN
dpc-1651	359	13	:	:	PUNCT
dpc-1651	359	14	a	a	DET
dpc-1651	359	15	single	single	ADJ
dpc-1651	359	16	-	-	PUNCT
dpc-1651	359	17	blinded	blind	VERB
dpc-1651	359	18	,	,	PUNCT
dpc-1651	359	19	controlled	control	VERB
dpc-1651	359	20	therapeutic	therapeutic	ADJ
dpc-1651	359	21	study	study	NOUN
dpc-1651	359	22	.	.	PUNCT
dpc-1651	360	1	j	j	NOUN
dpc-1651	360	2	drugs	drug	NOUN
dpc-1651	360	3	dermatol.2013;12(4):e68	dermatol.2013;12(4):e68	NOUN
dpc-1651	360	4	-	-	PUNCT
dpc-1651	360	5	73	73	NUM
dpc-1651	360	6	.	.	PUNCT
dpc-1651	361	1	50	50	NUM
dpc-1651	361	2	.	.	PUNCT
dpc-1651	361	3	elad	elad	PROPN
dpc-1651	361	4	s	s	PROPN
dpc-1651	361	5	,	,	PUNCT
dpc-1651	361	6	epstein	epstein	PROPN
dpc-1651	361	7	jb	jb	PROPN
dpc-1651	361	8	,	,	PUNCT
dpc-1651	361	9	von	von	PROPN
dpc-1651	361	10	bültzingslöwen	bültzingslöwen	PROPN
dpc-1651	361	11	i	i	PRON
dpc-1651	361	12	,	,	PUNCT
dpc-1651	361	13	drucker	drucker	PROPN
dpc-1651	361	14	s	s	PROPN
dpc-1651	361	15	,	,	PUNCT
dpc-1651	361	16	tzach	tzach	ADV
dpc-1651	361	17	r	r	NOUN
dpc-1651	361	18	,	,	PUNCT
dpc-1651	361	19	yarom	yarom	ADP
dpc-1651	361	20	n.	n.	ADJ
dpc-1651	361	21	topical	topical	ADJ
dpc-1651	361	22	immunomodulators	immunomodulator	NOUN
dpc-1651	361	23	for	for	ADP
dpc-1651	361	24	management	management	NOUN
dpc-1651	361	25	of	of	ADP
dpc-1651	361	26	oral	oral	ADJ
dpc-1651	361	27	mucosal	mucosal	NOUN
dpc-1651	361	28	conditions	condition	NOUN
dpc-1651	361	29	,	,	PUNCT
dpc-1651	361	30	a	a	DET
dpc-1651	361	31	systematic	systematic	ADJ
dpc-1651	361	32	review	review	NOUN
dpc-1651	361	33	;	;	PUNCT
dpc-1651	361	34	part	part	PROPN
dpc-1651	361	35	ii	ii	PROPN
dpc-1651	361	36	:	:	PUNCT
dpc-1651	361	37	miscellaneous	miscellaneous	ADJ
dpc-1651	361	38	agents	agent	NOUN
dpc-1651	361	39	.	.	PUNCT
dpc-1651	362	1	expert	expert	NOUN
dpc-1651	362	2	opin	opin	NOUN
dpc-1651	362	3	emerg	emerg	NOUN
dpc-1651	362	4	drugs	drug	NOUN
dpc-1651	362	5	.	.	PUNCT
dpc-1651	363	1	2011;16(1):183–202	2011;16(1):183–202	X
dpc-1651	363	2	.	.	PUNCT
dpc-1651	364	1	doi	doi	NOUN
dpc-1651	364	2	:	:	PUNCT
dpc-1651	364	3	10.1517/14728214.2011.528390	10.1517/14728214.2011.528390	X
dpc-1651	364	4	.	.	X
dpc-1651	365	1	pmid	pmid	NOUN
dpc-1651	365	2	:	:	PUNCT
dpc-1651	365	3	21244328	21244328	NUM
dpc-1651	365	4	.	.	PUNCT
dpc-1651	366	1	51	51	NUM
dpc-1651	366	2	.	.	PUNCT
dpc-1651	366	3	mumcu	mumcu	PROPN
dpc-1651	366	4	g	g	NOUN
dpc-1651	366	5	,	,	PUNCT
dpc-1651	366	6	ergun	ergun	NOUN
dpc-1651	366	7	t	t	PROPN
dpc-1651	366	8	,	,	PUNCT
dpc-1651	366	9	elbir	elbir	VERB
dpc-1651	366	10	y	y	PROPN
dpc-1651	366	11	,	,	PUNCT
dpc-1651	366	12	et	et	PROPN
dpc-1651	366	13	al	al	PROPN
dpc-1651	366	14	.	.	PROPN
dpc-1651	367	1	clinical	clinical	ADJ
dpc-1651	367	2	and	and	CCONJ
dpc-1651	367	3	immunological	immunological	ADJ
dpc-1651	367	4	effects	effect	NOUN
dpc-1651	367	5	of	of	ADP
dpc-1651	367	6	azithromycin	azithromycin	NOUN
dpc-1651	367	7	in	in	ADP
dpc-1651	367	8	behçet	behçet	PROPN
dpc-1651	367	9	’s	’s	PART
dpc-1651	367	10	disease	disease	NOUN
dpc-1651	367	11	.	.	PUNCT
dpc-1651	368	1	j	j	PROPN
dpc-1651	368	2	oral	oral	ADJ
dpc-1651	368	3	pathol	pathol	NOUN
dpc-1651	368	4	med.2005;34(1):13–16	med.2005;34(1):13–16	NOUN
dpc-1651	368	5	.	.	PUNCT
dpc-1651	369	1	doi	doi	NOUN
dpc-1651	369	2	:	:	PUNCT
dpc-1651	369	3	10.1111	10.1111	NUM
dpc-1651	369	4	/	/	SYM
dpc-1651	369	5	j.16000714.2004.00265.x	j.16000714.2004.00265.x	NOUN
dpc-1651	369	6	.	.	PUNCT
dpc-1651	370	1	pmid	pmid	NOUN
dpc-1651	370	2	:	:	PUNCT
dpc-1651	370	3	15610401	15610401	NUM
dpc-1651	370	4	.	.	PUNCT
dpc-1651	371	1	52	52	NUM
dpc-1651	371	2	.	.	PUNCT
dpc-1651	372	1	alpsoy	alpsoy	PROPN
dpc-1651	372	2	e	e	PROPN
dpc-1651	372	3	,	,	PUNCT
dpc-1651	372	4	durusoy	durusoy	PROPN
dpc-1651	372	5	c	c	NOUN
dpc-1651	372	6	,	,	PUNCT
dpc-1651	372	7	yilmaz	yilmaz	PROPN
dpc-1651	372	8	e	e	PROPN
dpc-1651	372	9	,	,	PUNCT
dpc-1651	372	10	et	et	PROPN
dpc-1651	372	11	al	al	PROPN
dpc-1651	372	12	.	.	PROPN
dpc-1651	372	13	interferon	interferon	PROPN
dpc-1651	372	14	alfa-2a	alfa-2a	PUNCT
dpc-1651	372	15	in	in	ADP
dpc-1651	372	16	the	the	DET
dpc-1651	372	17	treatment	treatment	NOUN
dpc-1651	372	18	of	of	ADP
dpc-1651	372	19	behçet	behçet	ADJ
dpc-1651	372	20	disease	disease	NOUN
dpc-1651	372	21	:	:	PUNCT
dpc-1651	372	22	a	a	DET
dpc-1651	372	23	randomized	randomized	ADJ
dpc-1651	372	24	placebo	placebo	NOUN
dpc-1651	372	25	-	-	PUNCT
dpc-1651	372	26	controlled	control	VERB
dpc-1651	372	27	and	and	CCONJ
dpc-1651	372	28	double	double	ADJ
dpc-1651	372	29	-	-	PUNCT
dpc-1651	372	30	blind	blind	ADJ
dpc-1651	372	31	study	study	NOUN
dpc-1651	372	32	.	.	PUNCT
dpc-1651	373	1	arch	arch	ADJ
dpc-1651	373	2	dermatol	dermatol	NOUN
dpc-1651	373	3	.	.	PUNCT
dpc-1651	374	1	2002;138(4):467–471	2002;138(4):467–471	X
dpc-1651	374	2	.	.	X
dpc-1651	374	3	doi	doi	NOUN
dpc-1651	374	4	:	:	PUNCT
dpc-1651	374	5	10.1001	10.1001	NUM
dpc-1651	374	6	/	/	SYM
dpc-1651	374	7	archderm.138.4.467	archderm.138.4.467	PROPN
dpc-1651	374	8	.	.	PUNCT
dpc-1651	375	1	pmid	pmid	NOUN
dpc-1651	375	2	:	:	PUNCT
dpc-1651	375	3	11939808	11939808	NUM
dpc-1651	375	4	.	.	PUNCT
dpc-1651	376	1	53	53	NUM
dpc-1651	376	2	.	.	PUNCT
dpc-1651	376	3	dasgeb	dasgeb	PROPN
dpc-1651	376	4	b	b	PROPN
dpc-1651	376	5	,	,	PUNCT
dpc-1651	376	6	kornreich	kornreich	PROPN
dpc-1651	376	7	d	d	NOUN
dpc-1651	376	8	,	,	PUNCT
dpc-1651	376	9	mcguinn	mcguinn	PROPN
dpc-1651	376	10	k	k	PROPN
dpc-1651	376	11	,	,	PUNCT
dpc-1651	376	12	okon	okon	PROPN
dpc-1651	376	13	l	l	PROPN
dpc-1651	376	14	,	,	PUNCT
dpc-1651	376	15	brownell	brownell	PROPN
dpc-1651	376	16	i	i	PROPN
dpc-1651	376	17	,	,	PUNCT
dpc-1651	376	18	sackett	sackett	PROPN
dpc-1651	376	19	dl	dl	PROPN
dpc-1651	376	20	.	.	PROPN
dpc-1651	376	21	colchicine	colchicine	PROPN
dpc-1651	376	22	:	:	PUNCT
dpc-1651	376	23	an	an	DET
dpc-1651	376	24	ancient	ancient	ADJ
dpc-1651	376	25	drug	drug	NOUN
dpc-1651	376	26	with	with	ADP
dpc-1651	376	27	novel	novel	ADJ
dpc-1651	376	28	applications	application	NOUN
dpc-1651	376	29	.	.	PUNCT
dpc-1651	377	1	br	br	PROPN
dpc-1651	377	2	j	j	PROPN
dpc-1651	377	3	dermatol	dermatol	NOUN
dpc-1651	377	4	.	.	PUNCT
dpc-1651	378	1	2018;178(2):350–6	2018;178(2):350–6	NUM
dpc-1651	378	2	.	.	PUNCT
dpc-1651	379	1	doi	doi	NOUN
dpc-1651	379	2	:	:	PUNCT
dpc-1651	379	3	10.1111	10.1111	NUM
dpc-1651	379	4	/	/	SYM
dpc-1651	379	5	bjd.15896	bjd.15896	NOUN
dpc-1651	379	6	.	.	PUNCT
dpc-1651	380	1	pmid	pmid	NOUN
dpc-1651	380	2	:	:	PUNCT
dpc-1651	380	3	28832953	28832953	NUM
dpc-1651	380	4	.	.	PUNCT
dpc-1651	381	1	54	54	NUM
dpc-1651	381	2	.	.	PUNCT
dpc-1651	382	1	harte	harte	PROPN
dpc-1651	382	2	mc	mc	PROPN
dpc-1651	382	3	,	,	PUNCT
dpc-1651	382	4	saunsbury	saunsbury	PROPN
dpc-1651	382	5	ta	ta	PROPN
dpc-1651	382	6	,	,	PUNCT
dpc-1651	382	7	hodgson	hodgson	PROPN
dpc-1651	382	8	ta	ta	PROPN
dpc-1651	382	9	.	.	PUNCT
dpc-1651	383	1	thalidomide	thalidomide	PROPN
dpc-1651	383	2	use	use	NOUN
dpc-1651	383	3	in	in	ADP
dpc-1651	383	4	the	the	DET
dpc-1651	383	5	management	management	NOUN
dpc-1651	383	6	of	of	ADP
dpc-1651	383	7	oromucosal	oromucosal	NOUN
dpc-1651	383	8	disease	disease	NOUN
dpc-1651	383	9	:	:	PUNCT
dpc-1651	383	10	a	a	DET
dpc-1651	383	11	10	10	NUM
dpc-1651	383	12	-	-	PUNCT
dpc-1651	383	13	year	year	NOUN
dpc-1651	383	14	review	review	NOUN
dpc-1651	383	15	of	of	ADP
dpc-1651	383	16	safety	safety	NOUN
dpc-1651	383	17	and	and	CCONJ
dpc-1651	383	18	efficacy	efficacy	NOUN
dpc-1651	383	19	in	in	ADP
dpc-1651	383	20	12	12	NUM
dpc-1651	383	21	patients	patient	NOUN
dpc-1651	383	22	.	.	PUNCT
dpc-1651	384	1	oral	oral	ADJ
dpc-1651	384	2	surg	surg	NOUN
dpc-1651	384	3	oral	oral	ADJ
dpc-1651	384	4	med	med	ADJ
dpc-1651	384	5	oral	oral	ADJ
dpc-1651	384	6	pathol	pathol	NOUN
dpc-1651	384	7	oral	oral	ADJ
dpc-1651	384	8	radiol	radiol	NOUN
dpc-1651	384	9	.	.	PUNCT
dpc-1651	385	1	2020;130(4):398–401	2020;130(4):398–401	PROPN
dpc-1651	385	2	.	.	PUNCT
dpc-1651	385	3	doi	doi	PROPN
dpc-1651	385	4	:	:	PUNCT
dpc-1651	385	5	10.1016	10.1016	NUM
dpc-1651	385	6	/	/	SYM
dpc-1651	385	7	j.	j.	PROPN
dpc-1651	385	8	oooo.2020.06.009	oooo.2020.06.009	PROPN
dpc-1651	385	9	.	.	PUNCT
dpc-1651	386	1	pmid	pmid	NOUN
dpc-1651	386	2	:	:	PUNCT
dpc-1651	386	3	32622799	32622799	NUM
dpc-1651	386	4	.	.	PUNCT
dpc-1651	387	1	55	55	NUM
dpc-1651	387	2	.	.	PUNCT
dpc-1651	388	1	radulescu	radulescu	PROPN
dpc-1651	388	2	m.	m.	PROPN
dpc-1651	388	3	the	the	DET
dpc-1651	388	4	pharmacologic	pharmacologic	ADJ
dpc-1651	388	5	management	management	NOUN
dpc-1651	388	6	of	of	ADP
dpc-1651	388	7	common	common	ADJ
dpc-1651	388	8	lesions	lesion	NOUN
dpc-1651	388	9	of	of	ADP
dpc-1651	388	10	the	the	DET
dpc-1651	388	11	oral	oral	ADJ
dpc-1651	388	12	cavity	cavity	NOUN
dpc-1651	388	13	.	.	PUNCT
dpc-1651	389	1	dent	dent	PROPN
dpc-1651	389	2	clin	clin	PROPN
dpc-1651	389	3	north	north	PROPN
dpc-1651	389	4	am	am	PROPN
dpc-1651	389	5	.	.	PUNCT
dpc-1651	390	1	2016;60(2):407	2016;60(2):407	NOUN
dpc-1651	390	2	–	–	PUNCT
dpc-1651	390	3	420	420	NUM
dpc-1651	390	4	.	.	PUNCT
dpc-1651	391	1	doi	doi	NOUN
dpc-1651	391	2	:	:	PUNCT
dpc-1651	391	3	10.1016	10.1016	NUM
dpc-1651	391	4	/	/	SYM
dpc-1651	391	5	j.cden.2015.12.003	j.cden.2015.12.003	PROPN
dpc-1651	391	6	.	.	PUNCT
dpc-1651	392	1	pmid	pmid	NOUN
dpc-1651	392	2	:	:	PUNCT
dpc-1651	392	3	27040292	27040292	NUM
dpc-1651	392	4	.	.	PUNCT
dpc-1651	393	1	56	56	NUM
dpc-1651	393	2	.	.	X
dpc-1651	393	3	akerzoul	akerzoul	PROPN
dpc-1651	393	4	n	n	CCONJ
dpc-1651	393	5	,	,	PUNCT
dpc-1651	393	6	chbicheb	chbicheb	PROPN
dpc-1651	393	7	s.	s.	PROPN
dpc-1651	393	8	low	low	PROPN
dpc-1651	393	9	laser	laser	PROPN
dpc-1651	393	10	therapy	therapy	NOUN
dpc-1651	393	11	as	as	ADP
dpc-1651	393	12	an	an	DET
dpc-1651	393	13	effective	effective	ADJ
dpc-1651	393	14	treatment	treatment	NOUN
dpc-1651	393	15	of	of	ADP
dpc-1651	393	16	recurrent	recurrent	ADJ
dpc-1651	393	17	aphtous	aphtous	ADJ
dpc-1651	393	18	ulcers	ulcer	NOUN
dpc-1651	393	19	:	:	PUNCT
dpc-1651	393	20	a	a	DET
dpc-1651	393	21	clinical	clinical	ADJ
dpc-1651	393	22	case	case	NOUN
dpc-1651	393	23	reporting	report	VERB
dpc-1651	393	24	two	two	NUM
dpc-1651	393	25	locations	location	NOUN
dpc-1651	393	26	.	.	PUNCT
dpc-1651	394	1	pan	pan	PROPN
dpc-1651	394	2	afr	afr	PROPN
dpc-1651	394	3	med	med	PROPN
dpc-1651	394	4	j.	j.	PROPN
dpc-1651	394	5	2018;30:205	2018;30:205	PROPN
dpc-1651	394	6	.	.	PUNCT
dpc-1651	395	1	pmid	pmid	NOUN
dpc-1651	395	2	:	:	PUNCT
dpc-1651	395	3	30574224	30574224	NUM
dpc-1651	395	4	.	.	PUNCT